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The 2018 edition of the EU Industrial R&D Investment 
Scoreboard (the Scoreboard) comprises the 2500 
companies investing the largest sums in R&D in the world 
in 2017/18. These companies, based in 46 countries, each 
invested over €25 million in R&D for a total of €736.4bn 
which is approximately 90% of the world’s business-
funded R&D. They include 577 EU companies accounting 
for 27% of the total, 778 US companies for 37%, 339 
Japanese companies for 14%, 438 Chinese for 10% and 
368 from the rest-of-the-world (RoW) for 12%. 
This report analyses the main changes in companies’ 
R&D and economic indicators over the past year and their 
performance over the past ten years. It also includes a 
patent-based analysis aimed at characterising further the 
innovation activity of the business sector in the 28 member 
states of the EU. Finally, the report comprises a 10-year 
analysis of the performance of Scoreboard companies 
based in Asian countries, examining in particular the role 
of foreign direct investment and related mergers and 
acquisitions. 
Summary
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Highlights
1 The top 2500 global R&D companies in the Scoreboard (all with R&D over €25m) account for approximately 90% of the world’s business-funded R&D. They invested €736.4 in R&D 
in 2017/18, up 8.3% on the previous year. The major contributors were the US (37%), the EU 
(27%), Japan (14%) and China (10%) followed by South Korea and Switzerland (4% each). Over 
the last decade, the EU has maintained a 26-27% share and the main change has been an 
increasing share for China with a decreasing share for Japan.
2 R&D is very concentrated with the top 10 companies contributing 15%, the top 50 40% and the top 100 53% of the total global 2500 R&D. Within the top 50 there are 18 based in the EU, 22 
US companies, 6 from Japan, 2 from Switzerland and one each from South Korea and China. 
Samsung is the top R&D investor (with €13.44bn) followed by Alphabet and Volkswagen.
3 The R&D sector specialisations of the four main regions are very different. The EU has 20.1% in ICT, 22.4% in health but 30.5% in automotive in contrast to the US with 51.4% of its R&D in 
ICT with 26.7% in health and only 7.8% in automotive. Japan has many similarities with the EU 
having 24.9% in ICT, 30.8% in automotive but only 12.4% in health. China has some similarities 
with the US having 44.7% in ICT, 11.4% in automotive but only 3.4% in health.  
4 Worldwide R&D growth in 2017/18 was driven by the ICT sector followed by health with M&A contributing to growth in most sectors. Since 2009 ICT services has shown the highest growth 
followed by automotive and ICT producers. The regional trends over the years are very clear with 
US companies increasing their share of the global ICT services sector with the EU’s reducing 
whereas EU companies’ share of automotive has increased with the US’s decreasing. These 
share differences are magnified by similar sector intensity differences.
5 R&D intensity (the R&D/sales ratio) varies substantially between sectors with the highest in-tensity for the high tech ICT and health sectors followed by medium tech sectors such as auto-
motive and engineering. The differences in sector specialisation for different regions lead to big 
differences in regional R&D intensity with the US averaging 6.3%, the EU and Japan 3.4% and 
China 2.8%. The sectoral intensity gaps have been increasing over the last few years with the 
EU companies widening their automotive intensity lead over those of the US and China but the 
US widening its intensity lead over the EU and China in both ICT and health. The EU gap in ICT 
is illustrated by the EU’s one large software firm out of the 16 ranked in the global top 150. But 
there are 109 EU software companies in the EU1000 - more need to grow into global players.
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6 The top 50 largest companies by R&D intensity are dominated by firms from ICT (24) and health (23) with the EU accounting for 14 of the companies, the US 25, Asia 9 and Switzerland 
2. Furthermore, out of the 250 companies with R&D over €500m, there are only 30 with R&D 
intensity, R&D growth and sales growth of at least 10%. These companies, 22 from ICT and 5 
from biopharma, are based in the US (22) and the EU and Asia (4 each).
7 The Scoreboard includes a separate listing of 1000 EU companies with R&D over €8m. The EU1000 shows a high degree of R&D concentration with 97% of the R&D from the 577 EU 
companies also in the global 2500 and 97% from the top 10 member states. The three larg-
est countries (Germany, the UK and France) contribute 68% of both total R&D and total sales. 
For the three largest countries the largest contributing sectors are automotive (29.7%), health 
(22.3%) and ICT (15.5%). Most German R&D is in medium-high tech sectors (primarily automo-
tive), the UK’s in high tech (primarily pharmaceutical) but France has more of a balance for high/
medium-high tech sectors.
8 The 2018 Scoreboard contains a study mapping business patents in the 28 member states of the EU, comparing the location of patent’s inventors and applicants (ownership). The results 
reveal a contrasting picture of inventorship vs ownership across the EU, i.e. in many countries 
a high proportion of local inventions are owned by foreign companies and, on the contrary, in a 
few countries, the number of applicants is much higher than the local inventions. The study also 
shows differing concentrations of ownership with the top three companies owning 30-60% of 
patents in many smaller countries but only 9-12% for the three largest countries.
9 Lastly, the 2018 Scoreboard examines 10-year performance of companies based in Asia and look in particular at the important and growing role played by FDI and cross-border M&As.  M&A 
activity towards the EU from Asian companies has grown substantially even if it is still small 
compared with the M&A from other regions towards the EU. Nearly all of Asia’s growth of out-
ward M&A activity is due to Chinese firms that increased M&A activity towards EU firms by more 
than fivefold, approaching the level of foreign M&As of Japan. A strong R&D intensity increase 
for the acquiring Chinese firms suggests that they have expanded their knowledge base by the 
acquisition of foreign companies. 
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The top 2500 Scoreboard companies invested in R&D 
€736.4bn in 2017/18, an increase of 8.3% with respect to 
the previous period1. Companies also raised most financial 
indicators: net sales reversed the negative trend shown 
since 2011, increasing more than the R&D investment 
(9.8%); overall profits showed an impressive growth of 
22.6%; capital expenditures recovered after 3 negative 
years (5.1%) and the number of employees continued to 
increase at a modest pace (2.1%). See evolution of key 
figures over the past 10 years in Figure S1.
 Worldwide, companies continued to increase significantly their R&D investments in 
2017/18 for the eighth consecutive year while showing good performance in most 
financial indicators.
 R&D growth worldwide led by ICT and Health industries while economic performance 
varied across sectors
Key findings
1 The apparent decrease from 2017 to 2018 is due to the appreciation of the Euro against most currencies. If the 2018 Scoreboard R&D is expressed at 2017 Scoreboard 
exchange rates, the total R&D for the 2500 companies is €800bn (see details in Annex 2 – Box A2.1 and Table A2.1).
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FIGURE S1: GLOBAL GROWTH RATE OF R&D AND NET SALES AND PROFITABILITY FOR THE PERIOD 2008-2017.
Note: Growth rates for the three variables have been computed on 1674 out of the 2500 companies for which data are available for the entire period 2008-2017.
Source: The 2018 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
Worldwide R&D growth was driven by the ICT services 
and producers sectors (13% and 11% respectively), 
followed by the Health sector (7.7%) while the lowest R&D 
performance was shown by the Industrials sector (3.3%) 
and by Aerospace & Defence (-4.3%). 
The growth in net sales was led by oil-related companies 
due to the recovery of oil prices but significant increases 
were reported also in Automobiles, ICT industries and in 
the Industrials sector. The overall increase of profits was 
mostly due to oil-related companies but profits’ growth 
of more than 20% were reported by ICT producers and 
Aerospace & Defence sectors while Health industries 
showed a decline in profits. The increases in Capex were 
observed especially in the ICT producers sector and also in 
oil-related companies. 
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 Other indicators of EU companies showed mixed performance
 Best R&D performance in the EU shown in Automobiles, Health and ICT industries
The 577 companies based in the EU invested €200.1bn in 
R&D, an important increase in this period (5.5%) although 
at a lower pace than in the previous year (6.7%). The 
Japanese companies presented a similar R&D growth rate 
than their EU counterparts (5.8%) while companies based 
in the US and China showed a much higher R&D growth 
rates (9.0% and 20.0% respectively). See comparison of 
EU and global companies’ R&D growth in Figure S2.
 R&D growth of EU companies below the world’s average growth rate 
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FIGURE S2: NOMINAL CHANGE OF R&D OVER THE PAST YEAR FOR THE EU AND WORLD SAMPLES OF COMPANIES.
Note: Growth rates have been computed for 566 EU and 2493 World companies for which R&D data are available for both years 2016 and 2017.
Source: The 2018 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
The net sales of the companies based in the EU reached 
€5.8trillion, 9% more than in the previous year. Net sales 
increases were registered in all industries. The best sales 
performance was shown in oil-related sectors but other 
industries showed also sales performance above the 
average, e.g. Chemicals (10.4%). 
The EU companies increased modestly capital expenditures 
(1.7%). The best performance of EU companies was 
in terms of profits (37.5%), which lead to a significant 
increase of their profitability level (from 7.6% to 10.1%). 
The 577 EU companies employed 19.4million people, just 
1.3% more than the year before.
For the EU sample, the largest contribution to R&D growth 
was made by Automobiles (6.1%), Health industries (4.6%) 
and ICT services (13.3%) and the lowest contributions 
made by Aerospace & Defence (0.9%) and Chemicals 
(0.6%). Among the largest member states, German and 
French companies showed the highest R&D growth (6.3% 
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and 8.1% respectively) while companies based in the 
Netherlands increased R&D only by a modest 0.6%.
In the EU sample, R&D growth was led by auto-
motive companies such as DAIMLER (15%), BMW 
(18%) and PEUGEOT (24%), and from other sec-
tors GLAXOSMITHKLINE (14%), SCHNEIDER (50%) 
and SIEMENS (10%). The poorest R&D performance 
was shown by ALLERGAN (-27%) and VOLKSWAGEN 
(-4%). R&D growth for some of these companies 
was increased by acquisitions, these included Peu-
geot which purchased GM Europe (Vauxhall/Opel) in 
mid-2017 and Schneider which made 5 acquisitions 
in 2017.
Worldwide an important sector shift occurred in ICT 
industries, mainly in ICT services that increased their R&D 
share from 10.8% to 14.2% but also in ICT producers 
(from 23.0% to 23.7%). On the other hand, sectors that 
underwent a decreases in R&D shares were mainly low-
tech sectors and also, to a lesser extent, Industrials, 
Aerospace & Defence and Chemicals. See Figure S3.
The largest contribution to the R&D growth of non-EU 
companies was made by ICT producers, ICT services, 
and Health industries with a negative contribution by the 
Aerospace & Defence sector. In the non-EU group, top R&D 
companies showing high R&D growth were MERCK US 
(49%), ALPHABET (18%), HUAWEI (17%), DELL (67%) and 
FACEBOOK (31%). The poorest performance was shown by 
BOEING (-33%), TOSHIBA (-39%) and HEWLETT PACKARD 
(-35%). Amongst these, acquisitions/divestments were 
important for Dell which acquired EMC and Hewlett 
Packard which sold its software division to Microfocus. 
Merck (US) acquired Afferent Pharma, Staywell and IOmet 
and Rigontec, Kalvista and Valee.
 Non-EU companies’ R&D growth also led by ICT and Health industries
 The high number of EU companies at the top of the world R&D ranking remains 
stable over time
In this Scoreboard edition, the top R&D investor is 
SAMSUNG (€13.44bn) from South Korea. The 2nd position 
is taken by the US company ALPHABET (€13.39) and 
the 3rd one for the German company VOLKSWAGEN 
(€13.14bn). 
There is a high number of EU companies among the top 
R&D investors: 2 companies in the top 10, 18 companies 
in the top 50 (same number as in 2004) and 32 companies 
in the top 100. 
Among the top 100 R&D investors, the number of EU and 
non-EU companies is similar for the Automobiles sector 
(11 vs 9) and Aerospace & Defence (2 each), however 
these numbers are very different in ICT industries (5 vs 29) 
and Health (10 vs 17).
The world top 50 companies ordered by R&D intensity are 
naturally almost all from the high tech industries of ICT 
(24) and Health (23) and are based in the EU (14), US (25), 
Asia (9) and Switzerland (2).
 Over the past 10 years, the rapid R&D growth in Health, Automobiles and ICT 
industries reshaped the industrial structure
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 In terms of R&D intensity, EU companies are lagging as compared with the US and 
are being challenged by their Chinese counterparts
EU companies reinforced their specialisation in medium-
high tech sectors, increasing their R&D contribution to the 
global R&D of Automobiles by more than 6 percentage 
points. In contrast, EU companies reduced their global R&D 
share in ICT industries by more than 8 percentage points 
and to a lesser extent in low tech and Chemicals sectors. 
See Figure S4. 
In line with the R&D shift, the net sales of EU companies 
increased their global weight in Automobiles, Aerospace 
& Defence and Health industries while decreasing 
it sharply in ICT industries and to a lesser extent in low 
tech. 
Among non-EU companies, the main R&D shift was 
observed by US companies that strengthened their 
position in high tech sectors, especially in ICT services and 
Health. Companies based in Asia underwent contrasting 
changes in global R&D shares, the Chinese companies 
increased their global R&D shares, especially in ICT and 
low tech sectors, whereas those of Japanese companies 
fell across the bord.
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FIGURE S3: EVOLUTION OF THE GLOBAL R&D INVESTMENT FOR INDUSTRIAL SECTORS.
Note: Figures displayed refer only to the 1674 companies (398 EU; 516 US; 326 Japan; 149 China; 285 RoW) with R&D data available for the all period 2008-2017
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE S4: GLOBAL R&D SHARE OF EU COMPANIES FOR INDUSTRIAL SECTORS IN 2008 AND 2017.
Note: Calculated for a sample of 1674 companies for which data are available for the entire period 2008-2017.
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
A comparison of the R&D intensity differences of the EU 
against US and Chinese companies over the past 6 years 
shows an increasing gap vis-à-vis the US and a positive 
difference against China that is decreasing over time. See 
Figure S5 and details in Chapter 3.
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Against the US, the R&D intensity gap is explained by both 
structural factors (higher share of high tec sectors for US) 
and intrinsic factors (higher US’ R&D intensities by sector). 
More specifically, the EU/US gap is mostly determined by 
increasing R&D intensity differences in ICT services, ICT pro-
ducers and Health industries whereas in Automobiles the EU 
shows an increasing positive R&D intensity difference.
The positive R&D intensity difference with the Chinese 
companies, explained by both intrinsic and structural fac-
tors, is decreasing due to a faster R&D growth of Chinese 
companies in ICT industries than the R&D growth of the EU 
in Automobiles, Health and Aerospace & Defence. See the 
EU/US and EU/China R&D intensity differences by sector in 
Figure S6. 
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FIGURE S5: EVOLUTION OF THE AVERAGE R&D INTENSITY FOR THE EU, US AND CHINESE SAMPLE OF COMPANIES.
Note: R&D intensity have been computed for 497 EU, 623 US and 376 Chinese companies for which R&D and Net Sales data are available for the entire period 2012-2017.
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE S6: R&D INTENSITY DIFFERENCES OF THE EU AGAINST US AND CHINESE COMPANIES FOR INDUSTRIAL SECTORS IN 2017/18.
Note: R&D intensity have been computed for 497 EU, 623 US and 376 Chinese companies for which R&D and Net Sales data are available for the entire period 2012-2017.
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
 Mapping business patents according to inventors and owners reveals contrasting 
pictures of innovation performance across the EU
The analysis of the location of patents’ inventors and 
applicants (ownership) shows that in the majority of 
cases, the number of patents invented in a country is 
much higher than the number of patents owned by local 
companies. These numbers are balanced in Denmark, 
France and Germany whereas in some countries the 
proportion of applicants is very high (in Cyprus, Luxemburg 
and Malta the number of applicants is between 4 and 10 
times larger than the number of inventions). See Table S1.
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The study also shows that Germany and the US compare 
as the most frequent second location of ownership for 
patents invented in EU countries (10 and 8 respectively). 
Moreover, business patents in some countries appear very 
much concentrated by a few companies, e.g. the ownership 
share of the top three companies is particularly high in 
Romania, Lithuania and The Netherlands (60%, 51% and 
44% respectively). In contrast, the patent concentration by 
the top three companies is much lower in Italy (5%) and 
the UK (9%).
Inventor Country
Patents by applicant 
versus inventor (% 
differences)
1st applicant country 
(ownership)
2nd applicant country 
(ownership)
Share of  
top 3 companies
Romania -85% Germany Romania 60%
Croatia -69% Croatia UK 41%
Hungary -63% Hungary Germany 37%
Slovakia -49% Slovakia Germany 16%
Czechia -40% Czechia Germany 15%
Poland -36% Poland Switzerland 14%
Greece -36% Greece US 29%
Estonia -35% Estonia Germany 25%
Lithuania -33% Lithuania Germany 51%
UK -31% UK US 9%
Slovenia -30% Slovenia Germany 20%
Bulgaria -30% Bulgaria US 15%
Spain -29% Spain Germany 14%
Italy -16% Italy Sweden 5%
Portugal -15% Portugal Germany 19%
Belgium -13% Belgium US 14%
Latvia -12% Latvia Finland 24%
Austria -7% Austria Germany 10%
Denmark -1% Denmark Germany 17%
France 1% France Switzerland 10%
Germany 1% Germany US 12%
Ireland 13% Ireland US 27%
Finland 14% Finland Switzerland 31%
Sweden 19% Sweden Switzerland 33%
Netherlands 23% Netherlands US 44%
Cyprus 371% Cyprus UK 39%
Luxembourg 484% Luxembourg US 42%
Malta 968% Malta Luxembourg 31%
TABLE S1: PATENTS IN THE EU’S BUSINESS SECTOR: DIFFERENCE BETWEEN APPLICANTS AND INVENTORS, AND CONCENTRATION (2013-2015).
Note: relative differences when counting patents by applicant rather than by inventor.
Source: own computation on Patstat 20118A.
Expansion of Asian firms (in the form of M&A activity) 
towards the EU has grown by almost 150% over the period 
2007 to 2016, but is still small compared to M&A activity 
from the US and RoW towards the EU. Asian firms perform 
the highest proportion of M&As within the region itself 
indicating the size and importance of its internal market. 
M&A activity outside Asia as of 2016 is mainly aimed at 
the EU and US, both having gained importance over the 
RoW during the 10 year period under analysis. 
Importantly, nearly all of Asia’s growth of outward M&A 
activity is due to Chinese firms that increased M&A 
activity towards EU firms by more than fivefold and 
approaching the level of foreign M&As of Japan by 
2016. Where Chinese foreign M&A activity has grown 
considerably, Japanese firms show a stable development 
over time.
 An analysis of 10-year performance of Scoreboard companies based in Asia shows 
the important and growing role of FDI and cross-border M&As 
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The 2018 edition of the “EU Industrial R&D Investment 
Scoreboard” (the Scoreboard)2 comprises the 2500 
companies investing the largest sums in R&D in 
the world and an additional 422 companies to provide 
data on the top 1000 R&D investing companies 
based in the EU3. In total, there are 2922 companies 
incorporated in the 2018 Scoreboard. 
The Scoreboard is based on information taken from the 
companies’ latest published accounts. For most companies 
these correspond to calendar year 2017, but significant 
number of companies have financial years ending on 31 
March 2017 (Japanese companies in particular). There are 
few companies included with financial years ending as 
late as end June 2018 and a few for which only accounts 
to end 2016 were available.
In order to avoid double counting, The Scoreboard considers 
only data from parent or independent companies. Normally, 
these companies integrate into their consolidated accounts 
the data of their subsidiary companies. 
It should be noted that the Scoreboard relies on the disclosure 
of R&D investment in companies’ published annual reports 
and accounts, and that due to different national accounting 
and disclosure practices; companies of some countries 
are less likely than others to disclose R&D investment 
consistently. For example, it is a legal requirement in some 
countries that R&D investment is disclosed in company 
annual reports. For these reasons, companies from some 
countries such as Southern or Eastern European countries 
might be under-represented while others such as the 
companies from the UK could be over-represented. 
The overall coverage in terms of R&D is similar to 
previous editions. The total amount of R&D investment 
of companies included in the 2018 Scoreboard (€736.4 
billion) is equivalent to 90% of the total expenditure on 
R&D financed by the business sector worldwide4.
The Scoreboard collects key information to enable the 
assessment of the R&D and economic performance of 
companies. The main indicators, namely R&D investment, 
net sales, capital expenditures, operating profits, number 
of employees and market capitalisation are collected 
following the same methodology, definitions and 
assumptions applied in previous editions. This ensures 
comparability so that the companies’ economic and 
financial data can be analysed over a longer period of 
time. 
The capacity of data collection is enhanced by information 
gathered about the ownership structure of the Scoreboard 
parent companies and the main indicators for their 
subsidiaries. In 2018, we have collected available 
indicators reported by the more than 700.000 subsidiary 
companies involved in this Scoreboard edition. This allows 
a better characterisation of companies, in particular 
regarding the sectoral and geographic distribution of their 
research and production activities and the related patterns 
of growth and employment. 
As shown in last year’s Scoreboard, the analysis of key 
indicators such as patent data of parent companies and 
their subsidiaries allows the reassignment of companies 
to countries where they perform their actual economic or 
innovation activity. 
In this edition we have continued to use patent data to 
characterise the innovation activity of the business sector 
throughout the 28 member states of the EU. 
2 The EU Industrial R&D Investment Scoreboard is published annually by the European Commission (JRC-Seville/DG RTD) as part of the GLORIA project (Global Industrial 
Research & Innovation Analyses). GLORIA is the follow-up of the IRIMA project (Industrial Research and Innovation Monitoring and Analysis). See: http://iri.jrc.ec.europa.eu/
home/.
3 In this report, the term EU company refers to companies whose ultimate parent has its registered office in a Member State of the EU. Likewise, non-EU company applies 
when the ultimate parent company is located outside the EU (see also the glossary and definitions in Annex 2 as well as the handling of parent companies and subsidiaries).
4 According to the latest figures reported by Eurostat (see Figure 1.1 in Chapter 1).
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Report structure 
In this edition, we follow the same structure of the 
2017 EU R&D Scoreboard report, including an extensive 
description of the dataset, an overview of main changes 
in R&D and economic performance over the past year and 
emphasising long-term analyses supported by our history 
database.
In chapter 1 we provide an overview of the main 
characteristics of the industrial R&D, including the main 
economic factors and technological drivers that have 
shaped R&D investments over the past year. The dataset 
of this Scoreboard edition is described in detail and, in 
particular, the geographic and sector distribution of R&D 
and its concentration at company, industry and country 
levels.
Chapter 2 presents an overview of global trends for 
industrial R&D. It outlines the main indicators for the top 
2500 companies and the main changes that took place 
over the past year. Companies are aggregated by industry 
and world region to analyse their performance in terms of 
R&D, net sales, profitability and employment over the past 
10 years.
Chapter 3 presents an analysis of the main R&D and 
economic indicators of companies aggregated by industrial 
sector, with comparisons of EU companies and their main 
worldwide counterparts. This chapter also includes an 
analysis of the nature and evolution of the R&D intensity 
differences between the EU companies and their US and 
Chinese counterparts. 
The performance of individual companies among the top 
R&D investors is analysed in chapter 4. The list of the top 
50 and top 100 R&D companies is examined highlighting 
those companies showing remarkable R&D and economic 
results and improvement in their R&D ranking over the last 
14 years. It also includes an analysis of the ranking of the 
top 50 large companies by R&D intensity.
Chapter 5 discusses trends in the R&D and economic 
performance of companies included in the extended 
sample comprising the top 1000 R&D investors based in 
the EU and focuses on the ten largest countries of the EU 
accounting for more than 98% of the total R&D of the 
sample of all 1000 companies based in the EU. 
Chapter 6 presents the results of a patent-based study 
aimed at characterising further the innovation activity 
of the business sector in the EU and particularly in the 
member states not represented by the Scoreboard 
dataset. This shows the inventorship-ownership patterns 
for the EU-28 member states by examining the location of 
patents’ applicants and inventors of the business sector.
Finally, chapter 7 examines ten year trends for top R&D 
companies in Asia compared to those in the EU and US, 
investigating, in particular, the role of FDI and related 
M&As in the performance of companies based in Asia.
The data have been collected by Bureau van Dijk – A 
Moody’s Analytics Company, following the same approach 
and methodology applied since the first Scoreboard 
edition in 2004. For background information please see 
Annex 1. 
The methodological approach of the Scoreboard, its 
scope and limitations are described in Annex 2, including a 
summary of main caveats in Box A2.1.
Annex 3 provides two complementary tables. The first 
one regarding main statistics for the world sample of 
companies aggregated by industrial sectors and the 
second one about the sector and country composition of 
the EU 1000 sample. The access to the full dataset is 
shown in Annex 4. 
The complete data set is freely accessible online at: http://
iri.jrc.ec.europa.eu/scoreboard18.html.
1 THE INDUSTRIALR&D LANDSCAPE
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This chapter provides an overview of global industrial R&D and the main economic factors and technological drivers that 
have shaped corporate R&D investments over the past year. It outlines the main characteristics of the 2018 Scoreboard 
dataset, including the distribution of companies and their R&D investments by country, world region and industrial sector. 
The industrial R&D landscape1
The top 2500 global R&D companies invested €736.4bn in R&D in 2017/18, accounting 
for 90% of the world’s business-funded R&D. Industrial R&D is very concentrated in 
few companies and sectors. The top 100 R&D investing companies are responsible 
for half of the total R&D and the four largest R&D investing sectors account for three 
quarters of the global 2500 R&D.
1.1 | Economic context and technological drivers
1.1.1 Economic environment for the Scoreboard companies in 2017/18
This section summarises the main economic factors and technological trends that affected companies’ R&D investment 
in the period 2017/18 covered by this report.
There were four major economic and governmental issues 
affecting the business environment for R&D companies 
in 2017/18. These were interest rates & exchange rates, 
growth rates of the major world economies, oil prices and 
the trade dispute between the US and China, which is 
also affecting some other countries. These four issues are 
discussed below. September 2018 also marked the ten 
year anniversary of the collapse of Lehman Brothers which 
was the event that triggered the financial crisis. Ten years 
on there is much good news to point to with banks better 
capitalised, asset prices recovered, solid global economic 
growth and low inflation in most advanced economies. 
However, the Bank of International Settlements reports 
that global debt in 2017 stood at 217% of global GDP 
compared to 179% in 2007 with a 56% increase in the 
debt of emerging market economies compared to 15% 
for advanced economies. But the make-up of this debt 
has changed with households less indebted but non-
financial corporates and governments more indebted. In 
the latter case this is partly due to the costs of responding 
to the crisis. The emerging market debt rise includes a big 
increase in Chinese debt, an area of concern.
Interest rates and exchange rates
Interest rates are important for companies since they 
determine the cost of borrowing for investment. The 
trend in 2017/18 has been for central banks to take 
steps to normalise policy so that they have firepower 
available in the event of another financial crisis. In the 
US the Federal Reserve has ended its QE (Quantitative 
Easing) programme and moved on to quantitative 
tightening (selling the bonds it bought during the crisis) 
and, given the strength of the US economy, has been able 
to raise interest rates three times in 2018 (March, June, 
September) to reach a 2-2.25% range in September. This 
follows three rises in 2017. Given that US unemployment 
has fallen to its lowest level for 49 years. The Bank of 
England has ended its QE programme, raised rates twice 
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during 2017/18 to a level of 0.75% in August 2018 
and is likely to raise them again. The ECB is ending its 
€2.4trn QE bond-buying programme in December 2018 
having reduced it for the final three months of the year 
but is expected to maintain its record low interest rates 
until summer 2019. Even in Japan the central bank has 
allowed long-term interest rates to rise slightly. This 
means that, after 10 years, emergency monetary policy 
is being withdrawn – slowly in most economies but faster 
in the US.
One of the effects of the Fed’s interest rate rises and of 
emerging market debt is that the dollar has appreciated 
(from 1€=$1.25 in February 2018 to 1€=$1.13 in late 
October) with corresponding falls for emerging market 
currencies, particularly for those countries that have debts 
denominated in dollars which are now more difficult to ser-
vice or pay back. From January to mid-September 2018 
the Argentinian peso was down 104%, Turkish lira down 
70%, Brazilian real down 25%, S. African rand down 22%, 
Russian rouble down 18% and Indian rupee down 14%.
The IMF’s July and October 2018 world economic outlooks 
for 2018/19 highlighted mounting risks to its April 2018 
outlook with growth projections revised down for the euro 
area and Japan. World output is now expected to grow 
by 3.7% in both 2018 and 2019. Advanced economies 
are projected to grow 2.4% and 2.1% in 2018 and 2019 
respectively with US growth 2.9% /2.5% (2018/2019), the 
euro area 2.2%/1.9% and Japan 1.0%/ 0.9%. Emerging 
and developing economies are expected to average 4.7% 
for both 2018 and 2019 with China 6.6%/6.2% (but 
remember there are doubts about China’s official growth 
statistics) and India 7.3%/7.4%. China has reduced the 
reserve requirements of its banks four times during 2018 to 
try to shore up its growth rate. In the US the combination of 
President Trump’s tax cuts and strong economic growth led 
to booming second quarter 2018 profits for the corporate 
sector. Under the new US tax rules, US companies now 
have a minimum global tax rate of 13.1% rising to 16.4%. 
If all profits were, say, booked through Ireland at 12.5%, 
the company would have to pay the difference to the US 
IRS. The US tax changes also mean that much of the US 
company cash previously parked offshore to avoid US tax 
is now finding its way back to the US and this could be 
used to increase M&A activity.
Oil prices rose from an average of $53 in 2017 to an 
expected $69 average for 2018. The IMF’s October 
outlook suggested that oil prices should be stable in 2019 
averaging $69. However, given the increase in the oil 
price to around $85 in late September 2018 it is always 
possible that the $69 may prove to be optimistic and 
higher prices in 2019 would add to inflationary pressures. 
The higher price level for 2018/19 compared to 2017 
suggests an increase in oil exploration activity and an 
improved outlook for oil service companies. Increased 
US shale oil production has helped to stabilise prices. 
In September 2018 the US became the world’s largest 
producer of crude oil for the first time since 1973. US oil 
production In August 2018 rose above 11 million bpd 
putting the US ahead of Russia thanks to US shale. The 
IMF’s commodity price index was up 3.3% from February 
to August 2018 driven by higher energy prices (energy up 
but food & metals prices down).
Growth rates of the major economies
Oil and commodity prices
Trade tensions
The trade dispute between the US and China appears to be 
mainly based on a US perception of intellectual property 
(IP) theft and unfair trade practices by China such as 
government subsidies. The US has a $375bn trade deficit 
with China and claims IP theft of another $300bn annually. 
The US Trade Representative Report of 2017 estimated IP 
theft by China at $225bn to $600bn per year. Examples 
of IP theft include direct theft from US companies by 
both hackers and ethnic Chinese staff of trade secrets, 
counterfeiting of famous brands and forced technology 
transfer or mandatory joint ventures as a condition for 
doing business in China. IP theft plus higher Chinese 
tariffs on many products, non-tariff barriers, failure to deal 
with counterfeiters and government subsidies to Chinese 
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companies are blamed for increasing the trade deficit and 
costing US jobs. However, although US tariff increases 
have overwhelmingly been directed against China they 
have also, for example, included steel and aluminium 
tariffs against Canada, the EU and Mexico. Agreement 
was recently reached by the US, Canada and Mexico on a 
new agreement (USMCA) to replace NAFTA in 2020 and, 
assuming this is ratified, it should reduce tensions in North 
America. Any further escalation of national tariffs through 
2019 could negatively affect global economic growth and 
is a major uncertainty facing companies.
The majority of R&D in the Scoreboard is carried out by 
advanced economy companies and R&D directors in those 
companies are likely to have been negotiating their 2019 
budgets with their CEOs in the last few months of 2018. 
Many CEOs have been enjoying increased profits (US Q2 
corporate profits were up 16.3% on Q2 2017) and will 
be expecting global economic growth in 2019 although 
slightly less than in 2018 together with fairly low inflation 
in advanced economies, reasonably stable oil prices but 
concerns over lower home currency sales from emerging 
markets due to currency changes. However, there are 
clouds on the horizon exemplified by the falls in share and 
bond prices in mid-October triggered by an IMF warning 
of ‘dangerous undercurrents’ and the Fed predicting 
further interest rate rises. The risks include record global 
debt, very high debt in certain countries, escalating trade 
tensions (particularly US/China), rising interest rates and 
the risk of a no-deal Brexit. In the medium term, companies 
with substantial debt will also face a risk from rising 
interest rates as interest rate normalisation progresses, 
led by the US. Overall, most R&D directors should be able 
to negotiate higher budgets for 2019 but not by as much 
as most expected earlier in the year. But this carries the 
proviso that the predicted global growth for 2019 is not 
threatened much more by increased trade friction. 
Summary of companies’ economic context
In 2017/18 the three main technological areas where R&D 
is developing new and improved products for the future 
are biotechnology, software /AI (artificial intelligence) and 
new/improved materials. Examples of new developments 
in these three areas include cancer immunotherapies, 
gene and stem cell therapies, software robots to automate 
back office processes, graphene and solid state batteries. 
Autonomous electric vehicles provide an example involving 
two of these areas (software/AI and new materials). 
Biologically compatible structures that facilitate the 
sustained release of hormones or enzymes provide 
another example involving two areas. A third example 
is digital health and the use of AI in drug discovery, in 
planning clinical trials and in diagnostics. Digital health 
start-ups in the US attracted nearly $6bn of investment 
in 2017. And radiotherapy company Elekta (Sweden) has 
partnered with IBM (US) to incorporate AI into its MOSAIQ 
oncology treatment management system.
The advent of new and rapidly developing technologies 
can be challenging for existing large companies with 
sizeable market shares in fields likely to be substantially 
affected by new technologies. Examples include Kodak (US) 
which failed to make the transition to digital photography, 
Nokia (Finland), the leader in mobile phones, which failed 
to make the transition to smartphones and Blockbuster 
video which was surpassed by Netflix (US). Even when 
a company invents a new technology as Xerox did with 
the mouse-driven PC, it may fail to bring it to market; in 
this case it was Apple and IBM/Microsoft that reaped the 
rewards.
New companies that challenge established ones often 
start as unicorns (private companies that grow rapidly from 
start-up to a value of over $1bn). Unicorns often succeed 
by developing new or greatly improved technologies. An 
example is Dyson which disrupted the apparently mature 
vacuum cleaner market with its patented bagless cyclone 
cleaners in attractive colourful new designs that enabled 
it to become market leader; its success has given it the 
resources to enter the electric car market. The global 
list of unicorns as of August 2018 gives an indication 
of where new innovative companies are being formed 
and developed and in which technological areas. Of 269 
global unicorns, the US provides 125, China 76, the EU 
29 (of which 15 are UK) and India 13. The majority are 
1.1.2 Key technological trends affecting the R&D companies in 2017/18
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in software/AI/internet with 9% in healthcare. Below we 
give some examples of new technologies in biotech, 
software/AI and new materials and others involving two of 
these areas and conclude with an update on autonomous 
electric vehicles.
Examples of important biotech developments include 
immunotherapy, gene therapy, stem cell therapy and 
advances in the treatment of neurological diseases. 
Immunotherapy uses the body’s immune system to 
attack, for example, cancer cells. Early success with immuno-
oncology therapies has led to increasing interest with more 
than 2,000 therapies now in some stage of development. 
Some second and third generation immuno-oncology 
treatments are giving very encouraging results with response 
rates of 80-95%. An example is CAR-T therapies where 
T-cells are removed from the body, re-engineered to attack 
cancer cells and then re-introduced. Exemplar companies 
are Celgene (with a promising clinical trial for multiple 
myeloma), Gilead (Yescarta for non-Hodgkin lymphoma) 
and Novartis (Kymriah for lymphoblastic leukaemia – the 
first CAR-T therapy to be approved by the FDA).
Gene therapy is another expanding area and Car-T 
therapy is a form of gene therapy since T-cells are 
genetically modified for it and two-thirds of all gene 
therapy trials are for cancer. Earlier this year the FDA said 
that it expects to approve 40 gene therapies by 2022 and 
there could well be cures for diseases such as sickle cell 
anaemia within 10 years. Gene therapy has, for example, 
recently been used to cure a rare inherited retinal disease 
(LCA) that leads to blindness in children. Another example 
is Biogen’s Spinraza for spinal muscular atrophy, a rare 
genetic disease that causes muscle wasting – most 
children with it will, if not treated, die before they are much 
older than one. Spinraza has just won the prestigious $3m 
annual Breakthrough Prize for Life Sciences.
Stem cell therapy. Stem cells are master cells that can 
transform into any type of cell in the body and therefore 
have huge potential to cure rather than treat disease. 
Early trials show stem cells’ potential to cure damaged 
heart tissue after heart attacks, in preventing MS from 
progressing, in curing Crohn’s disease, reviving the brains 
of stroke patients, repairing Achilles tendons, restoring 
the sight of AMD sufferers and helping patients paralysed 
by spinal injuries. This wide range of potential cures for 
serious disabilities means this area will receive increasing 
funding and is likely to see rapid progress over the next 
decade.
Neurological diseases such as Alzheimer’s, MS and 
Parkinson’s cause great suffering and there are no very 
effective treatments. There have, for example, been no 
new drugs approved for Alzheimer’s in the last 15 years. 
However, there are now a number of promising new drugs 
in clinical trials for the major neurological diseases. Biogen, 
for example, has two drugs for Alzheimer’s in Phase III 
clinical trials, one in Phase II and three in Phase I. 
Companies with ever more versatile software continue 
to provide examples of high growth R&D-led success. 
Software/Artificial Intelligence (AI) developments have 
been accelerated by the parallel development of ever more 
sophisticated chips by hardware companies. Cybersecurity 
is a particularly active area because of the way in which 
threats from state-sponsored hackers and malware are 
continually evolving and therefore requiring ever more 
effective countermeasures. AI is applied to cybersecurity 
by, for example, Darktrace (UK), a five-year old company 
that reached unicorn status in 2018 (having moved from 
start-up to a $1.65bn valuation). AI is also being applied to 
healthcare both in improving diagnoses and in developing 
breakthrough treatments by identifying patterns in the 
massive amounts of data and information now available 
on patients, drugs, treatments and human biotechnology. 
AI is also finding new applications in insurance, fraud 
detection, cognitive robotics and other areas. Accenture 
predicts that GDP growth rates in 2035 could be raised by 
50-100% over baseline by absorbing AI into economies.
AI is central to robotics both in pure software robotics 
(such as Blue Prism’s software robots for automating back 
office processes) and hardware robots ranging from robotic 
Technological developments in biotech
Software and Artificial Intelligence
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vacuum cleaners to robotic warehouses (e.g. Amazon and 
Ocado), automated farming & construction and self-driving 
cars (see below). The McKinsey Global Institute (MGI) 
estimates that the giant tech companies spent $20bn to 
$30bn on AI in 2016. That means that R&D in AI with its 
many applications is currently large and bound to increase.
New materials
Examples of developments using two of these technologies 
Update on autonomous electric vehicles
Examples of new materials include graphene, novel fuel 
cells, nanomaterials, higher efficiency photovoltaics, 
solid state batteries and, in the longer term, new higher 
temperature superconductors. These and other technologies 
will find applications such as giving enhanced range and 
faster charging times for electric vehicles. Most graphene 
applications are still in the early stages but there is potential 
for using the material in electronics, medicine, optoelectronics 
and nanostructures. Early graphene applications have 
These include bioengineering, robotics and autonomous 
electric vehicles (see below). An example of bioengineering 
is in improved biomechanical devices which currently last 
only as long as their batteries. Nanotechnology is being 
explored in the US to develop ultra-thin, lightweight, 
stretchable and biocompatible membranes which can 
convert mechanical energy generated within the body to 
electrical energy so creating a self-sufficient power supply. 
Another example is a smart wound dressing that can 
deliver oxygen and blood-vessel-promoting biochemical 
factors while monitoring healing. This combines electronics, 
microfabrication, biomaterials, drug delivery, sensors and 
actuators. And AI nano-machines could be injected into 
Electric road vehicles. Increasing amounts of R&D 
are being directed at electric vehicles (EVs) and their 
autonomous operation. Most automotive companies are 
now making or trialling EVs using lithium batteries and 
some have active autonomous driving programmes. And 
there are several projects on new technology batteries. 
Tesla, which only makes pure electric vehicles, has found it 
more difficult than expected to bring its lower cost Model 
3 up to its planned rate of mass production. It also leads 
the industry in reducing battery costs through investment 
in the Tesla/Panasonic first ever gigafactory (a factory 
able to produce many GWhrs p.a.). Production reached a 
been in water purification, sporting goods and supercar 
components. Other applications of novel materials include 
3D printing, the fabrication of nanomachines, biomaterials 
for use in medicine, microelectronics and materials for optical 
quantum computing. High temperature superconductors 
are finding applications in fault current limiters, power 
cables, energy storages and the military (US electric motors 
for propulsion and submarine detection using quantum 
interference detection).
humans to repair damage to parts of the body such as 
cells, muscles and bones.
Robotics combines AI/software, new materials and 
precision electromechanical devices and is finding more 
and more applications. Japan is particularly active in 
robotics because of its low birth-rate and ageing, declining 
population with an increasing demand for carers. MGI 
estimates that up to 800 million jobs could be displaced 
by automation by 2030 and these will include both blue 
and white collar jobs including some in finance, health 
and the law. It is not yet clear if new roles will be able to 
replace all those lost jobs.
level of 20GWhr in August 2018 and this is being raised 
to 35GWhr with the addition of further lines. Five Chinese 
battery companies are also building gigafactories and 
the two largest, Contemporary Amperex Technology (CAT) 
and BYD, will both have 24GWhr capacities. BYD plans to 
more than double its plant capacity by 2020. Both BMW 
and Volkswagen have ordered batteries from CAT. At least 
seven new battery gigafactories are planned to open in 
Europe by 2020. Some new entrants to the EV market 
such as Dyson are planning to use novel batteries but no 
reliable performance figures have yet been released for 
such batteries.
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Global electric car sales for the first five months of 2018 
were 598,000, up 71% on 2017. McKinsey says that 
global sales of electric vehicles passed one million for 
the first time in 2017 with two-thirds being pure electric. 
Global sales are expected to rise to 4.5 million in 2020 
(5% of world light vehicle sales) and nearly 60 million by 
2040. China is in the leadership position with larger sales 
than Europe and the US combined and 94% of these are 
produced in China. The low price of fuel and longer trip 
distances in the US reduce the cost advantage of EVs 
there, increase range anxiety and have held back US sales. 
The top three plug-in EV companies are Renault/Nissan/
Mitsubishi, Tesla and BYD, all with over 90,000 vehicles 
sold in the first seven months of 2018.
Autonomous driving. Amongst the companies working 
on autonomous driving systems, Waymo, an Alphabet 
subsidiary, is the technology leader with 9 million self-
driving road miles of testing so far but companies such as 
GM are also well advanced. Waymo’s experience means 
it now has only one driver intervention per 5,000 miles of 
autonomous test driving compared to GM’s 1 in 1,250miles 
and other car companies in the range 1 in 200miles to 80 
in 100 miles. Car companies are partnering to accelerate 
their development of autonomous driving technology. 
For example, Honda has just formed a partnership with 
GM to develop self-driving cars for mass production and 
Waymo with FiatChrysler and also with JaguarLandRover. 
The first commercial application of autonomous vehicles 
is expected to be Waymo’s robo-taxi service in Phoenix, 
Arizona to be launched around the end of 2018. 
Electric aircraft. Electric propulsion is not confined to 
cars with Airbus/Rolls-Royce/Siemens cooperating on a 
project called AirbusE-FanX based on a modified 100-seat 
BAe146 jet. Early trials will use an electric engine replacing 
one of the conventional engines followed by all-electric 
commercial flights possibly as soon as 2025. Boeing 
& JetBlue are backing Zunum Aero which is building a 
prototype hybrid electric regional aircraft planned to test 
fly in 2020. Electric aircraft will require new materials and 
lighter, higher energy density batteries. Wright Electric and 
EasyJet are partnering to develop an electric jet by 2027 
with a range of 335 miles. Pipistrel of Slovenia plans to 
test fly a 4-seat hybrid electric plane in 2019. Electric 
aircraft are being encouraged by Heathrow airport which is 
waiving landing fees for a year initially for the first regular 
electric service to use the airport. Hybrid electric aircraft 
are likely to be the first in use with battery electric power 
being used for take-off and landing to minimise airport 
noise and pollution.
1.2 | Characterisation of the R&D investment
This section outlines the main characteristics of the 2018 
Scoreboard dataset and highlights, in particular, the 
industrial R&D concentration at company, industry and 
country levels. 
The top 2500 global companies each invested more than 
€25 million in 2017/18, accounting together for a total of 
€736.4 billion. 
The amount of R&D investment by these 2500 companies 
is equivalent to 54% of the total expenditure on R&D 
worldwide (GERD) and about 90% of the R&D expenditure 
financed by the business sector worldwide. 
This is illustrated in figure 1.1 where the latest 2016 
territorial statistics are compared with the corresponding 
figures from the previous 2017 Scoreboard (GERD 
€1381bn, of which R&D financed by the business 
enterprise sector “BES-R&D” was €824bn and the 2017 
Scoreboard €742bn or 90% of global business-financed 
R&D).
The dataset is complemented with additional companies 
in order to cover the top 1000 R&D investing companies 
based in the EU, all of them having invested more than €8 
million in R&D in 2017/18. Of these 1000, 577 appear in 
the world top 2,500 and another 423 are added with R&D 
between €8m and €25m. The total R&D for the EU1000 is 
€206.3bn in 2017/18. 
This additional sample of 1000 companies is analysed 
separately in chapter 5. 
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The 2018 Scoreboard comprises companies with 
headquarters in 46 countries of which 19 are member 
states of the EU. The sample includes companies based 
in the EU (577), the US (778), China (438), Japan (339), 
Taiwan (99), South Korea (70), Switzerland (59), Canada 
(28), India (31) and a further 19 countries. See Table 1.1 
and Figure 1.2.
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FIGURE 1.1: COMPARISON OF R&D FIGURES OF THE SCOREBOARD AND TERRITORIAL STATISTICS.
Note: Total R&D expenditure (GERD) and R&D financed by the business sector (BES-R&D) in 2016 (green dark overlapping bar represent the BES-R&D).
Sources: Latest figures reported by Eurostat including most countries reporting R&D. The 2018 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
Companies’ distribution by country
Number of companies by country
EU non-EU
Germany 135 US 778
UK 135 China 438
France 75 Japan 339
Netherlands 40 Taiwan 99
Sweden 36 South Korea 70
Denmark 30 Switzerland 59
Italy 24 India 31
Ireland 24 Canada 28
Finland 18 Israel 21
Austria 16 Australia 14
Belgium 16 Norway 9
Spain 15 Brazil 7
Luxembourg 5 Singapore 6
Greece 2 Turkey 4
Portugal 2 New Zealand 3
Hungary 1 Russia 3
Malta 1 Saudi Arabia 2
Slovenia 1 Iraq 2
Poland 1 Further 9 countries 10
Total 577 Total 1923
TABLE 1.1: DISTRIBUTION OF COMPANIES BY COUNTRY.
Note: the 2500 companies all have R&D investment above €25 million.
Source: The 2018 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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FIGURE 1.2: DISTRIBUTION OF THE 2500 COMPANIES IN THE 2018 SCOREBOARD BY HEADQUARTERS COUNTRY.
Note: Number of companies indicated besides the country code (the world map includes only countries with at least 10 companies). R&D is represented with a bubble whose size 
is proportional to R&D in 2017/18 in the country.
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
Assigning companies to industrial sectors according to ex-
isting classification systems is not a straightforward task. 
In fact, sector definitions often do not fit unambiguously 
with actual company activities that may also change over 
time, and in addition, many companies operate in two or 
more very different industrial sectors. However companies 
usually indicate their main sector of activity in their annual 
reports, for example, public companies use a taxonomy 
such as the International Classification Benchmark (ICB)5.
According to the ICB, the Scoreboard comprises com-
panies operating in a wide range of manufacturing and 
services sectors, including more than 50 industries with a 
special concentration in the most innovative ones such as 
ICT, health, transport and the engineering related indus-
tries. In the Scoreboard we use different levels of sector 
aggregation to describe the sectoral distribution of com-
panies’ R&D. Tables 1.2 and 1.3 describe two typical levels 
of the industrial classification applied in the Scoreboard.
Companies’ aggregation by industrial sector
5 http://www.ftse.com/products/downloads/ICBStructure-Eng.pdf
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The number of companies by industry for the EU and non-
EU regions is shown in Table 1.4. The top 3 companies 
by level of R&D investment for each type of industry are 
presented in Table 1.5
Industrial 
Sector Sector classification ICB4 digits
N of 
firms
% of total 
R&D
Aerospace  
& Defence
Aerospace; Defence 51 2.6
Automobiles & 
other transport
Auto Parts; Automobiles; Commercial Vehicles & Trucks; Tyres 189 17.6
Chemicals Commodity Chemicals; Specialty Chemicals 129  2.9
Health industries Biotechnology; Health Care Providers; Medical Equipment; Pharmaceuticals 490 21.0
ICT producers
Computer Hardware; Electrical Components & Equipment; Electronic Equipment; 
Electronic Office Equipment; Semiconductors; Telecommunications Equipment
509 23.7
ICT services
Computer Services; Fixed Line Telecommunications; Internet; Mobile Telecommunica-
tions; Software
300 14.1
Industrials
Aluminium; Containers & Packaging; Diversified Industrials; Industrial Machinery; 
Iron & Steel; Nonferrous Metals; Transportation Services
293  5.4
Others*
Alternative Energy; Banks; Beverages; Construction & Materials; Electricity; Financial 
Services; Food & Drug Retailers; Food Producers; Forestry & Paper; Gas, Water & 
Multi-utilities; General Retailers; Household Goods & Home Construction; Leisure 
Goods; Life Insurance; Media; Mining; Nonlife Insurance; Oil & Gas Producers; Oil 
Equipment, Services & Distribution; Personal Goods; Real Estate Investment & 
Services; Support Services; Tobacco; Travel & Leisure
539 12.6
Total 2500 100
TABLE 1.2: INDUSTRIAL CLASSIFICATIONS APPLIED IN THE SCOREBOARD -8 INDUSTRIAL GROUPS.
* Sectors in the “Others” group are presented at ICB-3 digits level. 
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
Sector R&D 
intensity* Sector classification ICB4 digits** N of firms % of total R&D
high
Aerospace; Biotechnology; Computer Hardware; Computer Services; Defence; 
Electronic Office Equipment; Health Care Providers; Internet; Leisure Goods; 
Medical Equipment; Pharmaceuticals; Semiconductors; Software; Technology 
Hardware & Equipment; Telecommunications Equipment
1111 54.1
medium-high
Auto Parts; Automobiles; Commercial Vehicles & Trucks; Commodity Chemicals; 
Containers & Packaging; Diversified Industrials; Electrical Components & 
Equipment; Electronic Equipment; Financial Services; Household Goods & 
Home Construction; Industrial Machinery; Personal Goods; Specialty Chemicals; 
Support Services; Tires; Travel & Leisure
966 36.0
medium-low
Alternative Energy; Beverages; Fixed Line Telecommunications; Food Producers; 
General Retailers; Media; Oil Equipment, Services & Distribution; Tobacco
148 3.6
low
Aluminium; Banks; Construction & Materials; Electricity; Food & Drug Retailers; 
Forestry & Paper; Gas, Water & Multi-utilities; Iron & Steel; Life Insurance; 
Mining; Mobile Telecommunications; Nonferrous Metals; Nonlife Insurance; Oil 
& Gas Producers; Real Estate Investment & Services; Transportation Services
275 6.3
Total  2500 100
TABLE 1.3: INDUSTRIAL CLASSIFICATIONS APPLIED IN THE SCOREBOARD -4 SECTORS BY R&D INTENSITY.
Note: This classification takes into account the average R&D intensity of all companies aggregated by ICB 3-digits sectors: High above 5%; Medium-high between 2% and 5%; 
Medium-low between 1% and 2% and Low below 1%. Some sectors are adjusted to compensate the insufficient representativeness of the Scoreboard in those sectors using the 
OECD definition of technology intensity for manufacturing sectors.
* For simplification, in this report these 4 groups are also referred to as high tech, medium-high tech, medium-low tech and low tech.
** Sectors included in the “Others” group in table 1.2 are presented at ICB3 level.
Source: The 2018 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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Industry  EU non-EU Total
Aerospace & Defence 16 (31.4%) 35 (68.6%) 51
Automobiles & other transport 49 (25.9%) 140 (74.1%) 189
Chemicals 22 (17.1%) 107 (82.9%) 129
Health industries 112 (22.9%) 378 (77.1%) 490
ICT producers 64 (12.6%) 445 (87.4%) 509
ICT services 55 (18.3%) 245 (81.7%) 300
Industrials 83 (28.3%) 210 (71.7%) 293
Others 176 (32.7%) 363 (67.3%) 539
Total 577 (23.1%) 1923 (76.9%) 2500
TABLE 1.4: DISTRIBUTION OF COMPANIES BY INDUSTRIAL SECTOR AND REGION.
Note: The figures in brackets show each sector’s EU & non-EU percentages of the total number of companies in each sector.
Source: The 2018 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
Industrial R&D is highly concentrated. A small subset of 
companies, industries and countries account for a large 
share of the total R&D investment of the 2500 sample. 
As observed in the Scoreboard since 2004, this charac-
teristic R&D concentration remains practically unchanged 
from year to year.
Figure 1.3 presents the distribution of the 2500 compa-
nies ranked by their level of R&D investment. 
The R&D concentration (% of total R&D) for the top 10, 
top 50, top 100 and top 500 companies is respectively 
15%, 40%, 53% and 81%. 
There are 6 companies having an R&D investment of more 
than €10bn, 64 more than €2bn and 140 more than €1bn. 
The latter group of companies comprises 37 from the EU, 
49 from the US, 22 Japanese, 14 Chinese, 5 each from 
South Korea & Switzerland and 3 from Taiwan.
The 577 EU companies comprise 23% of the total 
of 2500 global companies. The industry groups with 
higher percentages than this are Aerospace & Defence, 
Automobiles, Industrials and Others. ICT producers have a 
much lower percentage while Chemicals and ICT services are 
lower and Health is the same. The reverse is true for non-EU 
with ICT producers, ICT services and Chemicals, for example, 
having much higher percentages than the overall 77%.
Health industries Automobiles & other transport
ROCHE Switzerland VOLKSWAGEN Germany
JOHNSON & JOHNSON US DAIMLER Germany
MERCK US US TOYOTA MOTOR Japan
ICT services ICT producers
ALPHABET US SAMSUNG South Korea
MICROSOFT US HUAWEI China
FACEBOOK US INTEL US
Aerospace & Defence Industrials
AIRBUS Netherlands GENERAL ELECTRIC US
BOEING US PHILIPS Netherlands
UNITED TECHNOLOGIES US HONEYWELL US
Chemicals Others
BASF Germany PANASONIC Japan
DOWDUPONT US SONY Japan
MONSANTO (acquired by Bayer in 2018) US LG ELECTRONICS South Korea
TABLE 1.5: TOP 3 COMPANIES BY R&D FOR THE MAIN INDUSTRIES COMPRISED IN THE 2018 SCOREBOARD.
Source: The 2018 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
Distribution of the R&D investment by company, sector and country
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The group of top 100 companies mostly operate in three 
sectors: 27 in Health industries (EU 10), 20 in Automo-
biles & other transport (EU 11) and 34 in ICT industries 
(EU 5).
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FIGURE 1.3: COMPANIES OF THE 2018 SCOREBOARD RANKED BY R&D.
Source: The 2018 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
R&D is very much concentrated by country and world 
region. This is illustrated by figure 1.4 which shows the 
R&D shares of the main countries and regions. 
The top 3, top 5 and top 10 countries account respectively 
for 62%, 75% and 91% of the total R&D investment. 
Within the EU, the R&D is even more concentrated, the 
top 3, top 5 and top 10 countries account respectively 
for 68%, 82% and 97% of the total R&D invested by the 
companies based in the 19 EU countries represented in 
the Scoreboard.
Japan 13.6% 
(339) 
USA 37.2%  
(778) 
Other EU countries 2.0% 
Finland 0.8% 
Italy 0.9% 
Ireland 1.1% 
Sweden 1.2% 
Netherlands 2.5% 
France 3.9% 
UK 3.9% 
Germany 10.9% 
Row 12.4% 
(368) 
South Korea 3.9% 
Switzerland 3.6% 
Taiwan 2.1% 
Other RoW 2.8% 
China 9.7% 
(438)  
EU Total 27.2% 
(577) 
 
FIGURE 1.4: R&D INVESTMENT BY THE 2500 COMPANIES BY MAIN COUNTRY/REGION (% OF TOTAL €736.4bn).
Note: Number of companies indicated besides the country code (the world map includes only countries with at least 10 companies). R&D is represented with a bubble whose size 
is proportional to R&D in 2017/18 in the country.
Source: The 2018 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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The R&D is also largely concentrated by industrial sector, 
as illustrated in figure 1.5 presenting the distribution of 
R&D by industry for the main countries/regions. The four 
largest R&D investing sectors (ICT producers, Health in-
dustries, Automobiles & other transport and ICT services) 
account for 76% of the total R&D of the 2500 companies. 
The main contribution to the total Scoreboard R&D:
– By EU companies is 47% to Automobiles & other 
transport, 47% to Aerospace & Defence and 29% to 
Health industries;
Finally, the R&D shares of industrial sectors for each main 
country/region are presented in figure 1.6. This figure 
shows that each country/region has a characteristic R&D 
specialisation. The top three sectors by level of R&D 
investment for each region account for:
– 67% within the EU (Automobiles & other transport 
31%; Health industries 22% and ICT producers 13%).
– 79% within the US (Health industries 27%; ICT produc-
ers 26% and ICT services 26%).
– 63% within Japan (Automobiles & other transport 
31%; ICT producers 20% and Health industries 12%).
– By US companies is 68% to ICT services, 47% to 
health industries, 40% to ICT producers and 39% to 
Aerospace & Defence;
– By Japanese companies is 32% to Chemicals, 24% to 
Automobiles & other transport and 22% to Industrials;
– By Chinese companies is 14% to ICT producers and 
Industrials and 20% to other sectors.
– 59% within China (ICT producers 33%; Automobiles & 
other transport 11%; and ICT services 15%).
Whereas the top five companies in the EU and the US both 
account for 20% of the total R&D of those regions, the 
top five in China account for 28% and for 24% in Japan. 
The top five companies in the EU contain four from the 
automobiles sector whereas the top five from the US have 
four from the ICT sector; that illustrates the different sector 
specialisations of the two regions. Japan is more similar 
to the EU with three of its top four companies from the 
automobiles sector.
0 20 40 60 80 100 120 140 160 180 
ICT producers
Health industries
Automobiles
& other transport
ICT services
Industrials
Chemicals
Aerospace
& Defence
Others
EU US Japan China RoW 
FIGURE 1.5: R&D INVESTMENT BY THE 2500 COMPANIES BY INDUSTRY AND MAIN COUNTRY/REGION (€bn).
Source: The 2018 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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FIGURE 1.6: R&D SHARES OF INDUSTRIAL SECTORS WITHIN MAIN COUNTRIES/REGIONS
Source: The 2018 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
2 GLOBAL INDUSTRIALR&D TRENDS
31The 2018 EU Industrial R&D Investment Scoreboard
This chapter provides an overview of the main trends in R&D and economic indicators for the world’s top 2500 companies 
that each invested more than €25 million in R&D in 2017/18. The first section concentrates on the evolution of companies’ 
main performance indicators over the previous year and the second analyses the long-term performance of companies 
aggregated by the main world regions. The 2500 companies are grouped into five main sets: the top 577 companies from 
the EU, 778 companies from the US, 339 from Japan, 438 Chinese companies and 368 companies from the Rest of the 
World group (RoW). The RoW group includes companies from Taiwan (99), South Korea (70), Switzerland (59), Canada (28), 
India (31), Israel (21) and companies based in a further 18 countries.
Global industrial R&D trends2
2017/2018 was the eighth consecutive year of R&D investment increase. The growth of 
net sales reversed the negative trend shown since 2011 and was higher than that of R&D 
investment. The number of employees for the 2500 companies continued to increase but 
at a modest pace.
2.1 | Changes in companies’ indicators in 2017/18
6 The company or sector contribution to the R&D growth of the sample is the nominal growth rate of the company or sector weighed by the R&D share of the company 
or sector. 
In 2017/18, the 2500 companies in aggregate increased 
significantly their R&D investments and showed good 
results across most performance indicators, especially 
in terms of net sales that have increased more than the 
R&D investment for the first time since 2011. However, as 
observed in past Scoreboard editions, companies’ results 
vary greatly across world regions and industries. Tables 
2.1 and 2.2 at the end of this section present the one-year 
change of main indicators for the whole set of companies 
and also by main region and country. 
• Overall R&D investment continued to increase 
significantly in 2017/18 for the eighth consecutive 
year. The 2500 Scoreboard companies invested 
€736.4 billion in R&D, 8.3% more than in 2016/17, 
following an increase of 5.9 % in the year before. The 
2017 Scoreboard reported R&D for the top 2500 
companies as €741.6bn. The reason for the apparent 
decrease from 2017 to 2018 is exchange rates. The 
US$ depreciated from 1€=$1.05 at end 2016 to 
1€=$1.20 at end 2017. If the 2018 Scoreboard R&D 
is expressed at 2017 Scoreboard exchange rates, the 
total R&D for the 2500 companies is €800bn.
• The 577 companies based in the EU invested €200.1bn 
in R&D, an important increase in this period (+5.5%) 
although at a lower pace than in the previous year 
(+6.7%). The Japanese companies presented a similar 
R&D growth rate than their EU counterparts (+5.8%) 
while companies based in the US and China showed 
a much higher R&D growth rates (+9.0% and +20.0% 
respectively). See figure 2.1.
• Worldwide R&D growth was driven by the ICT producers 
sector (+11.3%), followed by the ICT services sector 
(+13.0%) and the Health sector (+7.7%). The lowest 
R&D growth was shown by the Industrials sector 
(+3.3%) and by Aerospace & Defence which reduced 
R&D by 4.3%. 
• For the EU sample, the largest contribution6 to R&D 
growth was made by Automobiles (+6.1%), Health 
industries (+4.6%) and ICT services (+13.3%) and the 
R&D trends
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lowest contributions made by Aerospace & Defence 
(+0.9%) and Chemicals (+0.6%). Among the largest 
member states, German and French companies showed 
the highest R&D growth (6.5% and 8.1% respectively) 
while companies based in the Netherlands increased 
R&D only by a modest 0.6%. In the EU sample, R&D 
growth was led by automotive companies such as 
DAIMLER (15%), BMW (18%) and PEUGEOT (24%), 
and from other sectors GLAXOSMITHKLINE (14%), 
SCHNEIDER (50%) and SIEMENS (10%). The poorest 
R&D performance was shown by ALLERGAN (-27%) 
and VOLKSWAGEN (-4%). See figure 2.2. 
 R&D growth for some of these companies (and 
for some of the non-EU ones) was increased by 
acquisitions, these included Peugeot which purchased 
GM Europe (Vauxhall/Opel) in mid-2017 and Schneider 
which made 5 acquisitions in 2017.
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FIGURE 2.1: R&D INVESTMENT BY MAIN WORLD REGION IN THE LATEST TWO YEARS.
Note: Growth rates have been computed for 572 EU, 776 US, 339 Japanese, 438 Chinese and 366 RoW companies for which data are available for both years 2016 and 2017.
Source: The 2018 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
• The largest contribution to the R&D growth of non-EU 
companies was made by ICT producers, ICT services, 
and Health industries with a negative contribution by 
the Aerospace & Defence sector. In the non-EU group, 
top R&D companies showing high R&D growth were 
MERCK US (49%), ALPHABET (18%), HUAWEI (17%), 
DELL (67%) and FACEBOOK (31%). The poorest 
performance was shown by BOEING (-33%), TOSHIBA 
(-39%) and HEWLETT PACKARD (-35%). Amongst 
these, acquisitions/divestments were important for Dell 
which acquired EMC for $67bn in September 2016 and 
Hewlett Packard which sold its huge software division 
to Microfocus in September 2017. Merck (US) acquired 
Afferent Pharma, Staywell and IOmet in mid-2016 and 
Rigontec, Kalvista and Valee in 2017.
Other indicators
• The growth of net sales reversed the negative trend 
shown since 2011 and increased more than the R&D 
investment in 2017/18 (9.8% vs 8.3%). The growth in 
net sales was led by oil-related companies due to 
the recovery of oil prices but significant increases 
are observed also in Automobiles, ICT industries 
and in the Industrials sector. The overall profits of 
companies showed an impressive growth of 22.6% 
also due to oil-related companies. In the same line, 
companies’ capital investments (Capex) showed a 
significant recovery following 3 negative years. Capex 
increases are observed especially in the ICT producers 
sector and also in oil-related companies. The number 
of employees for the 2500 companies continued to 
increase but at a modest pace (2.1%).
• The net sales of the 577 companies based in the EU 
reached €5.8trillion, 9% more than in the previous 
year. Net sales increases were registered in all 
industries. The best sales performance was shown in 
oil-related sectors but other industries showed also 
sales performance above the average, e.g. Chemicals 
(10.4%).
• The EU companies increased modestly capital 
expenditures (1.7%). The best performance of EU 
companies was in terms of profits that showed an 
impressive growth of 37.5%, leading to a significant 
increase of their profitability level (from 7.6% to 
10.3%). The 577 companies employed 19.4million, 
just 1.3% more than the year before.
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• The 778 companies based in the US increased 
significantly net sales (9.1%) and more modestly 
capital expenditures (5.4%). US companies showed a 
high increase on profits (11.7%), above their growth 
rate of sales therefore increasing their profitability 
(from 12.7% to 13.5%). Finally, the US companies 
increased employee numbers by 2.7% to 11million.
• The 339 companies based in Japan raised net sales by 
8.2% and capital expenditures by 3%. They increased 
significantly profits (14.5%) and profitability increased 
to 8%. Number of employees of Japanese companies 
grew moderately by 2.4%.
• The 438 Chinese companies showed a robust growth 
in net sales (17.9%) and net profits (34.7%), reaching 
a profitability level of 7.9%. Chinese companies 
increased employees’ number by 3.4%. In terms of 
capital expenditure, Chinese companies showed a 
much better performance than their counterparts 
(14.2%).
• Sales per employee are highest for the RoW group at 
€499k followed by the US (€391k), Japan (€323k), the 
EU (€300k) and China (€258k).
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FIGURE 2.2: INDUSTRIES’ NET CONTRIBUTION TO THE ONE-YEAR R&D GROWTH RATE OF MAIN REGIONS*.
* R&D growth rate of the industry weighed by its R&D (the sum of industry contributions is the Region’s R&D growth).
Note: Growth rates have been computed for 572 EU, 776 US, 339 Japanese, 438 Chinese and 366 RoW companies for which R&D data are available for both years 2016 and 2017.
Source: The 2018 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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Factor World 2500
R&D in 2016/17, € bn 736.47
One-year change, % 8.3
Net Sales, € bn 18448.0
One-year change, % 9.8
R&D intensity, % 4.0
Operating profits, € bn 1909.3
One-year change , % 22.6
Profitability, % 10.5
Capex, € bn 1151.3
One-year change , % 5.1
Capex / net sales, % 6.3
Employees, million 55.0
One-year change, % 2.1
Market Cap, € bn 24538.5
One-year change, % 16.3
One-year change, % 8.3
TABLE 2.1: OVERALL PERFORMANCE OF THE 2500 COMPANIES IN THE 2018 SCOREBOARD.
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
Factor EU US Japan China RoW
No. of companies 577 778 339 438 368
R&D in 2017/18, € bn 200.1 274.2 99.9 71.2 91.0
World R&D share, % 27.2 37.2 13.6 9.7 12.4
One year change, % 5.5 9.0 5.8 20.0 7.0
 Net Sales, € bn 5822.3 4320.1 2906.0 2554.6 2845.0
One year change, % 9.0 9.1 8.2 17.9 7.6
R&D intensity, % 3.4 6.3 3.4 2.8 3.2
Operating Profit, € bn 587.8 580.7 232.3 195.3 313.2
One year change, % 37.5 11.7 14.5 34.7 19.6
Profitability (1) 10.3 13.5 8.0 7.9 11.1
Capex, € bn 339.6 254.6 178.7 168.4 210.1
One year change, % 1.7 5.4 3.0 14.2 5.4
Capex intensity, % 5.9 5.9 6.1 6.6 7.7
Employees, million 19.4 11.0 9.0 9.9 5.7
One year change, % 1.3 2.7 2.4 3.4 1.2
Sales/employee, k€ 577 778 339 438 368
TABLE 2.2A: OVERALL PERFORMANCE OF THE 2500 COMPANIES IN THE 2018 SCOREBOARD.
Note: The RoW group comprises companies based in Taiwan, South Korea, Switzerland, India and a further 20 countries.
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
Factor Germany UK France Netherlands
No. of companies 135 135 75 40
R&D in 2017/18, €bn 80.2 28.5 28.4 18.2
World R&D share, % 10.9 3.9 3.9 2.5
One year change, % 6.3 6.9 8.1 0.6
Net Sales, €bn 1893.6 1105.1 1104.8 468.8
One year change, % 6.6 16.7 9.1 7.1
R&D intensity, % 4.2 2.6 2.6 3.9
TABLE 2.2B: PERFORMANCE OF COMPANIES BASED IN THE LARGEST R&D COUNTRIES OF THE EU.
Note: The RoW group comprises companies based in Taiwan, South Korea, Switzerland, India and a further 20 countries.
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
7 The apparent decrease from 2017 to 2018 is due to the appreciation of the Euro against most currencies. If the 2018 Scoreboard R&D is expressed at 2017 Scoreboard 
exchange rates, the total R&D for the 2500 companies is €800bn (see details in Annex 2).
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Factor South Korea Switzerland Taiwan India
No. of companies 70 59 99 31
R&D in 2017/18, € bn 28.8 26.2 15.4 4.9
World R&D share, % 3.9 3.6 2.1 0.7
One year change, % 9.5 3.0 9.1 25.7
Net Sales, € bn 970.9 361.3 529.6 283.6
One year change, % 9.0 2.9 8.0 9.7
R&D intensity, % 3.0 7.3 2.9 1.7
TABLE 2.2C: PERFORMANCE OF COMPANIES BASED IN THE LARGEST COUNTRIES OF THE ROW GROUP.
Note: The RoW group comprises companies based in Taiwan, South Korea, Switzerland, India and a further 20 countries.
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
This section presents the evolution of the main company indicators over the past 10 years for the major world regions.
2.2 | Long-term performance of companies
The figures below illustrate 10 years evolution of R&D and 
the other main indicators for companies based in the EU, 
US, Japan and China. Figure 2.3 shows the world R&D share 
of each region and Figures 2.4 to 2.7 present the annual 
growth rates of R&D and net sales and profitability. These 
figures are based on our history database comprising the 
R&D and economic indicators over the whole 2008-2017 
period for 1674 companies (EU 398, US 516, Japan 326, 
China 149 and RoW 285).
Over the past 10 years, the R&D share of EU companies 
over the total R&D remained practically unchanged at 
about 27%. This figure directly depends on the exchange 
rate of the Euro against main currencies. Last year the 
share was about 26% and the increase mostly reflects 
the appreciation of the Euro against de US$ over the last 
period (see Box A2.1 in the methodological notes). The 
main change in this indicator is observed for the Japanese 
companies whose R&D share fell by ca. 8 percentage 
points. The loss of R&D share by Japanese companies 
corresponds to increases in R&D shares for the other 
countries/regions, especially for companies based in China. 
Companies based in the EU have showed positive R&D 
trends for most of the 10-years period. From 2012 to 
2016, the growth rate of EU R&D has been significantly 
higher than that of net sales, except for the last year 
where net sales have recovered strongly. In the last 
period, companies’ capital expenditures have improved 
following several years of negative performance or 
stagnation. In terms of profitability the EU companies 
showed a stable behaviour (with a significant increase 
over the past two years).
Companies based in the US continued to show significant 
R&D investment growth, especially in the past two years, 
that showed very high R&D growth. The level of capital 
expenditures of US companies fell significantly over 
previous years but also recovered significantly in the past 
year. In terms of net sales, US companies continue to 
recover the negative figures of 2015 recording a strong 
growth in 2017, similar to the level of R&D growth. The 
US-based companies have continued to show a stable 
high level of profitability since 2010. The profitability of 
the US companies is higher than their EU counterparts 
and especially higher than the Japanese and Chinese 
ones.
Japanese companies, hit hard by the crisis in 2008-2009 
and by the earthquake in 2011, showed a two years 
positive trend for both R&D investment and net sales. 
However in 2015 and 2016 the growth rates of R&D and 
especially that of net sales decelerated again. Finally, in 
the last period, Japanese companies showed a significant 
recovery for R&D, net sales and also capital expenditures. 
The profitability of Japanese companies continued the 
slightly upward trend observed since 2013, but remained 
at low levels, especially compared with that of the US 
companies.
The Chinese companies show a strong R&D trend over 
the whole 10 years period and their level of capital 
2.2.1 Long-term R&D trends
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expenditures that have decreased over the past two years 
recovered robustly in 2017. In terms of net sales, they have 
had high positive growth rates, except over 2015/16 where 
net sales significantly fell but recovering considerably over 
the last year. The China-based companies have decreased 
profitability slightly over the past years and remain lower 
as compared with their worldwide counterparts, especially 
lower than that of US companies.
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FIGURE 2.3: EVOLUTION OF R&D SHARES OF MAIN REGIONS.
Note: Figures displayed refer only to the 1674 companies (398 EU; 516 US; 326 Japan; 149 China; 285 RoW) for which data are available for the entire period 2008-2017.
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 2.4: ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH AND PROFITABILITY FOR THE EU COMPANIES.
Note: Growth rates for the three variables have been computed on 398 out of the 577 EU companies for which data are available for the entire period 2008-2017.
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 2.5: ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH AND PROFITABILITY FOR THE US COMPANIES.
Note: Growth rates for the three variables have been computed on 516 out of the 778 US companies for which data are available for the entire period 2008-2017.
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 2.6: ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH AND PROFITABILITY FOR THE JAPANESE COMPANIES.
Note: Growth rates for the three variables have been computed on 326 out of the 339 Japanese companies for which data are available for the entire period 2008-2017.
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 2.7: ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH AND PROFITABILITY BY THE CHINESE COMPANIES.
Note: Growth rates for the three variables have been computed on 149 out of the 438 Chinese companies for which data are available for the entire period 2008-2017.
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
2.2.2 Change in R&D, net sales and employees over 2008-2017
The changes in R&D, net sales and number of employees 
over the past 10 years are presented respectively in 
figures 2.8, 2.9 and 2.10. Companies are aggregated 
by main region and by groups of industrial sectors with 
characteristic R&D intensities8 (see definition in Chapter 
1 – Table 1.3). 
These figures refer to a set of 1484 companies that re-
ported R&D, net sales and employees over the whole peri-
od 2008-2017 (EU-407, US-473, Japan-327, China-124 
and RoW group-153).
Ten-year changes in R&D
• Worldwide companies increased R&D by 48%: 
– By sector, high tech 55%, medium-high tech 45%, 
medium-low tech 20% and low tech 32%. 
– By region, EU 51%, US 57%, Japan 10% and China 
437%.
• For EU companies, R&D increased in medium-high 
tech sectors (70%) and high tech (44%).
• The US companies increased significantly R&D in high 
tech (71%) and medium-low tech (53%) and de-
creased R&D in low tech sectors by 11%. 
8 For simplification, in this section these groups may be also referred to as high tech, medium-high tech, medium-low tech and low-tech.
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• The Japanese companies increased R&D in medi-
um-high tech (19%) and low tech sectors (5%) and 
decreased it in high tech (-2%) and medium-low tech 
sectors (-4%).
• For the companies based in China, all sectors showed 
3-digits increases in R&D, mainly in high tech (658%) 
and medium-low tech (610%). 
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FIGURE 2.8: R&D INVESTMENT IN 2008 AND 2017 BY MAIN REGION AND SECTOR GROUPS.
Note: Figures displayed refer only to the 1484 companies for which data are available for all variables (R&D, Net Sales and Employment) both years (2017 and 2008).
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
• For the Japanese companies, net sales increased in 
medium-high tech (30%) and decreases in medium-
low sectors (-2%).
• The companies based in China showed 3-digits rise 
in net sales for most sectors. Net sales went up in 
medium-high sectors (282%), medium-low sectors 
(222%) and high tech (191%). 
• Worldwide companies increased net sales by 21%: 
– By sector, high tech 55%, medium-high tech 34%, 
medium-low tech 13% and low tech -8%. 
– By region, EU 13%, US 12%, Japan 20% and China 
131%.
• For the EU companies, net sales increased in medium-
high tech (48%) and high tech (43%) and decrease in 
low tech (-17%).
• For the US companies, net sales increased in high 
tech (66%) and medium-low tech (24%) and main 
decreased in low tech (-56%).
Ten-year changes in net sales
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FIGURE 2.9: NET SALES IN 2008 AND 2017 BY MAIN REGION AND SECTOR GROUPS.
Note: Figures displayed refer only to the 1484 companies for which data are available for all variables (R&D, Net Sales and Employment) both years (2017 and 2008).
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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• Worldwide companies increased employment by 19%: 
– By sector, high tech 31%, medium-high tech 24%, 
medium-low tech -1% and low tech 8%. 
– By region, EU 11%, US 14%, Japan 20% and China 
49%.
• The EU companies increased employment in high tech 
(29%) and medium-high tech (26%) and decreased 
employment in medium-low and low tech sectors 
(-14% and -2% respectively).
• For the US companies, employment increased in high 
tech (26%), medium-high tech (8%) and decreased 
significantly in low tech (-25%).
• For the Japanese companies, employment increased in 
medium-low tech (34%) and medium-high tech (22%).
• For the companies based in China, main employment 
increases were in medium-low tech (121%) and medi-
um-high tech (86%).
Ten-year changes in employment
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FIGURE 2.10: EMPLOYMENT IN 2008 AND 2017 BY MAIN REGION AND SECTOR GROUPS.
Note: Figures displayed refer only to the 1484 companies for which data are available for all variables (R&D, Net Sales and Employment) both years (2017 and 2008).
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
It is important to remember that data reported by the 
Scoreboard companies do not inform about the actual 
geographic distribution of the number of employees. A 
detailed geographic analysis should take into account 
the location of subsidiaries of the parent Scoreboard 
companies (see for example in the 2015 Scoreboard 
report, an analysis of the location of companies’ economic 
and innovation activities).
Comparison EU/US in terms of R&D, net sales and employment
The comparison of 10-years changes in R&D, net sales 
and employment of the EU-407 sample with the US-473 
one shows that:
• Both samples increased employees and net sales by 
comparable amounts EU (11% and 13% respectively) 
and US (14% and 12% respectively).
• In low-tech sectors, both samples dropped net sales 
(EU -17% vs US -56%) and employees (EU -2% vs US 
-25%).
• US companies increased their R&D more than the EU 
companies (US 57% vs EU 51%) and, according to 
their sector specialisations, the US’s higher R&D in-
crease was in high tech sectors (71%) while that of 
the EU’s was in medium-high tech sectors (70%).
• In summary, the EU and US companies increased net 
sales and employment at a similar rate, however they 
show contrasting differences between high tech and 
medium-high tech sectors:
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 In high tech, the EU companies’ R&D increase of 44% 
is accompanied by 29% increase in employees while 
for the US’ ones their 71% increase in R&D corre-
sponded only to 26% increase in employees. However, 
the US companies showed a much higher increase of 
the productivity ratio net sales/employee.
 In medium-high tech, the EU companies’ R&D 
increase of 70% is accompanied by a 26% increase in 
employees while for the US’ ones their 22% increase 
in R&D corresponded to an 8% increase in employees. 
Moreover, the EU companies showed a much higher 
increase of the productivity ratio net sales/employee. 

3 R&D TRENDS BYINDUSTRY AND REGION
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This chapter presents the main R&D trends among the 2018 Scoreboard companies for the major regions and main 
industrial sectors. Industries are presented at various levels of aggregation according to the R&D volumes and R&D 
intensity of companies and depending on the issues to be illustrated. 
The first section discusses the main changes that took place over the past year for the major industrial sectors and world 
regions. The second section examines the changes on the distribution of the R&D investment of the Scoreboard com-
panies across regions and industrial sectors over the past 10 years. Finally, the third section compares the R&D intensity 
differences of the EU against US and Chinese companies over the past 6 years.
R&D trends by industry and region3
The rapid R&D growth in ICT, Health and Automobiles industries over the past 10 
years reshaped the worldwide industrial structure with EU companies increasing their 
share in Automobiles and US and Chinese companies’ increasing their share in ICT 
industries. These changes are magnified by regional differences in R&D intensity where 
EU companies appear lagging as compared with the US and being challenged by their 
Chinese counterparts.
Figures 3.1 and 3.2 provide the nominal one-year change 
of R&D and net sales for the main world regions and in-
dustrial sectors aggregated into 8 industrial groups (de-
fined in Chapter 1 – Table 1.2). More disaggregated in-
formation (at sector level, ICB 3-digits) is found in Annex 
A3 – Table A3.1, including main statistics for the world 
2500 sample. 
Worldwide, R&D growth was driven by the performance 
of the ICT industries, which registered a double digit R&D 
growth rate for both ICT services (13%) and ICT produc-
ers (11.3%) and, to a lesser extent, by Health industries 
(7.7%). The worst performance was shown by Aerospace 
& Defence (-4.3%)9.
In terms of net sales, the high growth rate of the world 
sample (9.8%) was mostly driven by oil-related sectors 
(due to the recovery of the oil price) but also by sectors 
that increased sales by a double digit rate (Chemicals, ICT 
Producers and Industrials). The lowest sales growth was 
shown by Aerospace & Defence (2.4%).
The impressive growth rate of companies’ profits (22.6%) 
was due to oil-related sectors and also to ICT producers 
(24%) and Aerospace & Defence (22%). There was only 
one sector showing a decrease in profits, Health industries 
(-6%). The profitability level increased for sectors showing 
higher growth rate of profits than net sales. The highest 
levels of profitability are showed by high tech sectors such 
as ICT services (14.6%) and the Health industries (14.2%). 
For the EU sample, R&D growth was also driven by the 
high R&D investing industries that increased significantly 
their R&D, i.e. ICT services (13.3%), ICT producers (6.2%), 
Automobiles (6.1%) and Health industries (4.6%). How-
ever, as observed in past Scoreboard editions, important 
sectors continued to show low R&D growth, in particular 
Aerospace & Defence (0.9%) and Chemicals (0.6%).
Among the largest EU companies, the twelve showing the 
biggest increases and decreases in R&D in 2017/18 are 
presented in table 3.1. The R&D growth of some of these 
companies is partly the result of mergers and acquisitions. 
3.1 | Main changes in indicators in 2017/18
9 This is partly explained by the R&D figures of Boeing. This company, accounting for about 40% of the US’ sector R&D, reported extraordinary high R&D costs in 2016 (as 
stated in the company’s annual report, due to “reclassification of $1,235 million of 787 flight test aircraft costs to research and development and higher reach-forward 
losses on the 747 and KC-46A Tanker programs”. As a result of this, Boeing’s R&D figures in 2017 indicate a 33% drop with respect to 2016.
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Examples are Peugeot which acquired Opel & Vauxhall 
from GM, Valeo’s acquisition of FTE Automotive and Sch-
neider’s five acquisitions in 2017. Bayer acquired Mon-
santo in January 2018 so this will show up in the 2019 
Scoreboard. Aptiv is the name given to one of the parts of 
Delphi Automotive when it split into two separate compa-
nies – that is the reason for its 26.5% reduction.
company One-year R&D growth (%) company
One-year R&D 
growth (%)
DAIMLER 15.0 AKZO NOBEL -25.7
BMW 18.3 ROYAL BANK OF SCOTLAND -20.0
PEUGEOT 23.7 TOTAL -13.1
GLAXOSMITHKLINE 14.0 DEUTSCHE BANK -9.3
SIEMENS 9.5 ASTRAZENECA -4.2
LLOYDS BANKING 83.6 AIRBUS -7.8
BAYER 8.1 BANCO SANTANDER -14.8
SCHNEIDER 49.9 APTIV -26.5
VALEO 26.3 PHILIPS -13.3
SAP 9.7 BARCLAYS -30.7
SANOFI 5.7 VOLKSWAGEN -3.9
CONTINENTAL 9.5 ALLERGAN -27.0
TABLE 3.1: LARGEST R&D INCREASES AND DECREASES AMONG THE EU COMPANIES IN 2017/18.
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
Regarding net sales, the EU sectors showing the highest 
increase were in Others (12%, mainly from oil-related sec-
tors), Chemicals (10.4%) and Industrials (8.4%). The low-
est growth in net sales was recorded in and Aerospace & 
Defence (2.3%).
Among the largest EU companies, the following showed 
the highest increase in net sales: ROYAL DUTCH SHELL and 
BP (31%), CHRISTIAN DIOR (104%), AHOLD (27%), TOTAL 
(17%), METRO (29%). Oil prices were responsible for the 
increases at three of these companies. 
And those that showed the biggest net sales decrease 
were: CECONOMY (-36%), STANDARD LIFE (-28%), JOHN-
SON CONTROLS (-20%), DEUTCHE BANK (-11%), ORANO 
(-64%).
For the non-EU sample of companies, R&D growth was 
driven by the high tech industries, especially by high R&D 
increases in the US and China, i.e. ICT producers (US 13%, 
China 17%), ICT services (US 11%, China 32%), Health in-
dustries (US 11%, China 36%). 
Among the largest non-EU companies, the twelve showing 
the biggest increases and decreases in R&D in 2017/18 
are presented in table 3.2. The R&D growth of some of 
these companies is partly the result of mergers and ac-
quisitions. Examples include Dell which acquired EMC for 
$67bn and Merck (US) with the six acquisitions mentioned 
earlier. Amongst the large decreases in R&D, the 35% de-
crease on Hewlett Packard’s R&D was due to the sale of 
its large software division to Microfocus. 
Regarding the growth of net sales by non-EU companies, 
the best performance were observed in Chinese compa-
nies across most of sectors and for US companies in high 
tech sectors, e.g. in ICT services (China 34%, US 13%) and 
Chemicals (China 45%, US 15%). 
Among the largest non-EU companies, the following 
showed the highest increase in net sales: AMAZON.COM 
(31%) CHINA PETROLEUM & CHEMICALS (22%), PET-
ROCHINA (25%), EXXON MOBIL (18%), SAMSUNG (19%), 
JXTG (47%) and CHEVRON (22%).
And those that decreased significantly net sales: PETROLEOS 
DE VENEZUELA (-24%), STATOIL (-23%), ALTABA (-99%), 
HYUNDAI HEAVY INDUSTRIES (-31%), TOSHIBA (-19%) and 
CHINA GREATWALL (-88%).
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company One-year R&D growth (%) company
One-year R&D 
growth (%)
MERCK US 48.7 BOMBARDIER -16.9
ALPHABET 18.4 HONEYWELL -14.4
HUAWEI 16.6 PETROBRAS -51.1
DELL TECHNOLOGIES 67.2 PFIZER -4.9
FACEBOOK 31.0 REGENERON PHARMACEUTICALS -60.0
MICROSOFT 13.0 CELGENE -11.2
SAMSUNG 11.5 ALTABA -57.3
APPLE 15.3 GILEAD SCIENCES -17.7
JOHNSON & JOHNSON 16.0 GENERAL MOTORS -9.9
SNAP 722.0 HEWLETT PACKARD -35.3
TATA MOTORS 74.2 TOSHIBA -39.5
BRISTOL-MYERS SQUIBB 22.9 BOEING -33.0
TABLE 3.2: LARGEST R&D INCREASES AND DECREASES AMONG THE NON-EU COMPANIES IN 2017/18.
Note: Amazon showed a 41% increase in its ‘technology & content’ investment to $23bn. However, as explained in chapter 4, since Amazon does not separate the technology and 
content components, it is not possible to include most of this R&D in the Scoreboard.
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 3.1: NOMINAL CHANGE OF R&D OVER THE PAST YEAR FOR MAIN INDUSTRIES AND REGIONS.
Note: Growth rates have been computed for 572 EU, 776 US, 339 Japanese and 438 Chinese companies for with data are available for both years 2016 and 2017.
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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This section examines the changes on the distribution of 
the R&D investment of the Scoreboard companies across 
regions and industrial sectors over the past 10 years. The 
analysis shows characteristic differences and changes 
in the global R&D shares, reflecting the R&D speciality 
of regions and structural changes over 2008-2017. The 
Figure 3.3 shows the evolution of the R&D shares for main 
industries and Figures 3.4 and 3.5 show the R&D weight 
of the EU and US companies in the global composition 
of each industry. The financial crisis was triggered by the 
collapse of Lehmann Bros. in September 2008 and there 
appears to be some evidence of the effects of this in 
Figure 3.3 where the automotive sector, which is sensitive 
to the economic environment, shows a decrease in share 
from 2007 to 2009 and then a recovery through to 2015.
On the whole, the main sector shift in the past 10 years 
is observed in ICT industries. In ICT services the R&D 
share increased from 10.8% to 14.2% and ICT producers 
from 23.0% to 23.7%. On the other hand, sectors that 
underwent a decreases in R&D shares were mainly low-
tech sectors and also, to a lesser extent, Industrials, 
Aerospace & Defence and Chemicals.
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FIGURE 3.2: NOMINAL CHANGE OF NET SALES OVER THE PAST YEAR FOR MAIN INDUSTRIES AND REGIONS.
Note: Growth rates have been computed for 565 EU, 727 US, 339 Japanese and 435 Chinese companies for which Net Sales data are available for both years 2016 and 2017.
Source: The 20178 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
3.2 | Ten-year change in sector composition
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EU companies reinforced their specialisation in medium-
high tech sectors, increasing significantly their R&D 
contribution to the global R&D of Automobiles by more 
than 6 percentage points (from 40.1% to 46.7%). On the 
other side, EU companies reduced their global R&D share 
in ICT industries by more than 8 percentage points and to 
a lesser extent in low tech and Chemicals sectors.
US companies strengthened their position in high tech 
sectors, increasing substantially their global R&D weight 
in ICT services and Health (respectively by 8 and 4 
percentage points). On the other extreme, US companies 
strongly reduced their R&D share in Automobiles and 
Aerospace & Defence (by 6 percentage points).
For Asian companies, contrasting changes in global R&D 
shares are observed for those based in China and Japan. 
Chinese companies increased their global R&D shares for 
all sectors (mostly in low tech, ICT services and Industrials) 
whereas Japanese companies’ global R&D shares fell 
across the bord (mostly in ICT industries, low tech sectors 
and Automobiles). 
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FIGURE 3.3: EVOLUTION OF THE GLOBAL R&D SHARE FOR INDUSTRIAL SECTORS. 
Note: Calculated for a sample of 1674 companies for which data on R&D, Net Sales and Operating Profits are available for the entire period 2008-2017.
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 3.4: EVOLUTION OF THE GLOBAL R&D SHARE OF THE EU COMPANIES FOR MAIN INDUSTRIAL SECTORS.
Note: Figures displayed refer only to the 398 EU companies with R&D data available for the all period 2008-2017.
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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It is interesting to analyse the difference of R&D intensity 
between samples of companies based in different regions 
or countries in terms of structural and intrinsic factors (see 
Box 3.1)10. This has been discussed in past Scoreboard 
editions (e.g. in 2012) especially focusing the EU/US 
case. In this section, the analysis is extended to EU/China 
comparisons, also taking into account the trends of such 
R&D intensity differences. The figures 3.6 and 3.7 show 
respectively the evolution of the structural and intrinsic 
R&D intensity differences between the EU/US and EU/
China over the past 6 years11. Figures 3.8 and 3.9 show the 
R&D intensity differences broken down by main industries. 
• As observed in previous Scoreboards, the sample of 
EU companies present a persistent and increasing 
R&D intensity gap vis-à-vis its US counterparts. The 
largest part of this gap is due to structural factors 
(sector composition effect) but the gap over the past 
6 years has increased also in terms of intrinsic factors 
(R&D intensity differences sector by sector) in similar 
proportions to the structural gap.
• At the sector level, the EU/US gap is mostly explained 
by increasing R&D intensity differences in ICT services, 
ICT producers and Health industries whereas in 
Automobiles the EU shows an increasing positive R&D 
intensity difference.
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FIGURE 3.5: EVOLUTION OF THE GLOBAL R&D SHARE OF THE US COMPANIES FOR MAIN INDUSTRIAL SECTORS. 
Note: Figures displayed refer only to the 516 US companies with R&D data available for the all period 2008-2017.
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
3.3 | R&D intensity differences across regions: structural  
vs intrinsic factors
10 It should be reminded that the scope of this analysis is limited to the considered sample of companies that do not necessarily represent the actual industrial structure of 
their respective territorial unit, i.e. due to the limited number of companies, the samples are not representative in terms of sector composition although the R&D coverage 
is very high thanks to the characteristic concentration of industrial R&D.
11 Over this period, there is a sufficient number of companies with data fully available to allow a meaningful analysis.
Comparison EU/US:
Comparison EU/China:
• The EU companies show higher R&D intensities than 
their Chinese counterparts, especially with regard to 
intrinsic factors. However, the trend over the past 6 
years indicates a reduction of this difference that is 
more pronounced in terms of structural factors.
• At the sector level, the EU companies show higher R&D 
intensities than the Chinese ones in Automobiles, Health 
and Aerospace & Defence; and lower R&D intensities 
in both ICT producers and ICT services. The trends 
over the past 6 years indicate a strengthening of such 
R&D intensity differences, especially regarding the ICT 
producers sector.
49The 2018 EU Industrial R&D Investment Scoreboard
-3.0 
-2.5 
-2.0 
-1.5 
-1.0 
-0.5 
0.0 
2012 2013 2014 2015 2016 2017 
R&
D
 in
te
ns
ity
 g
ap
  
Structural intrinsic 
FIGURE 3.6: TREND IN THE EU-US R&D INTENSITY GAP– STRUCTURAL VS INTRINSIC COMPONENT.
Note: R&D intensity gaps have been computed for 497 EU and 623 US companies for which R&D and Net Sales data are available for the entire period 2012-2017.
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 3.7: TREND IN THE EU-CHINA R&D INTENSITY GAP– STRUCTURAL VS INTRINSIC COMPONENT.
Note: R&D intensity gaps have been computed for 497 EU and 376 Chinese companies for which R&D and Net Sales data are available for the entire period 2012-2017.
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 3.8: EU-US R&D INTENSITY GAP – SECTORAL TRENDS.
Note: R&D intensity gaps have been computed for 497 EU and 623 US companies for which R&D and Net Sales data are available for the entire period 2012-2017.
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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Box 3.1 
R&D intensity difference between 
two regions in terms of structural 
and intrinsic factors
The difference in R&D intensity between 
world regions or countries can be expressed 
in two terms: one representing the sectoral 
composition effect (i.e. due to structural 
differences) and the other representing 
underinvestment in R&D (i.e. due to intrinsic 
differences in R&D intensities, sector by 
sector). The following formula can be applied:
where:
- X and Y refer to the world regions/countries 
for which the comparison is performed;
- RDI = R&D intensity
- P is the share of sector i (in terms of 
production/turnover) within the given world 
region/country (X or Y)
The first term on the right side of the formula 
is the sectoral composition effect, taking into 
account the different shares of the various 
sectors within the compared world regions/
countries. If this term is negative, it means 
that the share of the R&D-intensive sectors 
within the total economy of region/country Y 
is larger than that in region/country X. 
The second term on the right side of the 
formula is the ‘R&D underinvestment 
effect’, accounting for the differences in 
R&D intensity sector by sector. If this term is 
negative, it means that the R&D intensities 
of sectors with high share within the total 
economy of region/country X are lower than 
those in region/country Y. 
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FIGURE 3.9: EU-CHINA R&D INTENSITY GAP – SECTORAL TRENDS.
Note: R&D intensity gaps have been computed for 497 EU and 376 Chinese companies for which R&D and Net Sales data are available for the entire period 2012-2017.
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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This chapter describes the performance of individual companies, with a focus on the results of companies at the top 
of the world R&D ranking, highlighting those companies that show considerable changes in economic and R&D perfor-
mance. Due to data availability, R&D figures for some companies may be under- or over-stated. The most extreme 
example of this is Amazon which would be positioned at #3 or #4 in the world R&D ranking if it had separated its 
R&D and content investments in its annual report (see explanations in Box 4.1).
Performance of top global R&D investors4
SAMSUNG is the top R&D investor worldwide, followed by ALPHABET and VOLKSWAGEN. 
The other companies in the top-ten are MICROSOFT, HUAWEI, INTEL, APPLE, ROCHE 
JOHNSON & JOHNSON and DAIMLER. Within the top 50 R&D investors there are 18 based 
in the EU, 22 US companies, 6 from Japan, 2 from Switzerland and one each from South 
Korea and China.
4.1 | Main changes in 2017/18
In this section, the world’s top 100 R&D companies 
are analysed, underlining those presenting important 
performance changes over the last reporting period.
In this Scoreboard edition, the top R&D investor is the 
company SAMSUNG (€13.44bn) from South Korea. The 2nd 
position is taken by the US company ALPHABET (€13.39) 
and the 3rd one for the German company VOLKSWAGEN 
(€13.14bn). The other companies in the top-ten are 
MICROSOFT, INTEL, APPLE, and JOHNSON & JOHNSON 
from the US, HUAWEI from China, ROCHE from Switzerland 
and DAIMLER from Germany.
The top 100 companies, accounting for 53% of the total 
R&D by the 2500 companies, showed growth of R&D 
(7.9%) somewhat below the world average (8.3%) and 
also lower growth of net sales (8.0% vs 9.7%).
Seventy-six companies in the top 100 have shown positive 
R&D investment growth. Among them, 40 companies had 
double-digit R&D growth, and of these, 23 companies also 
showed double-digit growth in net sales.
Most of the top 100 companies showing double-digit R&D 
increases are in the ICT producers (13), Health industries 
(9) and ICT services (7). The 5 companies showing the 
largest increase in R&D are TATA MOTORS (74.2%), DELL 
TECHNOLOGIES (67.2%), HON HAI PRECISION INDUSTRY 
(59.9%), ABBOTT LABORATORIES (52.3%) and WESTERN 
DIGITAL (50%). Several of these large increases are due 
to acquisitions. Examples are DELL which acquired EMC for 
$67bn, ABBOTT laboratories which acquired St. Jude Medical 
for $25bn in January 2017, HON HAI which acquired Sharp 
of Japan in mid-2016 and WESTERN DIGITAL which acquired 
SanDisk for $19bn in mid-2016.
As mentioned above, 17 companies had double-digit 
growth in R&D and net sales, the top 5 companies among 
them are DELL, ABBOTT, WESTERN DIGITAL, TENCENT and 
ALIBABA.
Twenty-four companies in the top 100 have experienced 
a decrease in R&D investment. The companies with the 
largest decrease in R&D are HONEYWELL (-14%); BANCO 
SANTANDER (-15%); GILEAD SCIENCES (-18 %); ALLERGAN 
(-27%) and BOEING (-33%). HONEYWELL spun off its 
resins & chemicals business as AdvanSix in late 2016 and 
announced in 2017 that other units would be divested.
The R&D intensity of companies in the top 100 (7.1%) 
remained practically the same of the previous year, due 
to R&D growth (7.9%) being similar to net sales growth 
(8.0%). The EU companies in the top 100 have slightly 
higher R&D intensity than that of non-EU companies 
(7.3% vs 7.1%). This difference is largely due to big low 
intensity non-EU companies such as Petrochina and China 
State Construction.
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Among the top 100 companies, 5 made losses (DELL, AL-
LERGAN, GENERAL ELECTRIC, ERICSSON and TEVA PHAR-
MACEUTICAL) with 22 showing profitability of only 5% or 
less but 31 showed profitability over 20%. All but two of 
the 31 operate in high R&D-intensive sectors (PROCTER & 
GAMBLE and BANCO SANTANDER).
4.2 | Long-term performance of top R&D companies
This section analyses the behaviour of the top companies 
over the long-term based on our historical database 
containing company data for the period 2002-2017. 
Results of companies showing outstanding R&D and 
economic results are underlined. 
The R&D ranking of the top 50 companies is presented 
in figure 4.1 and table 4.2 shows changes in such ranking 
since the first Scoreboard in 2004. A ranking of the top 
R&D investors by R&D intensity is shown in Table 4.3, 
indicating the reasons for main changes observed over 
the last period. It is important to note, as stated in the 
previous reports, that the growth of companies is often 
accompanied by mergers and acquisitions. 
There are 18 EU companies (same number as in 2004) and 
32 non-EU companies among the top 50 R&D investors. 
In the EU group, four companies left the top 50 (Alcatel, 
Istituto Finanziario Industriale, Philips, BAE Systems) and 
four companies joined the top 50 (Boehringer Ingelheim, 
Fiat Chrysler, SAP and Continental). ALCATEL first merged 
with LUCENT and the combined entity was later acquired 
by NOKIA.
In the non-EU group, thirteen companies left the top 
50 (FUJITSU, CANON, DELPHI, HITACHI, HEWLETT-
PACKARD, MATSUSHITA ELECTRIC, NEC, MOTOROLA, 
NORTEL NETWORKS (acquired), WYETH (acquired), SUN 
MICROSYSTEMS (acquired), NTT and TOSHIBA) and 
thirteen companies joined the top 50 (Amgen, Apple, 
Denso, CELGENE, Gilead Sciences, Alphabet, Huawei, 
Oracle, Panasonic, Qualcomm, Takeda Pharmaceuticals, 
Facebook and Abbvie that demerged from ABBOTT).
The distribution of the top 50 companies by main industrial 
sector and region changed from 2004 to 2018 as follows:
• Automobiles & Parts, from 13 (EU 7) to 14 (EU 8)
• Health industries, from 11 (EU 3) to 16 (EU 5)
• ICT industries,  from 13 (EU 3) to 16 (EU 4)
Three EU companies improved in the R&D ranking by at 
least 20 places – these are Bayer (now ranked 29th), SAP 
(now 47th) and CONTINENTAL (48th). 
There are 13 non-EU companies that gained more than 20 
places. They include Samsung (now 1st), ALPHABET (now 
2nd), HUAWEI (now 5th), APPLE (now 7th), ORACLE (now 
17th), QUALCOMM (now 28th), TAKEDA (now 49th), LG 
ELECTRONICS (now 50th), GILEAD SCIENCES (now 49nd), 
BRISTOL-MYERS SQUIBB (now 26th), CELGENE (now 41rd), 
FACEBOOK (15th) and BOEING (57th).
Two companies dropped twenty or more places but 
remained within the top 50: SONY (now 39th) and 
PANASONIC (now 36th).
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Companies showing the largest 10-years changes in R&D, net sales  
and employees
Companies among the top 100 R&D investors presenting 
remarkable results in terms of R&D, sales and employees 
over the past 10 years are listed in table 4.1 (ordered by 
level of R&D growth). 
The high growth companies, at the top of the table, 
showed more than 3-fold increase of R&D and employees 
and more than 5-fold increase of net sales. 
Box 4.1 
Understatement or overstatement 
of R&D figures
The Scoreboard relies on consistent disclo-
sure of R&D investment in published annual 
reports and accounts. However, due to differ-
ent national accounting standards and dis-
closure practices, in some cases, R&D costs 
cannot be identified separately in compa-
nies’ accounts, e.g. appearing integrated 
with other operational expenditures such as 
engineering costs. To avoid overstatement 
of R&D figures, the Scoreboard methodol-
ogy excludes R&D figures that are not dis-
closed separately (see methodological notes 
in Annex 2). Inevitably, the strict application 
of this criterion can lead to understating the 
actual R&D effort of some companies. 
An example of a possible large understate-
ment of R&D figures is the US company Am-
azon. The figure for Amazon’s R&D used in 
the Scoreboard is just the very small capi-
talised element of R&D. The vast majority of 
Amazon’s R&D is expensed under the head-
ing ‘Technology & Content’ – an investment 
of $22.62bn in 2017, up 41% on 2016. 
Amazon does not split this figure between 
technology and content. However, from 
Amazon’s annual reports for 2012-15 it is 
estimated that approximately $10.3bn of 
the $12.5bn for 2015 is technology (R&D). 
This has been increased by another $10.1bn 
from 2015 to 2017 and up to two-thirds of 
the increase is thought to be R&D. Assuming 
conservatively that only half is R&D, then 
2017 R&D is $15.3bn plus the capitalised 
R&D of $0.4bn, i.e. $15.7bn (€13.1bn) - that 
would place this company in the 3rd or 4th 
position of the world R&D ranking.
Firm R&D investment 2017 (€bn) 
Change in R&D 
2008-2017 (%) 
Change in net sales 
2008-2017 (%) 
Change in employees 
2008-2017 (%)
High 
growth 
firms
BAIDU 1.7 4135.5 2551.7 516.0
TENCENT 2.2 3002.5 3223.2 623.2
ALLERGAN 1.7 1110.2 528.7 251.1
APPLE 9.7 944.3 511.4 250.4
ALPHABET 13.4 474.8 408.6 296.2
SHIRE 1.4 218.3 401.6 511.4
Low 
growth 
firms
PROCTER & GAMBLE 1.6 -6.7 -12.9 -30.3
IBM 4.3 -7.3 -23.6 -8.0
NOKIA 4.9 -7.6 -54.4 -18.1
GENERAL MOTORS 6.1 -8.9 -1.5 -25.6
LEONARDO 1.5 -14.3 -23.3 -38.5
HITACHI 2.5 -20.1 -6.3 -15.1
TABLE 4.1: COMPANIES AMONG THE TOP 100 R&D INVESTORS SHOWING THE LARGEST CHANGES IN R&D, NET SALES AND EMPLOYEES.
* Procter and Gamble demerged several units over the 10-year period.
Source: The 2018EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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On the other extreme, the firms at the bottom of the 
table underwent a simultaneous drop of R&D, net sales 
and employees. Some of these large changes are due to 
acquisitions and divestments. An example is SHIRE which 
acquired Baxalta for $32bn in 2016 and made at least 
three other acquisitions in 2014-15. ALLERGAN also has 
a long record of acquisitions and doubled its sales and 
quadrupled its R&D just from 2013 to 2016. ALLERGAN 
was acquired by Activis in early 2015 and Activis then 
changed its name (and that of the combined entity) back 
to ALLERGAN. Amongst the big decreases is PROCTER & 
GAMBLE which decided to divest 100 brands in 2014 and 
sold 43 of these to Coty for $12.5bn.
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50. PEUGEOT, France 
49. GILEAD SCIENCES, US 
48. RENAULT, France 
47. AMGEN, US 
46. AIRBUS, Netherlands 
45. BOEHRINGER, Germany 
44. CONTINENTAL, Germany 
43. ERICSSON, Sweden 
42. DENSO, Japan 
41. CELGENE, US 
40. SAP, Germany 
39. SONY, Japan 
38. ELI LILLY, US 
37. NISSAN MOTOR, Japan 
36. PANASONIC, Japan 
35. DELL TECHNOLOGIES, US 
34. GENERAL ELECTRIC, US 
33. ABBVIE, US 
32. IBM, US 
31. FIAT CHRYSLER AUTOMOBILES, Netherlands 
30. GLAXOSMITHKLINE, UK 
29. ASTRAZENECA, UK 
28. QUALCOMM, US 
27. NOKIA, Finland 
26. BRISTOL-MYERS SQUIBB, US 
25. CISCO SYSTEMS, US 
24. ORACLE, US 
23. BAYER, Germany 
22. HONDA MOTOR, Japan 
21. SANOFI, France 
20. SIEMENS, Germany 
19. ROBERT BOSCH, Germany 
18. GENERAL MOTORS, US 
17. BMW, Germany 
16. PFIZER, US 
15. FACEBOOK, US 
14. FORD MOTOR, US 
13. NOVARTIS, Switzerland 
12. TOYOTA MOTOR, Japan 
11. MERCK US, US 
10. DAIMLER, Germany 
9. JOHNSON & JOHNSON, US 
8. ROCHE, Switzerland 
7. APPLE, US 
6. INTEL, US 
5. HUAWEI, China 
4. MICROSOFT, US 
3. VOLKSWAGEN, Germany 
2. ALPHABET, US 
1. SAMSUNG, South Korea 
R&D investment (Euro million) 
US
EU
Japan
South Korea 
Switzerland
China
FIGURE 4.1: THE WORLD’S TOP 50 COMPANIES BY THEIR TOTAL R&D INVESTMENT IN THE 2018 SCOREBOARD.
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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Rank 
2018 Company Country
R&D in 2017/18 
(€bn)
R&D intensity 
(%)
Rank change 
2004-2018
1 SAMSUNG South Korea 13.4 7.2 up 32
2 ALPHABET US 13.4 14.5 up > 200 
3 VOLKSWAGEN Germany 13.1 5.7 up 5
4 MICROSOFT US 12.3 13.3 up 9
5 HUAWEI China 11.3 14.7 up > 200 
6 INTEL US 10.9 20.9 up 8
7 APPLE US 9.7 5.1 up 97
8 ROCHE Switzerland 8.9 19.5 up 10
9 JOHNSON & JOHNSON US 8.8 13.8 up 3
10 DAIMLER Germany 8.7 5.3 down 7
11 MERCK US US 8.5 25.3 up 18
12 TOYOTA MOTOR Japan 7.9 3.6 down 7
13 NOVARTIS Switzerland 7.3 17.5 up 7
14 FORD MOTOR US 6.7 5.1 down 13
15 FACEBOOK US 6.5 19.1 up > 200 
16 PFIZER US 6.2 14.1 down 14
17 BMW Germany 6.1 6.2 up 11
18 GENERAL MOTORS US 6.1 5.0 down 12
19 ROBERT BOSCH Germany 5.9 7.6 up 9
20 SIEMENS Germany 5.5 6.7 down 15
21 SANOFI France 5.5 15.5 down 5
22 HONDA MOTOR Japan 5.4 4.8 up 9
23 BAYER Germany 5.2 11.2 up 37
24 ORACLE US 5.1 15.3 up 22
25 CISCO SYSTEMS US 5.1 12.6 up 5
26 BRISTOL-MYERS SQUIBB US 5.0 28.7 up 16
27 NOKIA Finland 4.9 21.2 down 17
28 QUALCOMM US 4.6 24.5 up 64
29 ASTRAZENECA UK 4.5 24.1 down 4
30 GLAXOSMITHKLINE UK 4.4 12.8 down 19
31 FIAT CHRYSLER Netherlands 4.3 3.9 up 13
32 IBM US 4.3 6.5 down 22
33 ABBVIE US 4.2 17.7 new
34 GENERAL ELECTRIC US 4.0 4.0 up 3
35 DELL TECHNOLOGIES US 4.0 6.0 new
36 PANASONIC Japan 3.7 6.3 down 29
37 NISSAN MOTOR Japan 3.7 4.1 down 3
38 ELI LILLY US 3.5 18.2 up 3
39 SONY Japan 3.4 5.4 down 24
40 SAP Germany 3.3 14.2 up 30
41 CELGENE US 3.3 30.5 up > 200 
42 DENSO Japan 3.3 8.8 down 7
43 ERICSSON Sweden 3.3 15.9 down 26
44 CONTINENTAL Germany 3.2 7.3 up 73
45 BOEHRINGER SOHN Germany 3.1 17.0 up 17
46 AIRBUS Netherlands 3.0 4.5 down 11
47 AMGEN US 3.0 15.6 down 10
48 RENAULT France 3.0 5.0 down 3
49 GILEAD SCIENCES US 2.9 13.5 up > 200 
50 PEUGEOT France 2.9 4.5 down 12
TABLE 4.2: THE TOP 50 COMPANIES IN THE 2018 SCOREBOARD: RANK CHANGE 2004-2018.
Note: companies in “blue” went up more than 20 ranks and in “red” lost more than 20 ranks.
Source: The 2018 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
58 The 2018 EU Industrial R&D Investment Scoreboard
The previous section analysed the top 50 companies 
by size of R&D investment. However, since some 
large companies have very large sales, the size of 
their R&D investment may not be a reliable guide to 
the importance of R&D in maintaining the company’s 
competitive edge. For example, Petrochina has R&D of 
€1.6bn and is #88 in the Scoreboard but R&D is neither 
a key driver nor the main component of its competitive 
edge. That is highlighted by its R&D intensity of 0.6%. 
The same applies to China State Construction which has 
an R&D intensity of 1.2% and to Shell with an intensity 
of 0.3%. This section therefore examines the subset of 
large companies in the Scoreboard with R&D intensity 
of 10% or more and R&D of at least €1bn. These are 
substantial companies for which R&D is a key factor in 
their continuing success. The criteria for inclusion in the 
top 50 by R&D intensity are:
• R&D should be over €1bn in 2017/18 which means 
only the top 139 companies in the Scoreboard are 
eligible. 
• And R&D intensity should be over 10%. The top 50 
such companies are selected with Cisco Systems at 
#50 with intensity of 12.6%. That means 12.6% or 
more is required to be in the top 50 for 2018 compared 
to 12.7% in 2017.
The top 50 large companies with high R&D intensity are 
displayed in table 4.3 which also shows each company’s 
R&D, R&D rank and intensity rank with the intensity rank 
change from 2017. We will now look at the top 50’s new 
entrants and leavers, at its make-up by sector and region 
and then at a special subset of high growth/high intensity 
companies.
4.3 | Ranking of large companies by R&D intensity
4.3.2 New entrants, leavers and big changes
4.3.3 The top 50 by sector and world region
There are five new entrants for 2018 – Snap, Adobe, GSK, 
Leonardo and Cisco. Snap entered because of a massive 
increase in R&D; it was #599 in the 2017 Scoreboard but 
rose to #110 for 2018. Three of the other four companies 
had intensities below 12.7% in 2017 (but over 12% for 
both GSK & Cisco) while Adobe had R&D below €1bn in 
2017. These five replaced 2017 top 50 companies Intuit, 
Applied Materials, Altaba, Micron Technology and Vertex 
Pharma. The R&D of Intuit, Altaba and Vertex fell below 
€1bn in 2018, Micron’s intensity fell below 10% and 
Applied Materials’ intensity fell to 12.2% (making it #51 
in 2018) because its sales grew much more than its R&D. 
A total of 11 companies rose or fell in the top 50 
rankings by 9 or more places. The big risers were AbbVie, 
Astellas, Biogen, Johnson & Johnson whose R&D 
increased so the intensity rose and Ericsson & Sanofi 
whose sales were down with a modest rise in R&D so 
the intensity also increased but for a different reason. 
The big fallers were Huawei, ASML and Boehringer 
for which sales rose more than R&D (so intensity was 
down). Boehringer’s R&D also declined a little (by 1.1%). 
Then two companies reduced their R&D - Gilead by 
17.7% and Allergan by 27%.
Just three sectors – biopharmaceuticals, hardware and 
software account for 47 of the top 50 with three other 
sectors contributing one company each. This is not 
surprising since these three sectors are the most R&D 
intensive and companies in them depend on a flow of 
new and innovative products to maintain their competitive 
edge. The details are:
• Biotech & pharmaceuticals accounts for 23 companies 
in the top 50
• Technology hardware contributes 15 of the top 50
• Software accounts for 9 of the top 50
• Aerospace & Defence, general retail and travel & 
leisure each contribute one company.
The average R&D intensity for the 23 biopharma 
companies is a high 18.1% compared to the sector 
average from past Scoreboard analyses of the global 
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biopharma sector of 10-11%. This reflects the presence 
of the four large US biotechs in the top 50 together with 
biotech-oriented pharmaceutical groups such as Roche 
(which fully acquired Genentech in 2009). The average for 
the 14 hardware companies in the top 50 is 17.3% (we 
use 14 not 15 since we exclude the exceptional 183% for 
Snap) compared to a global average of 8-9%. For software 
the average intensity of the 9 companies in the top 50 is 
16.6% compared to a global average of 15%.
The regional make-up of the top 50 is heavily weighted 
towards the US which has exactly one half of the 50 
companies. The details are:
• The US has 25 of the top 50 high intensity large 
companies
• The EU is the next largest with 14 of the top 50
• Asia has 9 of the top 50 
• Switzerland has 2 companies (Roche & Novartis)
There is a clear regional specialisation in certain sectors 
with the US having 7 of the 9 software/internet companies 
with one each from the EU and Asia. The US also has 7 of 
the 15 hardware companies but is more closely followed 
by the EU with 5 and then Asia with 3. In biopharma, the 
US has 10 companies, the EU 7, Asia 4 and Switzerland 2. 
This is consistent with the Scoreboard’s findings from the 
whole dataset of 2,500 global companies where the US is 
by far the largest regional contributor to ICT producers/ICT 
services and the largest to health industries.
An R&D intensity above sector average as is the case 
for most of the top 50 is a driver of sales growth since 
innovative new products give a company an edge over 
competitors in the market provided the R&D is well-
directed. It is therefore not surprising that many companies 
in the top 50 have moved well up the rankings in the main 
Scoreboard of 2,500 companies in both R&D and sales 
in the last few years. Examples are Alphabet (#2 in 2018 
but #26 in 2012), Baidu (#81 in 2018 but #450 in 2012), 
Salesforce.com (#107 in 2018 but #493 in 2012), Celgene 
(#41 in 2018 but #97 in 2012) and NXP Semiconductors 
(#109 in 2018 but # 203 in 2012).
The ranking of the top 50 companies by R&D intensity in 
table 4.3 takes no account of the differing growth rates 
of the various companies. There is a special subset of all 
high R&D intensity companies that also have high R&D 
growth and high sales growth. These are companies that 
are increasing their market share and also investing more 
in new products and services to improve their market 
position still further. We examine a set of these companies 
in the next section.
4.3.4 High R&D intensity companies with high R&D & sales growth
Of the 139 Scoreboard companies with R&D over €1bn, 
table 4.3 shows that only 50 have R&D intensity of 12.6% 
or more. Furthermore, just 17 of the 139 companies have 
all three measures of R&D intensity, R&D growth and sales 
growth in double figures (10% or more). If, however, we 
broaden the R&D criterion to the top 250 companies in the 
Scoreboard which have R&D of €500m or more we find 
that 30 of them have all three measures in double figures. 
Not surprisingly, 13 of the 30 also appear in the top 50 by 
R&D intensity – these are the companies with R&D over 
€1bn and intensity of 12.6% or more. The 30 high growth/
high intensity companies are displayed in table 4.4 which 
shows the companies, their rank by R&D intensity, their 
sectors, R&D, R&D intensity, R&D growth and sales growth. 
The sectoral split is as follows:
• Technology Hardware accounts for 12 of the top 30
• Software contributes 10 of the 30
• Biopharmaceuticals accounts for another 5 companies
• There are also companies from the automotive (2) and 
electronics sectors to take the total up to 30
The big difference between this sectoral split and that 
for the top 50 companies by R&D intensity alone is that 
biopharma companies, by far the largest of the three 
main sectors in the top 50, becomes the smallest of the 
three in the top 30. That reflects the longer term nature 
of biopharma R&D where pipeline drugs need extensive 
clinical trials before being approved by regulators. This 
means that it is harder to grow both sales and R&D as fast 
in the short-term compared to companies in the hardware 
or software sectors.
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The regional make-up of the top 30 has some similarities 
to that of the top 50 by R&D intensity but with a higher 
US proportion:
• The US has 22 of the 30 companies (73.3%) compared 
to 50% for the top 50. The 22 companies consist of 10 
from hardware, 8 from software, 3 from biopharma and 
one automotive (Tesla)
• Both the EU and Asia have 4 companies (13.3%) each 
from four different sectors. These are automotive, 
hardware, pharma and software for the EU and 
electronics, hardware, pharma and software for Asia. 
The four Asian companies comprise 2 from Japan and 
2 from China.
The US is clearly very strong in the ICT sectors as was 
mentioned above in the top 50 analysis.
Given the high growth and high intensity of the top 30 
companies in table 4.4, one would expect to find many 
companies there that have moved well up the main 
global 2,500 Scoreboard rankings in the last few years. 
Examples include Snap (#110 in 2018 but around #1100 
in 2016), Facebook (#15 in 2018 but #295 in 2012) and 
Tesla (#120 in 2018 but #467 in 2014).
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2017/18 world rank 
by R&D Intensity. 
( )= 2016/17
rank
R&D €bn (rank 
in brackets is by 
2017/18 R&D)
 
Company name
(All have 
R&D>€1bn)
Industrial Sector
R&D 
Intensity 
2017/18 
%
Intensity rank 
change
 from 2016/17
 & reason (if
change >5)
1 (new) 1.26bn (110) Snap Hardware 183% R&D up over €1bn
2 (2) 1.06bn (130) Ctrip.com International Travel & Leisure 30.8% =
3 (3) 3.31bn (41) Celgene Biotech 30.5% =
4(4) 4.96bn (26) Bristol-Myers Squibb Biopharma 28.7% =
5 (6) 1.1bn (127 ) Electronic Arts Software 25.6% +1
6 (5) 8.47bn (131) Merck US Biopharma 25.3% -1
7 (8) 4.56 (28) Qualcom Hardware 24.5% +1
8 (7) 1.74bn (78) Daiichi Sankyo Pharma 24.6% -1
9 (5) 4.51bn (29) AstraZeneca Biopharma 24.1% -4
10 (17) 1.6bn (83) Mediatek Hardware 24.0% +7 (sales down)
11 (15) 4.92bn (27) Nokia Hardware 21.2% +4
12 (10) 10.92bn (6) Intel Hardware 20.9% -2
13 (20) 8.88bn (8) Roche Biopharma 19.5% +7 (R&D up)
14 (11) 6.47bn (15) Facebook Software/internet 19.1% -3
15 (17) 2.74bn (52) Broadcom Hardware 18.7% +2
16(12) 1.5bn (94) Nvidia Hardware 18.5% -4
17 (26) 1.88bn (69) Biogen Biotech 18.4% +9 (R&D up)
18 (19) 2.4bn (58) Takeda Pharma Pharma 18.4% +1
19 (15) 3.47bn (38) Eli Lilly Pharma 18.2% -4
20 (29) 4.15bn (33) AbbVie Pharma 17.7% +9 (R&D up)
21 (24) 7.33bn (13) Novartis Pharma 17.5% +3
22= (31) 1.63bn (82) Astellas Pharma Pharma 17.0% +9 (R&D up)
22=(13) 3.08bn (45) Boehringer Sohn Pharma 17.0% -9 (R&D ↓, sales ↑)
24 =New) 1.02bn (136) Adobe Systems Software 16.8% R&D up over €1bn
24= (30) 1.3 (109) NXP Semiconductor Hardware 16.8% +6 (R&D up)
26 (40) 3.26 (43) Ericsson Hardware 15.9% +14 (R&D ↑, sales ↓)
27 (27) 2.97bn (47) Amgen Biotech 15.6% =
28 (40) 5.45bn (21) Sanofi Pharma 15.5% +12 (R&D↑, sales↓)
29 (23) 1.07bn (129) ST Microelectronics Hardware 15.4% -6 (R&D down)
30=(38) 1.66(81) Baidu Software 15.3% +8 (R&D up)
30=(28) 5.08bn (24) Oracle Software 15.3% -2
32 (36) 1.3bn (107) Salesforce.com Software 14.9% +4 
33 (22) 11.33bn (5) Huawei Hardware 14.7% -11 (sales↑>R&D↑)
34 (34) 13.39bn (2) Alphabet Software/internet 14.5% = 
35 (43) 1.14bn (123) eBay General Retail 14.3% +8 (R&D up)
36= (40) 1.3bn (108) Otsuka Pharma 14.2% +4 
36= (44) 3.33bn (40) SAP Software 14.2% +8 (R&D up)
38 (35) 6.17bn (16) Pfizer Pharma 14.1% -3
39 (47) 2.14bn (62) Merck DE Pharma 13.9% +8`(R&D up)
40 (50) 8.8bn (9) Johnson & Johnson Pharma 13.8% +10 (R&D up)
41 (32) 2.93bn (49) Gilead Sciences Biotech 13.5% -9 (R&D down)
42 (36) 12.28bn (4) Microsoft Software 13.3% -6 (sales↑>R&D↑)
43 (new) 1.52bn (93) Leonardo Aerospace & Defence 13.1% New (intensity ↑)
44= (21) 1.72bn (80) Allergan Pharma 12.9% -23 (R&D down)
44= (46) 1.93bn (68) Novo Nordisk Pharma 12.9% +2
44= (45) 1.8 (76) ZTE Hardware 12.9% +1
47= (33) 1.16bn (119) ASML Hardware 12.8% -14 (sales↑>R&D↑)
47= (new) 4.35bn (30) GSK Pharma 12.8% New (intensity ↑)
47= (49) 2.04bn (64) Western Digital Hardware 12.8% +2
50 (new) 5.05bn (25) Cisco Systems Hardware 12.6% New (intensity ↑)
TABLE 4.3: RANKING BY R&D INTENSITY OF TOP LARGE SCOREBOARD COMPANIES WITH R&D>€1BN
Note: The colours indicate world region (red for US, blue for EU, black for Asia & green for Switzerland)
Source: The 2018 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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Rank 
by R&D 
intensity
Company
(All high growth  
& high intensity)
Sector R&D 2017/18& rank €bn
R&D
Intensity 
(>10%)
R&D 
Growth 
(>10%)
Sales 
Growth 
(>10%)
1 Snap Hardware 1.26bn (110) 183% 722% 104%
2 Incyte Pharma 0.96bn (147) 74.9% 145.3% 38.9%
3 Ubisoft Software 0.78bn (175) 45.2% 21.0% 18.6%
4 Workday Software 0.76bn (183) 42.5% 33.8% 36.1%
5 Alexion Pharma Pharma 0.73bn (193) 24.7% 16.0% 15.1%
6= Eisai Pharma 0.97bn (145) 21.8% 26.0% 11.3%
6= AMD Hardware 0.97bn (146) 21.8% 15.1% 24.7%
6= Intuit Software 0.94bn (150) 21.8% 14.4% 10.3%
9 Ferrari Automotive 0.74bn (188) 21.7% 13.9% 10.0%
10 Symantec Software 0.80bn (174) 19.7% 16.3% 20.6%
11 Facebook Software/internet 6.47bn (15) 19.1% 31.0% 47.1%
12 Analog Devices Hardware 0.81bn (171) 19.0% 48.1% 49.3%
13 Broadcom Hardware 2.74bn (52) 18.7% 23.1% 33.2%
14 Nvidia Hardware 1.5bn (94) 18.5% 22.8% 40.6%
15 Abbvie Pharma 4.15bn (33) 17.7% 21.1% 10.1%
16 Adobe Systems Software 1.02bn (136) 16.8% 25.4% 24.7%
17 Renesas Electronics 0.94bn (151) 16.3% 62.6% 65.6%
18 Baidu Software 1.66bn (81) 15.3% 27.2% 20.2%
19 Kla-Tencor Hardware 0.51bn (250) 15.1% 15.5% 16.0%
20 Salesforce.com Software 1.3bn (107) 14.9% 28.5% 24.9%
21 Huawei Hardware 11.33bn (5) 14.7% 16.6% 15.7%
22 Alphabet Software/internet 13.39bn (2) 14.5% 18.4% 22.8%
23 Microsoft Software 12.28bn (4) 13.3% 13.0% 14.3%
24 ASML Hardware 1.16bn (119) 12.8% 12.6% 33.2%
25 Western Digital Hardware 2.04bn (64) 12.8% 50.0% 46.9%
26 Applied Materials Hardware 1.48bn (95) 12.2% 15.3% 34.3%
27 Tesla Automotive 1.15bn (120) 11.7% 65.2% 68.0%
28 Shire Pharma 1.43bn (98) 11.3% 22.1% 33.0%
29 LAM Research Hardware 0.99bn (141) 10.7% 17.3% 38.2%
30 Texas Instruments Hardware 1.26bn (111) 10.1% 10.1% 11.9%
TABLE 4.4: RANKING BY R&D INTENSITY OF SCOREBOARD COMPANIES (R&D>€500M AND BOTH R&D & SALES GROWTH >10%) 
Note: The colours indicate world region (red for US, blue for EU, black for Asia).
Source: The 2018 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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This chapter examines the R&D and economic trends of companies based in Members States of the EU. This specific 
analysis is based on an extended sample of companies representing the top 1000 R&D investors in the EU, i.e. the 
577 EU companies included in the world top 2500 sample and 423 additional companies based in the EU. The 
EU1000 have a total R&D of €206.3bn but just the top 577 companies account for €200.1bn or 97% of this. The 
distribution of the EU 1000 companies across industrial sectors and countries can be found in Annex 3. 
The first section presents the one-year changes in R&D and the financial performance indicators of companies, especially 
those based in the top 10 largest Member States. The second section analyses the long-term trends of company results, 
mainly in terms of R&D, net sales and employment.
Analysis of the top EU 1000 R&D investors5
The EU1000 shows a high concentration of R&D. The three largest countries (Germany, 
the UK and France) contribute to two thirds of both total R&D and total sales. Most 
German R&D is in the automotive sector, the UK’s in pharmaceuticals while France has 
more of a balance R&D sector composition.
5.1 | Changes in the main indicators in 2017/18
As explained in chapter 1 for the world sample of 
companies, industrial R&D is very concentrated by country 
and sector. Among the EU 1000 sample, there are 899 
companies based in the top 10 Member States accounting 
for 97.1 % of the total R&D. Moreover, the overall 
performance of the EU 1000 group is largely driven by 
the results of companies based in Germany, France and 
the UK, accounting for 61% of the companies, 68% of the 
total R&D and 68% of total net sales. Just three broad 
sectors (automotive, health and ICT) account for 72% of 
the EU1000’s total R&D.
The top 1000 R&D companies in the EU invested 
€206.3bn, 5.4% more than the previous year.
The German companies made the largest contribution to 
the results of the EU 1000 sample. They increased R&D 
by 6.3% and net sales by 6.5%. These results reflect to a 
large extent the performance of the German companies in 
the country’s large Automobiles sector (5.7% in R&D and 
6.3% in net sales). Indeed the top five German automotive 
companies account for 45% of all German R&D in the 
EU1000. Companies from this sector showing the highest 
R&D growth were DAIMLER and BMW and from other 
sectors SIEMENS, BAYER and SAP. 
The companies based in the UK increased R&D by 6.9% 
but showed a large increase in net sales (16.2%) due 
mainly to the impact of the oil price in companies such 
as SHELL and BP. The largest contributions to R&D growth 
were made by companies from several different sectors, 
e.g. GLAXOSMITHKLINE, LLOYDS, SHIRE, VODAFONE, 
ROLLS-ROYCE. 
Companies based in France increased R&D by 8.2% and 
sales by 9.1%. Among these companies, the largest 
contribution to the R&D growth came from the Automobiles 
sector (PEUGEOT, RENAULT, VALEO), ICT producers and 
Health (e.g. SCHNEIDER and SANOFI). As mentioned in 
earlier chapters the R&D growth of Peugeot, Valeo and 
Schneider benefited from recent acquisitions.
Apart from the three top Member States, among the group 
of largest EU countries, those whose companies increased 
R&D above the EU average were:
Italy by 9.5%, mostly due to R&D increases of companies 
such as TELECOM ITALIA, LEONARDO and INTESA 
SANPAOLO.
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Sweden by 6.1%, with large contributions from companies 
such as ELECTROLUX, ERICSSON, HEXAGON and 
FINGERPRINT CARDS.
Among the large countries, the groups of companies that 
decreased R&D are from Ireland (-3.8%) and from Spain 
(-2.4%). In Ireland, high R&D growth of companies such as 
ALLIED IRISH BANKS and ACCENTURE has been offset by 
a large reduction of R&D by ALLERGAN. And in Spain, high 
R&D growth of companies such as GRIFOLS and INDRA 
SISTEMAS has been offset by reduction of R&D by BANCO 
SANTANDER and SENER GRUPO DE INGENIERIA.
In terms of net sales, companies from Spain showed high-
er than average growth and those from Ireland presented 
negative results.
In 2017/18, the average R&D intensity of the EU-1000 
companies decreased because of the lower increase of 
R&D investments compared to that of net sales, 5.4% vs 
8.5%. 
It is important to remember that in many countries, the 
aggregate country indicators depend to a large extent on 
the figures of a very few firms. This is due, either to the 
country’s small number of companies in the Scoreboard 
or to the concentration of R&D in a few large firms. For 
example, five German automotive companies account 
for 45% of German R&D, Ericsson and Volvo account for 
53% of the total R&D by the Swedish companies, Nokia 
for 76% of the companies based in Finland, Telecom Italia 
and Leonardo for 54% of the companies based in Italy and 
Airbus & FiatChrysler for 40% of Netherlands R&D. 
Country No. of companies
R&D in 2017 
(€bn)
R&D Share 
within EU (%)
 R&D one year 
growth (%)
Net Sales one 
year growth (%)
Germany 219 81.3 39.4 6.3 6.5
UK 275 30.5 14.8 6.9 16.2
France 111 29.0 14.0 8.2 9.1
Netherlands 53 18.5 8.9 0.6 5.3
Sweden 77 9.5 4.6 6.1 4.5
Ireland 27 8.5 4.1 -3.8 -1.1
Italy 39 6.5 3.2 9.5 6.3
Finland 36 6.4 3.1 1.1 5.2
Denmark 42 5.3 2.6 1.7 3.8
Spain 20 4.6 2.2 -2.4 8.3
Top 10 countries 899 200.2 97.0 5.2 8.4
Other EU 101 6.1 3.0 13.0 11.2
Total EU 1000 206.3 100 5.4 8.5
TABLE 5.1: R&D TRENDS FOR COMPANIES BASED IN THE TOP 10 EU MEMBER STATES.
Note: For the sample of 1000 EU companies.
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
Sector R&D in 2017 (€bn)
Germany 1-year 
change (%)
France 1-year 
change (%)
UK 1-year 
change (%)
 R&D Net Sales  R&D Net Sales  R&D Net Sales 
Aerospace & Defence 9.0 -1.8 13.5 -3.0 2.9 15.4 5.6
Automobiles & other transport 61.3 5.7 6.3 14.5 15.3 -8.2 6.6
Chemicals 5.7 2.1 10.6 -7.6 10.2 -0.3 19.9
Health industries 46.0 7.1 5.0 7.2 -0.7 8.3 14.1
ICT producers 26.7 8.9 5.7 23.1 2.2 2.3 5.4
ICT services 15.2 10.7 3.4 9.8 2.3 17.7 2.9
Industrials 12.1 10.8 7.9 -7.2 20.4 24.1 24.1
Others 30.3 2.9 6.4 5.2 8.9 3.7 18.1
Total 206.3 6.3 6.5 8.2 9.1 6.9 16.2
TABLE 5.2: GROWTH OF R&D AND NET SALES FOR THE GERMAN, FRENCH AND UK COMPANIES - BREAK DOWN FOR 7 MAJOR INDUSTRIAL SECTORS.
Note: For the sample of 1000 EU companies.
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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This section presents the evolution of the main company performance indicators over the past 10 years for the compa-
nies in the EU 1000 group. 
5.2 | Long-term trends for companies based in the large 
Member States
5.2.1 Long-term trends
The annual growth rates of R&D and net sales and 
profitability for companies based in Germany, France, 
UK and Netherlands over the past 10 years is provided 
respectively in figures 5.1, 5.2, 5.3 and 5.4. These figures 
are based on our history database comprising these 
indicators over the whole 2008-2017 period for EU 
companies based in Germany (147), France (81), UK (126) 
and NL (30).
Companies based in Germany continued the strong 
performance in terms of R&D shown since 2010, recovering 
to and then improving on levels of R&D growth prior to the 
crisis. However, the growth of net sales has not followed 
the same path, a slowdown from 2010 to 2013 has been 
followed by a hesitant recovery from 2013 to 2014/15, 
then again sales decreased from 2015 to 2016 and finally 
recovered significantly over the last period. On the other 
hand, German companies have maintained a stable level 
of profitability over the past 10 years in the 5-8% range 
with a positive trend over the past two years. 
Companies based in France showed a low but positive 
trend in R&D growth after the decrease from 2013 to 
2014, but at much lower levels than their EU or non-EU 
counterparts although growth recovered significantly 
from 2016 to 2017. The growth of net sales reversed 
the negative trend showed over 2010-2014 increasing 
significantly from 2016 to 2017. The average profitability 
of the French companies showed a negative trend from 
2011 to 2015 but it then increased from 2015 to 2016 
and remained stable in 2017 at 9%.
Companies based in the UK showed a strong recovery of 
R&D and net sales in 2009 to 2010 that then reversed 
in 2010 to 2012. In 2012-2013 their R&D investment 
resumed to grow at significant pace but with a level of 
net sales practically unchanged. In 2014/15 the R&D 
level remained practically unchanged although with 
a significant decrease of net sales but both R&D and 
sales increased strongly from 2015-2017. The average 
profitability of the UK companies was the highest of the 
three countries throughout the period although, like their 
French counterparts, showed a decreasing trend from 
2011-2015 but a strong increase in 2016/17 remaining 
stable at 10-11% over the last two years.
Companies based in the Netherlands registered an 
increase in R&D and sales over 2009-2012 and then 
a slowdown over 2012 to 2013. From 2015 to 2016, 
R&D and sales grew moderately and over the last 
period R&D stagnated while sales continued to grow at 
significant pace. The profitability of companies based in 
the Netherlands remained stable at 5-6% from 2010 to 
2016, showing a slight upward trend to 7% in 2017. Two 
companies –FiatChrysler and Airbus account for 40% of 
Netherlands R&D. Their HQs are in the Netherlands but 
their main operations are located elsewhere.
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FIGURE 5.1: ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH AND PROFITABILITY BY THE GERMAN COMPANIES.
Note: Growth rates for the three variables have been computed on 147 out of the 219 German companies for which data are available for the entire period 2008-2017.
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 5.2: ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH AND PROFITABILITY BY THE FRENCH COMPANIES.
Note: Growth rates for the three variables have been computed on 81 out of the 111 French companies for which data are available for the entire period 2008-2017.
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 5.3: ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH AND PROFITABILITY BY THE UK COMPANIES.
Note: Growth rates for the three variables have been computed on 126 out of the 275 UK companies for which data are available for the entire period 2008-2017.
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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The levels of R&D, net sales and employment in 2008 and 
2017 are presented in figures 5.5, 5.6 and 5.7 for groups 
of industrial sectors with characteristic R&D intensities12 
(see definition in Chapter 1 – Table 1.3). 
The figures refer to a set of 618 companies that reported 
R&D, net sales and number of employees in the first and 
the last year of the period 2008-2017 (DE-153, FR-77, 
UK-131, NL-29 and Other EU-228). 
Over the past 10 years, the R&D, net sales and employment 
changes for the whole sample of EU companies are very 
similar to those of the EU sample within the world set 
(concentration effect).
The overall changes for each indicator are:
• R&D increased by 50%(high tech 43%, medium-high 
tech 70%, medium-low tech 15% and low tech 10%)
• Net sales increased by 12%(high tech 43%, medium-
high tech 46%, medium-low tech 14% and low tech 
-14%)
• Employment increased by 11% (high tech 29%, 
medium-high tech 26%, medium-low tech -15% and 
low tech -2%).
These three indicators changed in very different proportions 
across member states and sector groups. By sector groups 
the highest increases were:
• In high tech (R&D - DE 80%; Net sales - DE 76%; 
Employment, DE 56%)
• In medium-high tech (R&D - UK 129%; Net sales - UK 
60%; Employment - DE 29%)
• In medium-low tech (R&D – Other EU 72%; Net sales - 
UK 69%; Employment - UK 1%)
• In low tech sectors (R&D - NL 179%; Net sales - NL 
127%; Employment - NL 77%)
The above results analysed by member state show distinct 
characteristics of the R&D investing companies in each 
country. Germany has the largest proportion of its R&D 
in medium-high tech, with the UK having the largest 
proportion in high tech while France has almost equal 
proportions in high tech and medium-high tech. In terms 
of changes over 2008-2017:
• German companies increased their R&D by 80% and 
employment by 56% in high tech whereas French 
companies grew R&D only by 37% and employment 
5.2.2 Change in R&D, net sales and employment over 2008-2017  
for groups of sectors and top EU company aggregates
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FIGURE 5.4: ONE-YEAR R&D INVESTMENT AND NET SALES GROWTH AND PROFITABILITY BY THE DUTCH COMPANIES.
Note: Growth rates for the three variables have been computed on 30 out of the 53 Dutch companies for which data are available for the entire period 2008-2017.
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
12 For simplification, in this section these groups are referred to as high tech, medium-high tech, medium-low tech and low-tech.
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by a similar rate (36%). This means that the ratio 
R&D/employees in the high tech sector increased for 
German companies but stagnated for French ones. On 
the other hand, German companies increased the ratio 
sales/employee more than the French companies for 
high tech and for the whole sample.
• UK companies showed a large percentage increase 
(over 100%) in medium-high tech R&D but from a low 
base and a moderate increase in high tech R&D. There 
was an overall stagnation in sales (-7%) due to a 27% 
decrease in the low tech sector which has companies 
with very large sales, e.g. oil & gas, mining and banks. 
However, there was a large net sales growth in 3 
groups (high, medium-high and medium- tech groups). 
• Companies based in the Netherlands, which has 
negligible R&D in low and medium-low tech sectors, 
showed significant increases for the 3 indicators.
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FIGURE 5.5: R&D INVESTMENT IN 2008 AND 2017 BY SECTOR AND MAIN EU GROUPS.
Note: Figures displayed refer only to the 618 companies for which data are available for all variables (R&D, Net Sales and Employment) both years (2017 and 2008).
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 5.6: NET SALES IN 2008 AND 2017 BY SECTOR AND MAIN EU GROUPS.
Note: Figures displayed refer only to the 618 companies for which data are available for all variables (R&D, Net Sales and Employment) both years (2017 and 2008).
Source: The 2018EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
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FIGURE 5.7: EMPLOYMENT IN 2008 AND 2017 BY SECTOR AND MAIN EU GROUPS.
Note: Figures displayed refer only to the 618 companies for which data are available for all variables (R&D, Net Sales and Employment) both years (2017 and 2008).
Source: The 2018 EU Industrial R&D Investment Scoreboard. European Commission, JRC/DG RTD.
6 MAPPING BUSINESS INNOVATION ACTIVITIES 
THROUGHOUT THE EU
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This chapter make use of patents data at European level to complement and integrate the information gathered from 
the Scoreboard companies on the EU R&D landscape. The main aim is to provide further insights on technological inno-
vations in the EU, especially for countries scarcely (or not at all) represented in the Scoreboard among the top corporate 
R&D investors. 
Mapping business innovation activities 
throughout the EU
6
The number of patents invented in a country is much higher than the number of patents 
owned by local companies. Germany and the US compare as the most frequent second 
location of ownership for patents invented in EU countries (10 and 8 respectively). Con-
centration of business patents by companies changes a lot from one country to the other.
6.1 | Business R&D activities in the EU-28
For 14 years, the Scoreboard has monitored the activities 
of the top corporate R&D investors worldwide. Despite 
efforts to increase its coverage of R&D activities in 
European countries, a number of countries are still not 
represented in the Scoreboard. 
Indeed, also when considering the top 1000 EU companies, 
eight countries are still not represented, while for a 
number of other countries the R&D activities financed by 
the business sector are hardly captured (see table 6.1). 
This is mainly due to two reasons, either R&D performers 
in such countries are too small to be included in the 
Scoreboard sample, or they are subsidiaries of foreign 
Scoreboard companies and thus their R&D is consolidated 
and attributed to the country where the headquarters of 
the parent company is located. 
For these reasons, Scoreboard figures are not directly 
comparable with Eurostat ones. Indeed, due to size and 
corporate group consolidation, Scoreboard figures can be 
higher or lower than the Eurostat figures of R&D financed 
by the business enterprise sector, the BES-R&D (see 
column 2 of table 6.1). For the sake of clarity, we remind 
the reader that the BES-R&D is different from BERD; 
the latter captures the R&D performed in the business 
enterprise sector, but that can be financed by different 
entities. In general, BERD tend to be higher than BES-R&D 
(see column 3 of table 6.1).
How to close this information gap? In this chapter we use the 
full sample of patents filed at the European Patent Offices 
(EPO) to provide evidence on the patenting activities of 
the business sector in the EU-28 countries. We do so using 
a field in the Patstat database that allows isolating those 
patents for which the applicant operates in the business 
sector. In order to control for the multiple filing of the same 
invention at different Intellectual Property Offices, different 
patent applications have been matched through INPADOC 
(International Patent Documentation) families to avoid 
double counting.13 This allows us fulfilling a long lasting 
need for a better coverage of the technological activities 
of the business sector in the EU countries with a focus 
on inventorship-ownership patterns across countries and 
companies. 
13 http://www.epo.org/searching/essentials/patent-families/inpadoc.html.
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Country
Companies in the 
2018 EU1000 
Scoreboard 
SB-R&D/
BES-R&D
BERD/
BES-R&D
BES-R&D 
(R&D funded by business 
enterprise sector)
Germany 219 1.22 1.05 58239
France 111 1.06 1.17 27203
UK 275 1.40 1.35 21333
Italy 39 1.12 1.16 11077
Sweden 77 1.20 1.22 8396
The Netherlands 53 2.15 1.15 6663
Austria 32 0.24 1.44 5222
Belgium 34 0.41 1.19 5929
Spain 20 0.79 1.15 6039
Denmark 42 0.93 1.08 4771
Finland 36 1.18 1.22 3325
Ireland 27 5.83 1.47 1516
Poland 4 0.01 1.19 1684
Czech Republic 2 0.05 1.57 1122
Hungary 1 0.15 1.48 751
Portugal 4 0.14 1.09 953
Slovenia 2 0.24 1.10 590
Greece 3 0.26 1.05 535
Romania 1.18 292
Luxembourg 18 2.18 1.10 312
Bulgaria  2.06 155
Slovakia   1.12 232
Croatia  1.10 175
Estonia   1.12 124
Lithuania  0.96 111
Latvia   1.23 31
Malta 1 0.93 1.13 33
Cyprus   1.14 17
TABLE 6.1: COMPARING SCOREBOARD R&D WITH BES-R&D AND BERD IN THE EU-28 (2015).
Note: BES-R&D reported in €million.
Source: own computation on the Industrial Research and Innovation Scoreboard 2016 and Eurostat.
Patents can be assigned to countries on the basis of the 
inventor residence as reported in the respective document, 
this is normally used to proxy where corporate R&D is 
performed and knowledge produced. Similarly, patents can 
be localised according to the ownership of the property 
right, reflecting the subject capturing the returns from 
innovation. 
It is well-known that there are great differences in the 
patenting activities across industrial sectors and across EU 
6.2 | Patents from the business sector across countries
countries. In figure 1 we report a map coloured according 
to the patent per capita from the business sector; patents 
are assigned to countries according to the location of 
inventors as reported in the patent documents. The figure 
basically confirms the geography of innovation activities 
in the EU, as reported by other works. The leadership in 
technological development (patent per capita) is mainly 
concentrated in central and northern Europe. 
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FIGURE 6.1: PATENTS PER CAPITA FROM THE BUSINESS SECTOR IN THE EU (ALLOCATED BY INVENTOR).
Note: patents are for 100,000 inhabitants. Numbers refer to the 2013-2015 period.
Source: own computation based on Patstat 20118A.
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The differences between the leaders and the bottom of 
distribution are very large; in Sweden there where about 
25 patents per 100,000 inhabitants filed at EPO during 
the period considered (we average numbers between 
2013 and 2015), while countries in the bottom of the 
distribution show numbers of two orders of magnitude 
lower (around 0.3). All-in-all, these differences reflect 
differences in the capabilities and possibilities needed 
to produce frontier technological knowledge as well 
as sector specialisations. Differences are so huge that 
it is difficult to foresee a closing gap in the short term. 
However, it should also be considered that part of the 
differences between countries is due to differences in 
their industrial specialisation.14
Thus far, we have considered knowledge generation and 
we now ask: to what extent EU countries differ when 
considering instead knowledge exploitation?
In table 6.2 we report, the percentage difference of the 
number of patents allocated by applicant with respect 
that allocated by inventor. For countries with negative 
figures the number of patents computed by applicant is 
lower than that computed by inventor; these countries 
produce more knowledge that what they actually ‘own’. 
According to this metric, EU countries can be classified in 
three groups: 1) those in ‘deficit’ (on the left part of the 
table); 2) those in substantial balance (difference lower 
than 5%), and; 3) those in ‘surplus’, owning more patents 
than that were actually invented there.
14 Indeed, there are big differences between sectors in their propensity to patent (the number of patents per €m of R&D) that can influence aggregate figures. For example, 
automotive components and IT hardware have on average ten times as many patents per €m of R&D as pharmaceuticals. A more detailed analysis of the differences in 
patent propensity across sectors can be found in Dernis, H., Dosso, M., Hervás, F., Millot, V., Squicciarini, M., & Vezzani, A. (2015). World corporate top R&D investors: Inno-
vation and IP bundles (No. JRC94932). Joint Research Centre (Seville site).
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Three European countries show a substantial balance 
between patents invented and patents owned: Denmark, 
Germany and France. The majority of EU countries show a 
negative balance. In particular, the number of patent per 
applicant in Romania, Croatia and Hungary is less than 
half of that by inventors. The majority of patent invented 
in these countries is filed by a company based somewhere 
else.
Finally, the group of countries with a clear surplus in 
the ownership of innovation compared to its creation. 
Among these countries there are Finland and Sweden, 
top performer also when considering patents invented 
per capita (see map above); these two countries seems to 
have a very active and creative business sector. However, 
also countries not particularly performing in terms of 
patent invented belong to this group. Among these 
countries (Cyprus, Luxembourg and Malta), the number 
of patent owned is between 4 and 10 times higher than 
those invented.15 Three countries – Ireland, Luxembourg 
and The Netherlands – host many company HQs for tax 
or takeover-protection reasons and this can substantially 
affect the figures as can the existence of ‘patent box’ tax 
reliefs in some countries. 
Countries in deficit Countries balanced Countries in surplus
Romania -85%  Denmark -1%  Ireland 13%
Croatia -69%  France 1%  Finland 14%
Hungary -63%  Germany 1%  Sweden 19%
Slovakia -49%   Netherlands 23%
Czech Republic -40%   Cyprus 371%
Poland -36%   Luxembourg 484%
Greece -36%   Malta 968%
Estonia -35%    
Lithuania -33%    
United Kingdom -31%    
Slovenia -30%    
Bulgaria -30%    
Spain -29%    
Italy -16%    
Portugal -15%    
Belgium -13%       
Latvia -12%      
Austria -7%       
TABLE 6.2: PERCENTAGE DIFFERENCES APPLICANTS VERSUS INVENTORS (2013-2015).
Note: relative differences when counting patents by applicant rather than by inventor.
Source: own computation on Patstat 20118A.
6.3 | Inventorship-Ownership patterns in EU countries
As we said, allocating patents by inventorship or 
ownership may provide different pictures (and insights) on 
the innovation activities of the business sector across the 
EU. However, it is also possible to consider inventor and 
applicant locations to respond to questions of the kind: 
who owns the patents invented in EU countries?
In table 6.3, for each EU-28 member state we report the 
distribution of patents there invented over the applicant 
countries. In particular, we report the top 3 countries in 
term of patent ownership and their share of ownership of 
the overall country of inventorship patent portfolio.
15 Companies often operate in several countries and may have diverse locations for their decision, production and innovation centres. Different location choices may be 
due to market strategies, optimisation of costs or fiscal purposes.
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Inventor 
Country
First applicant country Second applicant country Tird applicant country
Country Patent share Country Patent share Country
Patent 
share
Austria Austria 76% Germany 11% Switzerland 4%
Belgium Belgium 62% USA 12% France 11%
Bulgaria Bulgaria 55% USA 12% Germany 11%
Cyprus Cyprus 67% United Kingdom 25% Japan 5%
Czechia Czechia 53% Germany 16% Switzerland 11%
Germany Germany 87% USA 3% Switzerland 3%
Denmark Denmark 81% Germany 8% USA 4%
Estonia Estonia 63% Germany 8% Virgin Islands 7%
Spain Spain 70% Germany 10% USA 9%
Finland Finland 88% Switzerland 3% Sweden 2%
France France 82% Switzerland 5% Germany 3%
United Kingdom United Kingdom 63% USA 11% Netherlands 5%
Greece Greece 61% USA 14% Germany 6%
Croatia Croatia 27% United Kingdom 18% Denmark 14%
Hungary Hungary 31% Germany 27% Sweden 16%
Ireland Ireland 42% USA 21% France 20%
Italy Italy 80% Sweden 4% USA 4%
Lithuania Lithuania 56% Germany 23% USA 8%
Luxembourg Luxembourg 55% USA 31% Switzerland 6%
Latvia Latvia 59% Finland 14% Germany 10%
Malta Malta 63% Luxembourg 15% Belgium 5%
Netherlands Netherlands 86% USA 4% Germany 3%
Poland Poland 60% Switzerland 12% USA 11%
Portugal Portugal 76% Germany 8% USA 3%
Romania Germany 51% Romania 14% USA 13%
Sweden Sweden 79% Switzerland 6% Japan 4%
Slovenia Slovenia 65% Germany 15% Switzerland 6%
Slovakia Slovakia 40% Germany 26% USA 7%
TABLE 6.3: COUNTRY OWNERSHIP OF EU INVENTED PATENTS (2013-2015)
Note: in the second and third column shares greater than 10% are highlighted.
Source: own computation on Patstat 20118A.
The majority of business patents in the EU are owned by 
a company located in the country where inventors are, 
Romania being the only exception: German companies 
own about 51% of the patents invented there. The share 
of home ownership varies greatly: from the 27% of 
Croatia to the 88% of Finland. Companies from Croatia, 
Hungary, Ireland and Slovakia own less than 50% of 
patents invented there.16 Particularly interesting is the 
case of Ireland, where the majority of patents invented 
there is owned by foreign companies with HQs there for 
tax reasons, but for which the total number of patent 
owned is still larger than that of those invented. 
We come now to the second country in terms of ownership, 
as reported in the second column of the table. Germany and 
the US compare as the most frequent of origins of ownership 
(10 and 8 respectively). In some countries more than one 
quarter of patents invented there are owned by companies 
located in a single foreign country: Cyprus (UK, 25%), Slova-
kia (DE, 26%), Luxembourg (US, 31%), Hungary (DE, 27%).
16 Actually, these figures may even be slightly overestimated. Indeed, subsidiaries of foreign companies can be registered in a country as local companies. As described in 
note 2, we cleaned names and relocated patents across countries, but not considered the ownership structure in this exercise.
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Finally, in the last column we report the third country in 
terms of patent ownership. The US and Germany appear 
frequently also in this column (8 and 5 times respectively). 
Also Switzerland based companies own relevant shares of 
patents invented in the EU countries (it compares 4 times 
in the second column and 5 times in the third). In many 
cases the third country in terms of ownership still holds 
more than 10% of patents, hinting that for a number of 
countries the foreign ownership is rather geographically 
concentrated.
Inventors’ 
Country Top three patenting companies 
Share of patents of top 3 
companies
Austria Zumtobel Lighting (AT)- Siemens (DE) - Borealis (AT) 10%
Belgium
Alcatel Lucent (FR)- Cnh Case New Holland Belgium (BE) - P&G Procter 
Gamble (US)
14%
Bulgaria Ez As A Drink Productions (US)- Index 6 (BG) - Johnson Controls (FR) 15%
Cyprus Ottos Consultants (CY)- Gt Gettaxi (CY) - Elysee Piping Systems (GB) 39%
Czechia Skoda Auto (CZ)- Zentiva K S (CZ) - Siemens (DE) 15%
Germany Siemens (DE)- Robert Bosch (DE) - Basf (DE) 12%
Denmark Siemens (DE)- Novozymes (DK) - Novo Nordisk (DK) 17%
Estonia
Meiren Engineering (EE)- Perkinelmer Cellular Technologies (DE) - Guardtime Ip 
Holdings (VG)
25%
Spain
Bsh Bosch Und Siemens Hausgeraete (DE)- Hewlett Packard (US) - Telefonica 
(ES)
14%
Finland Nokia (FI)- Kone Corporation (FI) - Waertsilae (FI) 31%
France Thomson Licensing (FR)- Renault (FR) - Thales (FR) 10%
United Kingdom Rolls Royce (GB)- Nxp Semiconductors (NL) - Jaguar/Land Rover (GB) 9%
Greece Pharmathen (GR)- Bic Violex (GR) - Micrel Medical Devices (GR) 29%
Croatia Yazaki Europe (GB)- Xellia Pharmaceuticals (DK) - Ericsson (SE) 41%
Hungary Ericsson (SE)- Knorr Bremse Systems For Commercial Vehicles (DE) - Nokia (FI) 37%
Ireland
Alcatel Lucent (FR)- Connaught Electronics (IE) - Cook Medical Technologies 
(US)
27%
Italy Electrolux Appliances (SE)- Nuovo Pignone (IT) - Indesit (IT) 5%
Lithuania
Thermo Fisher Scientific Baltics Uab (LT)- Uab Ekspla (LT) - Atotech 
Deutschland (DE)
51%
Luxembourg Goodyear (US)- Tarkett Gdl (LU) - Paul Wurth (LU) 42%
Latvia Sonarworks (LV)- Olainfarm (LV) 24%
Malta Gfbiochemicals (MT)- Energy Machine Company (LU) 31%
Netherlands
Philips Electronics (NL)- Dutch State Mines Ip Assets (NL) - Nxp 
Semiconductors (NL)
44%
Poland
Advanced Digital Broadcast (CH)- International Tobacco Machinery Poland (PL) 
- Patents Factory Ltd (PL)
14%
Portugal
Novadelta Comercio e Industria De Cafes (PT)- Robert Bosch (DE) - Oliveira 
Irmao (PT)
19%
Romania Continental (DE)- Renault (FR) - Honeywell International (US) 60%
Sweden Ericsson (SE)- Volvo (SE) - Scania (SE) 33%
Slovenia
Bsh Bosch Und Siemens Hausgeraete (DE)- Lek Pharmaceuticals (SI) - Tajfun 
Planina Proizvodnja Strojev (SI)
20%
Slovakia
Bsh Bosch Und Siemens Hausgeraete (DE)- Continental Reifen Deutschland 
(DE) - Ga Drilling A S (SK)
16%
TABLE 6.4: MAIN COMPANY OWNERSHIP OF EU INVENTED PATENTS (2013-2015).17
Source: own computation on Patstat 20118A. 
17 Names have been retrieved from the pns_name field and further cleaned. Companies with the same name, but different locations, has been assigned to the location 
registering more patents. The relocation has involved relatively small number of companies with not marginal patenting activities; these companies have been manually 
checked.
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Finally, after having looked at the country distribution of 
ownership we zoom in and rank the first three owners at 
the company level. Similarly to before, in table 6.4, for 
each EU-28 member state we report we report the top 3 
countries in term of patent ownership and their combined 
share of ownership of the overall country of inventorship 
patent portfolio.
In some countries, the concentration of patents across 
private actors seems very high. For example, in Romania 
60% of patents invented there are owned by only three 
companies. Other countries showing very high shares 
are Lithuania (51%) and The Netherland (44%). In the 
latter, Philips is by far the first actor in term of patenting 
activities, filing about 40% of the patent invented there. 
In general, the first three companies own much lower 
shares. Italy is the country where patenting activity 
appears less concentrated (5%), followed by the United 
Kingdom (9%). This can be due both to differences in the 
way corporate groups are structured (using many different 
names for affiliates rather than keeping the name constant) 
or by a different sectoral structure of the economy or due 
to a stronger presence of small and medium enterprises. 
A visual inspection of the data suggests that the latter 
factor play an important role in determining the results.
7 TEN-YEAR TRENDS OF TOP R&D PERFORMERS FROM 
ASIAN COUNTRIES
81The 2018 EU Industrial R&D Investment Scoreboard
This chapter focuses on the contribution of corporate R&D to the rapid growth and expansion of Asian companies 
from the Scoreboard and compares this to their European and US counterparts. It looks at the trends of Scoreboard 
companies’ foreign direct investment (FDI) by region of origin (Asia, EU, US and RoW) and region of destination. This 
provides additional insights on the extent to which M&A contributed to the rapid growth of Asian companies’ R&D 
spending. This part of the analysis looks at the dynamics of M&A activity by Asian, EU and US companies, as well 
as the main sectors and regions of investment. For this, we use Scoreboard data together with data on mergers and 
acquisitions (M&A) from Zephyr.18
Ten-year trends of top R&D performers  
from Asian countries
7
Firms in more and more countries are now investing heavily 
in R&D, and Asia is rapidly becoming home to global top 
R&D investors. Among the top 2500 R&D companies 
ranked in 2017, 38% are Asian-based corporations with 
16% of the top 50 from Asia (12% from Japan, 2% each 
from S. Korea and China).
For analysing the trends of the largest R&D investing firms 
from the regions EU19 , US, Asia20 and RoW21, we use a panel 
dataset that covers 10 years of R&D Scoreboard data (from 
2007 to 2016) with the main variables: Sales, Employment, 
Capital Expenditures, R&D investments. Table 7.1 shows the 
averages of company characteristics by region of origin of 
the Scoreboard companies for the year 201622.
M&A activity towards the EU from Asian companies has grown substantially even if it is 
still small compared with the M&A from other regions towards the EU. Nearly all of Asia’s 
growth of outward M&A activity is due to Chinese firms.
7.1 | Description of top R&D performers by regions
18 From Bureau van Dijk.
19 EU28.
20 China, Hong Kong, India, Japan, South Korea, Malaysia, Singapore and Taiwan.
21 The rest of the countries not in the former groups, mainly Switzerland, Norway, South America, Canada, Middle East.
22 Here, we use a subset of the top 2500 firms of the year 2016 with data available on Net Sales, Employees, and R&D.
Region No. of companies
R&D 
(€million)
R&D 
intensity, 
%
Net Sales 
(€million)
Employees 
(million)
Operating 
profit 
(€million)
Capex 
profit 
(€million)
Labour 
productivity 
(Net Sales 
in € per 
employee)
Profitability, 
%
Asia 803 233 3.2 7338 25221 574 524 290959 7.8
EU 515 353 3.5 10103 35024 770 710 288462 7.6
US 771 372 6.2 6026 14425 770 369 417789 12.8
RoW 175 294 4.5 6483 20123 900 524 322166 13.9
Total 2264 312 4.2 7454 23380 711 509 318832 9.5
TABLE 7.1: COMPANY AVERAGES BY REGION OF ORIGIN FOR THE YEAR 2016.
Source: The 2018 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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On average, EU firms are the largest firms based on Net 
Sales and number of employees, followed by the Asian 
firms. Asian and EU firms are similar in terms of labour 
productivity, R&D intensity and profitability. US firms are 
the smallest firms based on number of employees and 
net sales, but are the more productive and profitable than 
their global counterparts. 
A great part of these regional differences can be explained 
by the sectoral distribution within each region, as specified 
in Table 7.2. For example, the high proportion of firms from 
the Others sector group – a collection of low R&D intensive 
sectors – heavily weighs on the averages of the Asian 
and EU firms in terms of size (net sales and employees) 
and, subsequently, the lower R&D intensities that these 
regions have. On the other hand, the high R&D intensity 
in the US is mainly due to a high proportion of firms from 
the high R&D intensive Health industries amongst the 
top R&D investors and a much higher than average R&D 
intensity for the ICT Services sector group, which also has 
the highest proportion in the US.
Specifically for this analysis, we merged the Scoreboard 
companies with a dataset from Zephyr on mergers and 
acquisitions (M&As). This provides us with the data on 
each of the 11 852 M&As of the top 2500 Scoreboard 
companies between 2007 and 2016, such as the year 
of the M&A and details on the acquirer and acquired 
company (country and sector23). Table 7.3 shows the 
region of the acquiring Scoreboard companies and the 
targeted company by region of origin of all these M&As. 
 Asia EU
Sector
No. of 
companies 
as % of 
Region total
R&D 
€million
Net Sales 
€million
Employees 
million
No. of 
companies 
as % of 
Region total
R&D 
€million
Net Sales 
€million
Employees 
million
Aerospace & Defence 1 50 1960 22870 3 577 11565 35449
Automobiles & other transport 12 449 12708 35191 8 1315 24067 76581
Chemicals 6 162 5052 10958 4 255 11115 24010
Health industries 10 194 2447 10420 19 442 3796 13844
ICT producers 24 283 5023 23609 12 356 4235 21242
ICT services 6 218 6193 29913 10 233 5094 20846
Industrials 16 122 5049 18942 16 122 6377 30989
Others 25 193 11372 34308 29 176 16216 51588
All firms 803 233 7338 25221 515 353 10103 35024
 US RoW
Sector
No. of 
companies 
as % of 
Region total
R&D 
€million
Net Sales 
€million
Employees 
million
No. of 
companies 
as % of 
Region total
R&D 
€million
Net Sales 
€million
Employees 
million
Aerospace & Defence 2 537 15080 41103 5 334 4248 17326
Automobiles & other transport 5 672 15370 36729 5 379 7154 22502
Chemicals 4 209 5844 11332 6 258 7507 14140
Health industries 29 332 2905 4975 13 937 6218 15368
ICT producers 20 471 5496 13992 15 236 2884 13410
ICT services 20 440 3972 10621 11 92 2083 7802
Industrials 7 219 7366 24528 18 135 4794 21360
Others 13 195 11762 25968 27 189 11692 32204
All firms 771 372 6026 14425 175 294 6483 20123
TABLE 7.2: SECTOR DISTRIBUTION BY REGION.
Source: The 2018 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
7.2 | M&A activity
23 The sectors are available on 4 digit level of the NACE classification.
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Asia has the highest proportion of within region M&As 
(69.9%), which mitigates the idea that Asian firms acquire 
EU firms at a large scale in order to increase their knowl-
edge base. Also in absolute terms, M&A activity by Asian 
firms towards EU firms remains rather limited, although a 
growing pattern can be perceived (see Figure 7.1 further 
down). 
EU firms perform 46% of their M&A activity outside the 
EU, the highest of all regions. This is distributed amongst 
the RoW (21.1%), the US (19.6%) and a surprisingly small 
proportion to Asia (5.4%). The EU is the most popular des-
tination for M&A activity by firms from RoW (27.5% - also 
due to the inclusion of European but non-EU firms, such 
as from Switzerland and Norway) and the US (18.4%), but 
only the second most popular destination for Asian firms 
(9.9% - after RoW, but before the US). Asia is the least 
popular region where EU, RoW and US firms perform their 
M&A activity: only 4-6% of M&As from companies from 
these regions target an Asian company.
If we look into these data with greater detail, splitting Asia 
into several main countries like China, Japan, India and 
other Asian countries24, we see that China has the highest 
within-country M&A activity: only 20% of the activity is 
performed outside China, of which one third targeting an 
EU or RoW firm and only 3.1% targeting US firms. 
On the other hand, Japan shows a much more open character 
with a similar proportion of M&As taken place outside 
the country as the EU, mainly targeting EU, RoW and US 
companies and to a lesser extent firms within Asia. Japan is 
the only country with a higher proportion of its M&A activity 
towards China than inward M&A activity from Chinese firms.
from\to Asia EU US RoW
Asia 69.9 9.9 6.7 13.5
EU 5.4 54.0 19.6 21.1
US 4.2 18.4 63.6 13.8
RoW 5.7 27.5 20.9 46.0
TABLE 7.3: PERCENTAGE OF M&As FROM ONE REGION TO THE OTHER REGIONS.
Source: The 2018 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
24 South Korea, Malaysia, Taiwan, Hong Kong, Singapore and Thailand.
from\to China Japan Other Asia India EU RoW US Number of M&As
China 80.1% 0.1% 2.1% 0.0% 7.7% 6.9% 3.1% 768
Japan 3.4% 55.8% 5.6% 4.2% 12.2% 9.6% 9.2% 1275
Other Asia 1.1% 1.3% 48.5% 0.5% 4.7% 40.1% 3.7% 379
India 0.0% 1.2% 2.5% 48.1% 18.5% 13.6% 16.0% 81
EU 1.8% 0.5% 1.3% 1.7% 54.0% 21.1% 19.6% 3275
RoW 1.9% 0.7% 1.6% 1.5% 27.5% 46.0% 20.9% 1373
US 1.6% 0.4% 1.0% 1.1% 18.4% 13.8% 63.6% 4701
TABLE 7.4: PERCENTAGE OF M&As BETWEEN REGIONS - WITH ASIA DISAGGREGATED IN VARIOUS MAIN COUNTRIES.
Source: The 2018 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
If we look at the development over time (in absolute 
number of actual M&As, see Figure 7.1), we see that 
M&A activity by Asian firms has increased over the 10 
year period of the dataset. The strongest growth is 
shown by M&As from Asian firms to the EU (+147% over 
10 year period), and although overall over the 10 year 
period the EU is a secondary target region (as we saw in 
Table 7.3, after RoW), since 2013 the EU is the most pop-
ular destination for M&A activity from Asian firms, with 
also the proportion of M&As towards the US increasing. 
Thus, during this period, foreign M&A activity by Asian 
firms has both increased and shifted from mainly RoW 
towards the EU and US.
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If we dig further into the M&A growth that Asian firms 
have shown by looking at the activities of the main Asian 
countries (China and Japan, see Figure 7.2), we can clearly 
see how China has become an important player in the 10 
year period of our analysis and surpassed Japan in the 
number of within-country M&A activity by 2013. Moreover, 
as of 2016, China is approaching Japan in the number of 
M&As outside the country. 
For comparison, also the tendencies of the two other ma-
jor regions are depicted (with the same scale on the verti-
cal axis). Both the EU and the US show – as Japan, but in 
contrary to China – very stable M&A activity, although both 
still on a higher level than China and Japan.
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FIGURE 7.1: M&A ACTIVITY BY ASIAN FIRMS TO OTHER REGIONS
Source: The 2018 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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FIGURE 7.2: WITHIN-COUNTRY AND OUTWARD M&A ACTIVITY PER MAIN COUNTRY/REGION
Source: The 2018 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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Thus, growth of Asian M&A activity towards the EU re-
sults almost completely from the growth of M&A activity 
by Chinese firms over the last 10 years. The proportion of 
Chinese M&A activity toward the EU has increased from 
11% in 2007 (only 2 out of 18 M&As) to almost 50% in 
2016 (17 out of 37) of this subset of main R&D investors 
from the R&D Scoreboard.
Region R&D Net Sales Employees R&D intensity Labour productivity
Asia 3.9 3.6 2.1 1.1 1.7
 China 2.1 2.5 1.4 0.8 1.8
 Japan 5.0 4.4 3.7 1.2 1.2
 Other Asian countries 12.4 7.6 9.0 1.6 0.8
EU 2.4 2.9 2.6 0.8 1.1
RoW 2.0 2.2 1.8 0.9 1.2
US 6.3 13.8 8.9 0.5 1.5
Total 4.0 4.1 2.7 1.0 1.5
TABLE 7.5: RATIO BETWEEN ACQUIRING AND NON-ACQUIRING FIRMS FOR SELECTED VARIABLES IN 2016.
Source: The 2018 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
7.3 | Comparing acquiring firms with non-acquiring firms
Table 7.5 displays the ratios of R&D, Net Sales and number 
of employees for acquiring companies over non-acquiring 
companies for the 2264 of the top 2500 Scoreboard firms 
for which all these data were available for the year 201625. 
Here, a ratio of 1.1 for R&D intensity of Asian firms means 
that acquiring Asian firms have an R&D intensity that is 
on average 1.1 times the R&D intensity of non-acquiring 
Asian firms in our dataset.
As becomes very clear from the table, acquiring companies 
tend to be larger in terms of net sales (4.1 times) and 
employees (2.7) and also invest significantly more than 
non-acquiring companies (4.0), resulting in similar R&D 
intensities (1.0) and higher labour productivity (1.5).
If we specify this ratio for the main countries in Asia, 
we see that Chinese acquiring firms had a lower R&D 
intensity than non-acquiring firms in 2016 (0.8), which is 
in contrast with their Asian counterparts and on par with 
EU and RoW counterparts. In fact, Chinese firms involved 
in M&A activity have the lowest average R&D intensity of 
all acquiring and non-acquiring firms: 2.3% compared to 
an average for all firms of 4.2% (both figures not depicted 
in the table). This provides evidence to the wide belief that 
Chinese companies are trying to increase their knowledge 
base by acquiring highly innovative firms.
This difference between acquiring and non-acquiring firms 
has been rather stable throughout the 10 year period of 
our dataset for all regions, except China as shown in Figure 
7.2. Unfortunately, the number of firms for which R&D, Net 
Sales and Employment are available reduces from 2264 
to 1408 firms when looking at the 10 year period 2007 
to 2016. If we compare acquiring and non-acquiring firms 
throughout this period, we find an interesting development, 
as shown in the following figures. 
For the EU, Japan and the US, the acquiring firms show a 
rather stable R&D intensity over time. For China on the other 
hand, the acquiring firms show a strong increasing trend, 
starting from a very low R&D intensity of 0.5% in 2007 
to 1.9% in 2016, underpinning the idea that these firms 
have expanded their knowledge base by the acquisition 
of foreign companies. However, non-acquiring companies 
from China have kept on increasing their R&D intensity in 
a similar fashion, indicating that R&D is becoming a more 
and more important factor for Chinese firms in general.
25 Here, a firm is considered as an acquiring firm from the year it has performed an M&A in our 10 year database and onwards. As such, the longer term effects of an 
acquisition are taken into account throughout the following years and it avoids changing subsamples from year to year. Of the 2264 firms in the sample, 1731 performed 
at least one acquisition over the period 2007-2016.
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FIGURE 7.3: DEVELOPMENT OF R&D INTENSITY ACQUIRING VS – NON ACQUIRING FIRMS.
Note: scales of R&D intensity are different.
Source: The 2018 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
7.4 | Sector analysis
The following table shows that there are no particular 
sectoral differences across regions in M&A behaviour. Firms 
from all sectors seem to behave similarly in all regions. 
Firms from the ICT Services sector seem to be the most 
active in M&As across all the regions, showing a higher 
proportion of M&As than firms. US firms from the Health 
sector are much less involved in M&A activity than the 
proportion of firms from this sector in the US would make 
us expect. This can be due to the fact that the US Health 
sector has many private research labs, firms with low sales 
that concentrate on a breakthrough innovation with private 
funding. These firms are less involved in M&A activity.
Sector group
China Japan EU US
% of 
companies
% of 
M&As
% of 
companies
% of 
M&As
% of 
companies
% of 
M&As
% of 
companies
% of 
M&As
Aerospace & Defence 2 2 3 4 2 5
Automobiles & other transport 11 10 12 8 8 7 5 3
Chemicals 3 2 10 11 4 6 4 4
Health industries 9 11 10 7 19 11 29 12
ICT producers 26 26 20 20 12 12 20 22
ICT services 10 16 2 6 10 13 20 28
Industrials 16 12 17 16 16 16 7 12
Others 24 21 28 32 29 32 13 13
TABLE 7.6: SECTOR GROUP OF ACQUIRING FIRMS.
Source: The 2018 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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When we look at the sectors where the targeted firms26 
belong to, firms from the four regions show only a slightly 
different behaviour. Scoreboard firms from all four regions 
concentrate their M&A activities in few sectors27: around 
three quarters of all M&A activity targets only three main 
sectors, or in the case of the US even more than 90%. 
Manufacturing is by far the most targeted sector, espe-
cially in Asia. The strength of the US Information & Com-
munication sectors (roughly comparable to the ICT Servic-
es sector in ICB classification) is shown by the high M&A 
activity of US firms: 41% of M&As target a firm from this 
sector in the US.
Asia EU US RoW
target sector % target sector % target sector % target sector %
Manufacturing 55 Manufacturing 41 Manufacturing 43 Manufacturing 44
Information & 
Communication
14
Information & 
Communication
22
Information & 
Communication
41
Information & 
Communication
23
Financial & Insurance 
Activities
9
Professional, Scientific & 
Technical Activities
10
Professional, Scientific & 
Technical Activities
8 Wholesale & Retail Trade 9
Top 3 target sectors 78 Top 3 target sectors 73 Top 3 target sectors 92 Top 3 target sectors 76
TABLE 7.7: RATIO BETWEEN ACQUIRING AND NON-ACQUIRING FIRMS FOR SELECTED VARIABLES IN 2016.
Source: The 2018 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
26 Unfortunately, looking at acquiring vs targeted regions including also the sectoral dimension leaves us with too few observations for analysis.
27 Due to data limitations, only NACE Rev 2 sector classification is available for targeted firms. This sector classification is not directly comparable with ICB classification 
as used in the remainder of the Scoreboard.
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Investment in research and innovation is at the core of 
the EU policy agenda. The Europe 2020 growth strategy 
includes the Innovation Union flagship initiative28 with 
a 3 % headline target for intensity of research and 
development (R&D)29. R&D investment from the private 
sector plays also a key role for other relevant Europe 2020 
initiatives such as the Industrial Policy30, Digital Agenda 
and New Skills for New Jobs flagship initiatives. 
The project “Global Industrial Research & Innovation 
Analyses” (GLORIA)31 supports policymakers in these 
initiatives and monitors progress towards the 3 % headline 
target. The Scoreboard, as part of the GLORIA project, aims 
to improve the understanding of trends in R&D investment 
by the private sector and the factors affecting it. 
The annual publication of the Scoreboard is intended to 
raise awareness of the importance of R&D for businesses 
and to encourage firms to disclose information about their 
R&D investments and other intangible assets.
The data for the Scoreboard are taken from companies’ 
publicly available audited accounts. As in more than 99% 
of cases these accounts do not include information on the 
place where R&D is actually performed, the company’s 
whole R&D investment in the Scoreboard is attributed to 
the country in which it has its registered office32. This should 
be borne in mind when interpreting the Scoreboard’s 
country classifications and analyses. 
The Scoreboard’s approach is, therefore, fundamentally 
different from that of statistical offices or the OECD when 
preparing business enterprise expenditure on R&D data, 
which are specific to a given territory. The R&D financed 
by business sector in a given territorial unit (BES-R&D) 
includes R&D performed by all sectors in that territorial 
unit33. Therefore, the Scoreboard R&D figures are 
comparable to BES-R&D data only at the global 
level.
The Scoreboard data are primarily of interest to those 
concerned with benchmarking company commitments and 
performance (e.g. companies, investors and policymakers), 
while BES-R&D data are primarily used by economists, 
governments and international organisations interested 
in the R&D performance of territorial units defined by 
political boundaries. The two approaches are therefore 
complementary. The methodological approach of the 
Scoreboard, its scope and limitations are further detailed 
in Annex 2 below. 
Background informationA .1
Scope and target audience
The Scoreboard is a benchmarking tool which provides 
reliable up-to-date information on R&D investment 
and other economic and financial data, with a unique 
EU-focus. The 2500 companies listed in this year’s 
Scoreboard account for more than 90%34 of worldwide 
R&D funded by the business enterprise sector and the 
Scoreboard data refer to a more recent period than 
the latest available official statistics. Furthermore, the 
28 The Innovation Union flagship initiative aims to strengthen knowledge and innovation as drivers of future growth by refocusing R&D and innovation policies for the main 
challenges society faces.
29 This target refers to the EU’s overall (public and private) R&D investment approaching 3 % of gross domestic product (see: http://ec.europa.eu/europe2020/pdf/tar-
gets_en.pdf).
30 The Industrial Policy for the Globalisation Era flagship initiative aims to improve the business environment, notably for small and medium-sized enterprises, and support 
the development of a strong and sustainable industrial foundation for global competition.
31 GLORIA builds on the IRIMA project (Industrial Research and Innovation Monitoring and Analysis). See: http://iri.jrc.ec.europa.eu/home /. The activity is undertaken jointly 
by the Directorate General for Research (DG RTD A; see: http://ec.europa.eu/research/index.cfm?lg=en) and the Joint Research Centre, Directorate Growth and Innovation 
(JRC-Seville; see: https://ec.europa.eu/jrc/en/science-area/innovation-and-growth).
32 The registered office is the company address notified to the official company registry. It is normally the place where a company’s books are kept.
33 The Scoreboard refers to all R&D financed by a company from its own funds, regardless of where the R&D is performed. BES-R&D refers to all R&D activities funded by 
businesses and performed by all sectors within a particular territory, regardless of the location of the business’s headquarters. The sources of data also differ: the Score-
board collects data from audited financial accounts and reports whereas BES-R&D typically takes a stratified sample, covering all large companies and a representative 
sample of smaller companies. Additional differences concern the definition of R&D intensity (BES-R&D uses the percentage of R&D in value added, while the Scoreboard 
considers the R&D/Sales ratio).
34 According to latest Eurostat statistics.
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dataset is extended to cover the top 1000 R&D investing 
companies in the EU. 
The data in the Scoreboard, published since 2004, allow 
long-term trend analyses, for instance, to examine links 
between R&D and business performance.
The Scoreboard is aimed at three main audiences. 
• Companies can use the Scoreboard to benchmark 
their R&D investments and so find where they stand 
in the EU and in the global industrial R&D landscape. 
This information could be of value in shaping business 
or R&D strategy and in considering potential mergers 
and acquisitions. 
• Investors and financial analysts can use the 
Scoreboard to assess investment opportunities and 
risks.
• Policy-makers, government and business or-
ganisations can use R&D investment information 
as an input to policy formulation or other R&D-related 
actions such as R&D tax incentives. 
Furthermore, the Scoreboard dataset has been made 
freely accessible so as to encourage further economic and 
financial analyses and research by any interested parties.
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Methodological notesA .2
The data for the 2018 Scoreboard have been collected 
from companies’ annual reports and accounts by Bureau 
van Dijk – A Moody’s Analytics Company (BvD). The source 
documents, annual reports & accounts, are public 
domain documents and so the Scoreboard is capable of 
independent replication. In order to ensure consistency with 
our previous Scoreboards, BvD data for the years prior to 
2012 have been checked with the corresponding data of 
the previous Scoreboards adjusted for the corresponding 
exchange rates of the annual reports. 
Main characteristics of the data
Limitations
The data correspond to companies’ latest published 
accounts, intended to be their 2016 fiscal year accounts, 
although due to different accounting practices throughout 
the world, they also include accounts ending on a range of 
dates between late 2015 and mid-2017. Furthermore, the 
accounts of some companies are publicly available more 
promptly than others. Therefore, the current set represents 
a heterogeneous set of timed data.
In order to maximise completeness and avoid double 
counting, the consolidated group accounts of the 
ultimate parent company are used. Companies which 
are subsidiaries of any other company are not listed 
separately. Where consolidated group accounts of the 
ultimate parent company are not available, subsidiaries 
are included.
In the case of a demerger, the full history of the continuing 
entity is included. The history of the demerged company 
can only go back as far as the date of the demerger to 
avoid double counting of figures.
In case of an acquisition or merger, pro forma figures for 
the year of acquisition are used along with pro-forma 
comparative figures if available. 
The R&D investment included in the Scoreboard is the cash 
investment which is funded by the companies themselves. 
It excludes R&D undertaken under contract for customers 
such as governments or other companies. It also excludes 
the companies’ share of any associated company or 
joint venture R&D investment when disclosed. However, 
it includes research contracted out to other companies or 
public research organisations, such as universities. 
Where part or all of R&D costs have been capitalised, the 
additions to the appropriate intangible assets are included 
to calculate the cash investment and any amortisation 
eliminated.
Companies are allocated to the country of their registered 
office. In some cases this is different from the operational 
or R&D headquarters. This means that the results are 
independent of the actual location of the R&D activity. 
Companies are assigned to industry sectors according to the 
NACE Rev. 235 and the ICB (Industry Classification Benchmark). 
In the Scoreboard report we use different levels of sector 
aggregation, according to the distribution of companies’ R&D 
and depending on the issues to be illustrated. In chapter 1, 
Tables 1.2 and 1.3 describe two typical levels of the industrial 
classification applied in the Scoreboard.
35 NACE is the acronyme for “Nomenclature statistique des activités économiques dans la Communauté européenne”.
Users of the Scoreboard data should take into account the 
methodological limitations, especially when performing 
comparative analyses (see summary of main limitation in 
Box A2.1 below). 
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The Scoreboard relies on disclosure of R&D investment 
in published annual reports and accounts. Therefore, 
companies which do not disclose figures for R&D 
investment or which disclose only figures which are not 
material enough are not included in the Scoreboard. Due 
to different national accounting standards and disclosure 
practice, companies of some countries are less likely than 
others to disclose R&D investment consistently. There is 
a legal requirement to disclose R&D in company annual 
reports in some countries.
In some countries, R&D costs are very often integrated with 
other operational costs and can therefore not be identified 
separately. For example, companies from many Southern 
European countries or the new Member States are under-
represented in the Scoreboard. On the other side, UK 
companies could be over-represented in the Scoreboard. 
For listed companies, country representation will improve 
with IFRS adoption.
The R&D investment disclosed in some companies’ 
accounts follows the US practice of including engineering 
costs relating to product improvement. Where these 
engineering costs have been disclosed separately, they 
have been excluded from the Scoreboard. However, the 
incidence of non-disclosure is uncertain and the impact of 
this practice is a possible overstatement of some overseas 
R&D investment figures in comparison with the EU. 
Where R&D income can be clearly identified as a result of 
customer contracts it is deducted from the R&D expense 
stated in the annual report, so that the R&D investment 
included in the Scoreboard excludes R&D undertaken 
under contract for customers such as governments or 
other companies. However, the disclosure practise differs 
and R&D income from customer contracts cannot always 
be clearly identified. This means a possible overstatement 
of some R&D investment figures in the Scoreboard for 
companies with directly R&D related income where this is 
not disclosed in the annual report.
In implementing the definition of R&D, companies exhibit 
variability arising from a number of sources: i) different 
interpretations of the R&D definition. Some companies 
view a process as an R&D process while other companies 
may view the same process as an engineering or other 
process; ii) different companies’ information systems for 
measuring the costs associated with R&D processes; iii) 
different countries’ fiscal treatment of costs.
Interpretation
There are some fundamental aspects of the Scoreboard 
which affect their interpretation.
The focus of the Scoreboard on R&D investment as 
reported in group accounts means that the results can 
be independent of the location of the R&D activity. 
The Scoreboard indicates the level of R&D funded by 
companies, not all of which is carried out in the country in 
which the company is registered. This enables inputs such 
as R&D and Capex investment to be related to outputs 
such as Sales, Profits, productivity ratios and market 
capitalisation. 
The data used for the Scoreboard are different from data 
provided by statistical offices, e.g. the R&D expenditures 
funded by the business enterprise sector and performed 
by all sectors within a given territorial unit (BES-R&D). 
The Scoreboard refers to all R&D financed by a particular 
company from its own funds, regardless of where that 
R&D activity is performed. BES-R&D refers to all R&D 
activities funded by businesses and performed within 
a particular territory, regardless of the location of the 
business’s headquarters. Therefore, the Scoreboard 
R&D figures are directly comparable to BES-R&D 
data only at the global level.
Further, the Scoreboard collects data from audited 
financial accounts and reports. BES-R&D typically takes 
a stratified sample, covering all large companies and a 
representative sample of smaller companies. Additional 
differences concern the definition of R&D intensity (BES-
R&D uses the percentage of value added, while the 
Scoreboard measures it as the R&D/Sales ratio) and the 
sectoral classification they use (BES-R&D follows NACE, 
the European statistical classification of economic sectors, 
while the Scoreboard classifies companies’ economic 
activities according to the ICB classification).
Sudden changes in R&D figures may arise because a 
change in company accounting standards. For example, 
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36 Since 2005, the European Union requires all listed companies in the EU to prepare their consolidated financial statements according to IFRS (International Financial 
Reporting Standards, see: http://www.iasb.org/).
37 Companies from some countries report their data in US dollars, e.g. in this edition, all companies based in Israel present their results in US dollars.
the first time adoption of IFRS36, may lead to information 
discontinuities due to the different treatment of R&D, 
i.e. R&D capitalisation criteria are stricter and, where the 
criteria are met, the amounts must be capitalised. 
For many highly diversified companies, the R&D investment 
disclosed in their accounts relates only to part of their 
activities, whereas sales and profits are in respect of all their 
activities. Unless such groups disclose their R&D investment 
additional to the other information in segmental analyses, it 
is not possible to relate the R&D more closely to the results 
of the individual activities which give rise to it. The impact 
of this is that some statistics for these groups, e.g. R&D as 
a percentage of sales, are possibly underestimated and so 
comparisons with non-diversified groups are limited.
At the aggregate level, the growth statistics reflect the 
growth of the set of companies in the current year set. 
Companies which may have existed in the base year but 
which are not represented in the current year set are not 
part of the Scoreboard (a company may continue to be 
represented in the current year set if it has been acquired 
by or merged with another but will be removed for the 
following year’s Scoreboard). 
For companies outside the Euro area, all currency amounts 
have been translated at the Euro exchange rates ruling 
at 31 December 2017 as shown in Table A2.137. The 
exchange rate conversion also applies to the historical 
data. The result is that over time the Scoreboard reflects 
the domestic currency results of the companies rather than 
economic estimates of current purchasing parity results. 
The original domestic currency data can be derived simply 
by reversing the translations at the rates above. Users can 
then apply their own preferred current purchasing parity 
transformation models. 
Country As of 31 Dec 2016 As of 31 Dec 2017
Australia $ 1.46 $ 1.54
Brazil 3.43 Brazilian real 3.97 Brazilian real
Canada $ 1.42 $ 1.51
China 7.33 Renminbi 7.81 Renminbi
Czech Republic 27.03 Koruna 25.54 Koruna
Denmark 7.43 Danish Kronor 7.44 Danish Kronor
Hungary 309.6 Forint 310.6 Forint
Hong Kong 8.33 HKD 9.37 HKD
India 71.63 Indian Rupee 76.69 Indiana Rupee
Iraq 1250 IQD 1428.57 IQD
Japan 123.15 Yen 135.32 Yen
Malaysia 4.72 Ringgit 4.87 Ringgit
Mexico 21.85 Mexican Peso 23.73 Mexican Peso
New Zeland 1.52 NZD 1.69 NZD
Norway 9.09 Norwegian Kronor 9.85 Norwegian Kronor
Poland 4.41 Zloty 4.18 Zloty
Russia 63.94 Rouble 69.06 Rouble
Saudi Arabia 3.95 SAR 4.50 SAR
Singapore 1.52 SGD 1.60 SGD
South Africa 14.42 ZAR 14.79 ZAR
South Korea 1265.82 Won 1282.05 Won
Sweden 9.55 Swedish Kronor 9.84 Swedish Kronor
Switzerland 1.07 Swiss Franc 1.17 Swiss Franc
Taiwan $ 34.05 new dollar $ 35.79 new dollar
Thailand 37.71 THB 39.20 THB
Turkey 3.17 Turkish lira 4.53 Turkish lira
UK £ 0.86 £ 0.89
US $ 1.05 $ 1.20
United Arab Emirates 3.86 Dirham 4.40 Dirham
TABLE A2.1: EURO EXCHANGE RATES APPLIED TO SCOREBOARD DATA FOR COMPANIES REPORTING IN DIFFERENT CURRENCIES (AS OF 31 DEC 2017).
Source: The 2018 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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Box A2.1 
Methodological caveats
Users of Scoreboard data should take into account 
the methodological limitations summarised here, 
especially when performing comparative analyses: 
A typical problem arises when comparing data 
from different currency areas. The Scoreboard data 
are nominal and expressed in Euros with all foreign 
currencies converted at the exchange rate of the 
year-end closing date (31.12.2017). The variation 
in the exchange rates from the previous year directly 
affects the ranking of companies, favouring those 
based in countries whose currency has appreciated 
with respect to the other currencies. In this reporting 
period, the exchange rate of the Euro appreciated 
by 14% and 10% against the US dollar and the 
Japanese Yen respectively, and appreciated by 3% 
against the pound sterling. However, ratios such as 
R&D intensity or profitability (profit as % sales) are 
based on the ratio of two quantities taken from a 
company report where they are both expressed in 
the same currency and are therefore less affected 
by currency changes.
The growth rate of the different indicators for 
companies operating in markets with different 
currencies is affected in a different manner. In fact, 
companies’ consolidated accounts have to include 
the benefits and/or losses due to the appreciation 
and/or depreciation of their investments abroad. 
The result is an ‘apparent’ rate of growth of the 
given indicator that understates or overstates the 
actual rate of change. For example, this year the 
R&D growth rate of companies based in the Euro 
area with R&D investments in the US is partly 
understated because the ‘losses’ of their overseas 
investments due to the appreciation of the Euro 
against the US dollar (from $1.05 to $1.2). 
Conversely, the R&D growth rate of US companies 
is partly overstated due to the ‘benefits’ of their 
investments in the Euro area. Similar effects of 
understating or overstating figures would happen 
for the growth rates of other indicators, such as net 
sales. 
When analysing data aggregated by country or 
sector, be aware that in many cases, the aggregate 
indicator depends on the figures of a few firms. 
This is due, either to the country’s or sector’s 
small number of firms in the Scoreboard or to the 
indicator dominated by a few large firms.
The different editions of the Scoreboard are not 
directly comparable because of the year-on-
year change in the composition of the sample of 
companies, i.e. due to newcomers and leavers. 
Every Scoreboard comprises data of several 
financial years (8 years since 2012 and 10 years 
since 2017) allowing analysis of trends for the 
same sample of companies.
In most cases companies’ accounts do not include 
information on the place where R&D is actually 
performed; consequently the approach taken in 
the Scoreboard is to attribute each company’s 
total R&D investment to the country in which the 
company has its registered office or shows its 
main economic activity. This should be borne in 
mind when interpreting the Scoreboard’s country 
classification and analyses.
Growth in R&D can either be organic, the outcome 
of acquisitions or a combination of the two. 
Consequently, mergers and acquisitions (or de-
mergers) may sometimes underlie sudden changes 
in specific companies’ R&D and sales growth rates 
and/or positions in the rankings. 
Other important factors to take into account include 
the difference in the various countries’ (or sectors’) 
business cycles which may have a significant impact 
on companies’ investment decisions, and the initial 
adoption or stricter application of the International 
Financial Reporting Standards (IFRS)38. 
38 Since 2005, the European Union requires all listed companies in the EU to prepare their consolidated financial statements according to IFRS (see: EC Regulation No 
1606/2002 of the European Parliament and of the Council of 19 July 2002 on the application of international accounting standards at http://eur-lex.europa.eu/LexUriServ/
LexUriServ.do?uri=CELEX:32002R1606:EN:HTML).
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1. Research and Development (R&D) investment 
in the Scoreboard is the cash investment funded 
by the companies themselves. It excludes R&D 
undertaken under contract for customers such as 
governments or other companies. It also excludes the 
companies’ share of any associated company or joint 
venture R&D investment. However, it includes research 
contracted out to other companies or public research 
organisations, such as universities. Being that disclosed 
in the annual report and accounts, it is subject to the 
accounting definitions of R&D. For example, a definition 
is set out in International Accounting Standard (IAS) 
38 “Intangible assets” and is based on the OECD 
“Frascati” manual. Research is defined as original and 
planned investigation undertaken with the prospect 
of gaining new scientific or technical knowledge and 
understanding. Expenditure on research is recognised 
as an expense when it is incurred. Development is 
the application of research findings or other knowledge 
to a plan or design for the production of new or 
substantially improved materials, devices, products, 
processes, systems or services before the start of 
commercial production or use. Development costs are 
capitalised when they meet certain criteria and when 
it can be demonstrated that the asset will generate 
probable future economic benefits. Where part or all of 
R&D costs have been capitalised, the additions to the 
appropriate intangible assets are included to calculate 
the cash investment and any amortisation eliminated.
2. R&D expenditures funded by the business enterprise 
sector (BES-R&D), provided by official statistics, refer 
to the total R&D performed within a territorial unit that 
has been funded by the business enterprise sector 
(private or public companies).
3. Net sales follow the usual accounting definition of 
sales, excluding sales taxes and shares of sales of joint 
ventures & associates. For banks, sales are defined 
as the “Total (operating) income” plus any insurance 
income. For insurance companies, sales are defined as 
“Gross premiums written” plus any banking income.
4. R&D intensity is the ratio between R&D investment 
and net sales of a given company or group of 
companies. At the aggregate level, R&D intensity is 
calculated only by those companies for which data 
exist for both R&D and net sales in the specified year. 
The calculation of R&D intensity in the Scoreboard is 
different from than in official statistics, e.g. BES-R&D, 
where R&D intensity is based on value added instead 
of net sales. 
5. Operating profit is calculated as profit (or loss) 
before taxation, plus net interest cost (or minus net 
interest income) minus government grants, less gains 
(or plus losses) arising from the sale/disposal of 
businesses or fixed assets.
6. One-year growth is simple growth over the previous 
year, expressed as a percentage: 1 yr growth = 
100*((C/B)-1); where C = current year amount, and B 
= previous year amount. 1yr growth is calculated only 
if data exist for both the current and previous year. At 
the aggregate level, 1yr growth is calculated only by 
aggregating those companies for which data exist for 
both the current and previous year.
7. Capital expenditure (Capex) is expenditure used 
by a company to acquire or upgrade physical assets 
such as equipment, property, industrial buildings. In 
accounts capital expenditure is added to an asset 
account (i.e. capitalised), thus increasing the asset’s 
base. It is disclosed in accounts as additions to tangible 
fixed assets.
8. Number of employees is the total consolidated 
average employees or year-end employees if average 
not stated.
Glossary
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The analysis of chapter 5 applies an extended sample 
of 1000 companies based in the EU. It consists of 577 
companies included in the world R&D ranking of top 2500 
companies and additional 423 companies also ranked by 
level of R&D investment. The composition by country and 
industry of the EU 1000 sample is presented in the table 
A3.2 below.
Complementary tablesA .3
Rank Sector
R&D in 
2017/18, 
€ bn
One-
year 
change, 
%
Net  
Sales,  
€ bn
One-
year 
change, 
%
R&D 
intensity, 
%
Operating 
profits, 
€ bn
One-
year 
change, 
%
Profita-
bility, %
Employees, 
million
One-
year 
change, 
%
1 Pharmaceuticals & 
Biotechnology
138.9 7.6 911.7 5.1 15.0 132.0 -10.6 14.9 2.5 2.3
2 Technology 
Hardware & 
Equipment
117.2 10.8 1348.4 10.7 8.7 177.9 18.4 14.0 3.7 1.2
3 Automobiles & Parts 117.0 7.1 2590.4 7.3 4.5 167.5 10.8 6.5 7.4 3.7
4 Software & 
Computer Services
94.4 13.6 1116.8 14.3 8.4 171.7 17.4 15.4 3.7 5.9
5 Electronic & 
Electrical Equipment
57.3 12.4 1174.1 10.0 4.9 126.6 32.9 10.8 5.0 3.7
6 Industrial 
Engineering
26.7 6.1 828.6 8.8 3.2 73.4 38.1 9.1 3.3 2.9
7 Chemicals 21.5 5.1 826.8 13.1 2.6 100.1 17.4 12.2 1.7 1.7
8 General Industrials 20.0 -0.6 689.7 6.0 2.9 50.8 -9.2 7.4 2.3 -4.1
9 Aerospace & 
Defence
19.0 -4.3 474.8 2.4 4.0 48.8 21.9 10.3 1.6 0.1
10 Health Care 
Equipment & 
Services
14.7 8.5 404.8 6.7 3.6 35.2 2.5 8.7 1.3 6.4
11 Leisure Goods 14.0 1.7 249.9 10.5 5.6 21.2 38.6 8.5 0.8 0.2
12 Construction & 
Materials
13.0 12.1 944.0 7.7 1.4 85.0 54.2 9.0 3.1 1.7
13 Banks 10.3 2.2 386.9 2.3 2.7 104.0 55.4 30.8 1.6 4.7
14 Fixed Line 
Telecommunications
8.4 4.9 490.4 0.8 1.7 66.2 4.0 13.7 1.3 -0.9
15 Oil & Gas Producers 7.9 2.4 2119.3 21.3 0.4 122.9 274.1 5.8 2.2 -1.9
Total 39 industries 736.4 8.3 18448.0 9.8 4.0 1909.3 22.6 10.5 55.0 2.1
TABLE A3.1: MAIN STATISTICS FOR THE 2018 SCOREBOARD SAMPLE OF WORLD COMPANIES AGGREGATED BY INDUSTRIAL SECTORS (TOP 15 SECTORS, ICB 3-DIGITS).
Source: The 2018 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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Industry
Country codes
AT BE CZ DE DK ES FI FR GR HU IE IT LU MT NL PL PT SE SI UK Total
Aerospace & Defence 1 3 1 1 5 1 2 1 9 24
Alternative Energy 3 2 1 6
Automobiles & Parts 3 20 1 1 5 5 3 3 8 49
Banks 2 5 2 1 1 2 2 2 2 2 3 24
Beverages 1 1 2 4
Chemicals 2 3 15 2 2 3 1 3 10 41
Construction & Materials 3 3 7 1 4 2 4 2 1 1 1 3 3 35
Electricity 1 1 1 1 2 2 1 2 1 1 3 16
Electronic & Electrical Equipment 3 3 15 2 3 8 1 4 2 5 4 15 65
Financial Services 5 1 1 1 3 3 14
Fixed Line Telecommunications 1 1 1 1 1 1 1 1 8
Food & Drug Retailers 1 3 4
Food Producers 1 2 1 2 3 2 5 9 25
Forestry & Paper 1 3 1 1 6
Gas, Water & Multiutilities 1 2 1 3 1 4 12
General Industrials 1 1 13 1 1 1 1 1 2 5 7 34
General Retailers 1 5 2 9 17
Health Care Equipment & Services 1 11 3 4 2 1 3 12 37
Household Goods & Home Construction 6 1 3 2 1 1 1 3 18
Industrial Engineering 5 1 34 2 2 7 9 2 7 2 5 11 8 95
Industrial Metals & Mining 2 4 4 1 1 1 3 1 2 19
Industrial Transportation 1 1 3 2 1 2 10
Leisure Goods 1 2 1 1 1 3 9
Life Insurance 1 2 3
Media 5 1 7 13
Mining 1 2 2 5
Mobile Telecommunications 1 2 1 3 7
Nonlife Insurance 1 1 1 3
Oil & Gas Producers 1 1 1 1 1 3 8
Oil Equipment, Services & Distribution 1 1 1 1 4
Personal Goods 5 2 4 1 12
Pharmaceuticals & Biotechnology 1 9 14 12 4 2 22 1 1 10 5 9 1 1 11 1 50 154
Real Estate Investment & Services 1 4 3 1 2 1 5 17
Software & Computer Services 2 19 6 2 4 17 1 3 1 6 48 109
Support Services 1 10 1 1 1 1 2 20 37
Technology Hardware & Equipment 3 2 6 2 1 4 1 1 5 7 11 43
Tobacco 1 1 2
Travel & Leisure 1 3 1 1 1 4 11
Total 32 34 2 219 42 20 36 111 3 1 27 39 18 1 53 4 4 77 2 275 1000
TABLE A3.2: DISTRIBUTION OF THE SAMPLE OF 1000 COMPANIES BASED IN THE EU BY COUNTRY AND INDUSTRY.
Source: The 2018 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD.
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The 2018 Scoreboard comprises two data samples:
• The world’s top 2500 companies that invested 
more than €25 million in R&D in 2017/18.
• The top 1000 R&D investing companies based in 
the EU with R&D investment exceeding €8 million.
For each company the following information is available: 
• Company identification (name, country of regis-
tration and sector of declared activity according 
to the Scoreboard sector classification).
• R&D investment 
• Net Sales 
• Capital expenditure 
• Operating profit or loss 
• Total number of employees
• Market capitalisation (for listed companies)
• Main company indicators (R&D intensity, Capex 
intensity, Profitability)
• Growth rates of main indicators over one year.
The following links provide access to the two Scoreboard 
data samples containing the main economic and financial 
indicators and main statistics over the past year.
 R&D ranking of world top 2500 companies
 R&D ranking of EU top 1000 companies
Access to the full datasetA .4
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